<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74777</article-id><article-id pub-id-type="doi">10.7554/eLife.74777</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Diverse ancestry whole-genome sequencing association study identifies <italic>TBX5</italic> and <italic>PTK7</italic> as susceptibility genes for posterior urethral valves</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-257295"><name><surname>Chan</surname><given-names>Melanie MY</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1968-1734</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-259514"><name><surname>Sadeghi-Alavijeh</surname><given-names>Omid</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-113809"><name><surname>Lopes</surname><given-names>Filipa M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-259515"><name><surname>Hilger</surname><given-names>Alina C</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-259520"><name><surname>Stanescu</surname><given-names>Horia C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-259518"><name><surname>Voinescu</surname><given-names>Catalin D</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3636-8689</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-259516"><name><surname>Beaman</surname><given-names>Glenda M</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-113876"><name><surname>Newman</surname><given-names>William G</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-259525"><name><surname>Zaniew</surname><given-names>Marcin</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-113865"><name><surname>Weber</surname><given-names>Stefanie</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-289227"><name><surname>Ho</surname><given-names>Yee Mang</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-259522"><name><surname>Connolly</surname><given-names>John O</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-259521"><name><surname>Wood</surname><given-names>Dan</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-289228"><name><surname>Maj</surname><given-names>Carlo</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-259524"><name><surname>Stuckey</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-259523"><name><surname>Kousathanas</surname><given-names>Athanasios</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author"><collab>Genomics England Research Consortium<contrib-group><contrib><name><surname>Ambrose</surname><given-names>JC</given-names></name></contrib><contrib><name><surname>Arumugam</surname><given-names>P</given-names></name></contrib><contrib><name><surname>Bevers</surname><given-names>R</given-names></name></contrib><contrib><name><surname>Bleda</surname><given-names>M</given-names></name></contrib><contrib><name><surname>Boardman-Pretty</surname><given-names>F</given-names></name></contrib><contrib><name><surname>Boustred</surname><given-names>CR</given-names></name></contrib><contrib><name><surname>Brittain</surname><given-names>H</given-names></name></contrib><contrib><name><surname>Brown</surname><given-names>MA</given-names></name></contrib><contrib><name><surname>Caulfield</surname><given-names>MJ</given-names></name></contrib><contrib><name><surname>Chan</surname><given-names>GC</given-names></name></contrib><contrib><name><surname>Giess</surname><given-names>A</given-names></name></contrib><contrib><name><surname>Griffin</surname><given-names>JN</given-names></name></contrib><contrib><name><surname>Hamblin</surname><given-names>A</given-names></name></contrib><contrib><name><surname>Henderson</surname><given-names>S</given-names></name></contrib><contrib><name><surname>Hubbard</surname><given-names>TJP</given-names></name></contrib><contrib><name><surname>Jackson</surname><given-names>R</given-names></name></contrib><contrib><name><surname>Jones</surname><given-names>LJ</given-names></name></contrib><contrib><name><surname>Kasperaviciute</surname><given-names>D</given-names></name></contrib><contrib><name><surname>Kayikci</surname><given-names>M</given-names></name></contrib><contrib><name><surname>Kousathanas</surname><given-names>A</given-names></name></contrib><contrib><name><surname>Lahnstein</surname><given-names>L</given-names></name></contrib><contrib><name><surname>Lakey</surname><given-names>A</given-names></name></contrib><contrib><name><surname>Leigh</surname><given-names>SEA</given-names></name></contrib><contrib><name><surname>Leong</surname><given-names>IUS</given-names></name></contrib><contrib><name><surname>Lopez</surname><given-names>FJ</given-names></name></contrib><contrib><name><surname>Maleady-Crowe</surname><given-names>F</given-names></name></contrib><contrib><name><surname>McEntagart</surname><given-names>M</given-names></name></contrib><contrib><name><surname>Minneci</surname><given-names>F</given-names></name></contrib><contrib><name><surname>Mitchell</surname><given-names>J</given-names></name></contrib><contrib><name><surname>Moutsianas</surname><given-names>L</given-names></name></contrib><contrib><name><surname>Mueller</surname><given-names>M</given-names></name></contrib><contrib><name><surname>Murugaesu</surname><given-names>N</given-names></name></contrib><contrib><name><surname>Need</surname><given-names>AC</given-names></name></contrib><contrib><name><surname>O'Donovan</surname><given-names>P</given-names></name></contrib><contrib><name><surname>Odhams</surname><given-names>CA</given-names></name></contrib><contrib><name><surname>Patch</surname><given-names>C</given-names></name></contrib><contrib><name><surname>Perez-Gil</surname><given-names>D</given-names></name></contrib><contrib><name><surname>Pereira</surname><given-names>MB</given-names></name></contrib><contrib><name><surname>Pullinger</surname><given-names>J</given-names></name></contrib><contrib><name><surname>Rahim</surname><given-names>T</given-names></name></contrib><contrib><name><surname>Rendon</surname><given-names>A</given-names></name></contrib><contrib><name><surname>Rogers</surname><given-names>T</given-names></name></contrib><contrib><name><surname>Savage</surname><given-names>K</given-names></name></contrib><contrib><name><surname>Sawant</surname><given-names>K</given-names></name></contrib><contrib><name><surname>Scott</surname><given-names>RH</given-names></name></contrib><contrib><name><surname>Siddiq</surname><given-names>A</given-names></name></contrib><contrib><name><surname>Sieghart</surname><given-names>A</given-names></name></contrib><contrib><name><surname>Smith</surname><given-names>SC</given-names></name></contrib><contrib><name><surname>Sosinsky</surname><given-names>A</given-names></name></contrib><contrib><name><surname>Stuckey</surname><given-names>A</given-names></name></contrib><contrib><name><surname>Tanguy</surname><given-names>M</given-names></name></contrib><contrib><name><surname>Taylor Tavares</surname><given-names>AL</given-names></name></contrib><contrib><name><surname>Thomas</surname><given-names>ERA</given-names></name></contrib><contrib><name><surname>Thompson</surname><given-names>SR</given-names></name></contrib><contrib><name><surname>Tucci</surname><given-names>A</given-names></name></contrib><contrib><name><surname>Welland</surname><given-names>MJ</given-names></name></contrib><contrib><name><surname>Williams</surname><given-names>E</given-names></name></contrib><contrib><name><surname>Witkowska</surname><given-names>K</given-names></name></contrib><contrib><name><surname>Wood</surname><given-names>SM</given-names></name></contrib><contrib><name><surname>Zarowiecki</surname><given-names>M</given-names></name></contrib></contrib-group></collab><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160350"><name><surname>Kleta</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-89681"><name><surname>Woolf</surname><given-names>Adrian S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5541-1358</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-259517"><name><surname>Bockenhauer</surname><given-names>Detlef</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-259519"><name><surname>Levine</surname><given-names>Adam P</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-251727"><name><surname>Gale</surname><given-names>Daniel P</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9170-1579</contrib-id><email>d.gale@ucl.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>Department of Renal Medicine, University College London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/027m9bs27</institution-id><institution>Division of Cell Matrix Biology &amp; Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester</institution></institution-wrap><addr-line><named-content content-type="city">Manchester</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/041nas322</institution-id><institution>Children's Hospital, University of Bonn</institution></institution-wrap><addr-line><named-content content-type="city">Bonn</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/041nas322</institution-id><institution>Institute of Human Genetics, University of Bonn</institution></institution-wrap><addr-line><named-content content-type="city">Bonn</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00he80998</institution-id><institution>Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust</institution></institution-wrap><addr-line><named-content content-type="city">Manchester</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/027m9bs27</institution-id><institution>Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester</institution></institution-wrap><addr-line><named-content content-type="city">Manchester</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04fzm7v55</institution-id><institution>Department of Pediatrics, University of Zielona Góra</institution></institution-wrap><addr-line><named-content content-type="city">Zielona Gora</named-content></addr-line><country>Poland</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01rdrb571</institution-id><institution>Department of Pediatric Nephrology, University of Marburg</institution></institution-wrap><addr-line><named-content content-type="city">Marburg</named-content></addr-line><country>Germany</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/042fqyp44</institution-id><institution>Department of Adolescent Urology, University College London Hospitals NHS Foundation Trust</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01rdrb571</institution-id><institution>Center for Human Genetics, University of Marburg</institution></institution-wrap><addr-line><named-content content-type="city">Marburg</named-content></addr-line><country>Germany</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/041nas322</institution-id><institution>Institute for Genomic Statistics and Bioinformatics, Medical Faculty, University of Bonn</institution></institution-wrap><addr-line><named-content content-type="city">Bonn</named-content></addr-line><country>Germany</country></aff><aff id="aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/026zzn846</institution-id><institution>Genomics England, Queen Mary University of London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03zydm450</institution-id><institution>Nephrology Department, Great Ormond Street Hospital for Children NHS Foundation Trust</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00he80998</institution-id><institution>Royal Manchester Children’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre</institution></institution-wrap><addr-line><named-content content-type="city">Manchester</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>Research Department of Pathology, University College London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Germino</surname><given-names>Gregory G</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Pollak</surname><given-names>Martin R</given-names></name><role>Senior Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>20</day><month>09</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e74777</elocation-id><history><date date-type="received" iso-8601-date="2021-10-17"><day>17</day><month>10</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-08-15"><day>15</day><month>08</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-08-10"><day>10</day><month>08</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.08.09.21261801"/></event></pub-history><permissions><copyright-statement>© 2022, Chan et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Chan et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74777-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-74777-figures-v2.pdf"/><abstract><p>Posterior urethral valves (PUV) are the commonest cause of end-stage renal disease in children, but the genetic architecture of this rare disorder remains unknown. We performed a sequencing-based genome-wide association study (seqGWAS) in 132 unrelated male PUV cases and 23,727 controls of diverse ancestry, identifying statistically significant associations with common variants at 12q24.21 (p=7.8 × 10<sup>−12</sup>; OR 0.4) and rare variants at 6p21.1 (p=2.0 × 10<sup>-8</sup>; OR 7.2), that were replicated in an independent European cohort of 395 cases and 4151 controls. Fine mapping and functional genomic data mapped these loci to the transcription factor <italic>TBX5</italic> and planar cell polarity gene <italic>PTK7</italic>, respectively, the encoded proteins of which were detected in the developing urinary tract of human embryos. We also observed enrichment of rare structural variation intersecting with candidate <italic>cis</italic>-regulatory elements, particularly inversions predicted to affect chromatin looping (p=3.1 × 10<sup>-5</sup>). These findings represent the first robust genetic associations of PUV, providing novel insights into the underlying biology of this poorly understood disorder and demonstrate how a diverse ancestry seqGWAS can be used for disease locus discovery in a rare disease.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>whole-genome sequencing</kwd><kwd>genome-wide association study</kwd><kwd>seqGWAS</kwd><kwd>CAKUT</kwd><kwd>PUV</kwd><kwd>posterior urethral valves</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000291</institution-id><institution>Kidney Research UK</institution></institution-wrap></funding-source><award-id>TF_004_20161125</award-id><principal-award-recipient><name><surname>Chan</surname><given-names>Melanie MY</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/S021329/1</award-id><principal-award-recipient><name><surname>Sadeghi-Alavijeh</surname><given-names>Omid</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/T016809/1</award-id><principal-award-recipient><name><surname>Woolf</surname><given-names>Adrian S</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000388</institution-id><institution>St Peter’s Trust for Kidney Bladder &amp; Prostate Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gale</surname><given-names>Daniel P</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>National Institute for Health and Care Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Levine</surname><given-names>Adam P</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000291</institution-id><institution>Kidney Research UK</institution></institution-wrap></funding-source><award-id>Paed_RP_002_20190925</award-id><principal-award-recipient><name><surname>Beaman</surname><given-names>Glenda M</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>BONFOR-Gerok Grant</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Hilger</surname><given-names>Alina C</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A genome-wide association study using whole-genome sequencing data identifies the first known susceptibility genes for posterior urethral valves, the most common cause of kidney failure in boys, implicating the transcription factor <italic>TBX5</italic> and planar cell polarity gene <italic>PTK7</italic>.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Posterior urethral valves (PUV) are the commonest cause of end-stage renal disease (ESRD) in children, affecting 1 in 4000 male births (<xref ref-type="bibr" rid="bib8">Brownlee et al., 2019</xref>; <xref ref-type="bibr" rid="bib85">Thakkar et al., 2015</xref>) and result in congenital bladder outflow obstruction. It is an exclusively male disorder, with over a third of those affected developing ESRD (i.e., requirement for dialysis or kidney transplantation) before the age of 30 years (<xref ref-type="bibr" rid="bib34">Heikkilä et al., 2011</xref>; <xref ref-type="bibr" rid="bib74">Sanna-Cherchi et al., 2009</xref>) and often associated with renal dysplasia, vesicoureteral reflux, and bladder dysfunction which are poor prognostic factors for renal survival (<xref ref-type="bibr" rid="bib74">Sanna-Cherchi et al., 2009</xref>). Management involves endoscopic valve ablation to relieve the obstruction, however the majority of affected children have long-term sequelae related to ongoing bladder dysfunction (<xref ref-type="bibr" rid="bib19">DeFoor et al., 2008</xref>).</p><p>The pathogenesis of PUV is poorly understood (<xref ref-type="bibr" rid="bib46">Krishnan et al., 2006</xref>). Although usually sporadic, familial clustering and twin studies suggest an underlying genetic component, although Mendelian inheritance is rare (<xref ref-type="bibr" rid="bib13">Chiaramonte et al., 2016</xref>; <xref ref-type="bibr" rid="bib29">Frese et al., 2019</xref>; <xref ref-type="bibr" rid="bib60">Morini et al., 2002</xref>; <xref ref-type="bibr" rid="bib77">Schreuder et al., 2008</xref>; <xref ref-type="bibr" rid="bib94">Weber et al., 2005</xref>). Several monogenic causes of other congenital bladder outflow obstruction disorders have been described including <italic>BNC2</italic> in urethral stenosis (<xref ref-type="bibr" rid="bib44">Kolvenbach et al., 2019</xref>); <italic>FLNA</italic> in syndromic urethral anomalies (<xref ref-type="bibr" rid="bib89">Wade et al., 2021</xref>); <italic>HPSE2</italic> and <italic>LRIG2</italic> in urofacial syndrome (<xref ref-type="bibr" rid="bib16">Daly et al., 2010</xref>; <xref ref-type="bibr" rid="bib80">Stuart et al., 2008</xref>); <italic>CHRM3</italic> in prune-belly like syndrome (<xref ref-type="bibr" rid="bib95">Weber et al., 2011</xref>); and <italic>MYOCD</italic> in megabladder (<xref ref-type="bibr" rid="bib37">Houweling et al., 2011</xref>). However, a monogenic etiology for isolated PUV has not been identified. Case reports of chromosomal abnormalities resulting in PUV as part of a wider syndrome (<xref ref-type="bibr" rid="bib20">Demirkan, 2021</xref>; <xref ref-type="bibr" rid="bib36">Houcinat et al., 2011</xref>; <xref ref-type="bibr" rid="bib86">Tong et al., 2015</xref>) and microarray-based studies linking rare copy number variants (CNVs) with PUV (<xref ref-type="bibr" rid="bib5">Boghossian et al., 2016</xref>; <xref ref-type="bibr" rid="bib9">Caruana et al., 2016</xref>; <xref ref-type="bibr" rid="bib26">Faure et al., 2016</xref>; <xref ref-type="bibr" rid="bib75">Schierbaum et al., 2021</xref>; <xref ref-type="bibr" rid="bib88">Verbitsky et al., 2019</xref>) suggest that structural variation, and in particular duplications (<xref ref-type="bibr" rid="bib75">Schierbaum et al., 2021</xref>; <xref ref-type="bibr" rid="bib88">Verbitsky et al., 2019</xref>), may be important, but no recurrent CNVs have demonstrated consistent association with PUV. The observation that isolated PUV does not usually follow a classical Mendelian inheritance pattern, and that a monogenic cause has not been identified, suggests that the underlying genetic architecture of this rare disorder is likely to be complex.</p><p>Here, we used whole-genome sequencing (WGS) data from a diverse ancestry cohort to perform a sequencing-based genome-wide association study (seqGWAS) investigating how common, low-frequency, and rare single-nucleotide and structural variation contribute to this complex disorder. The recently proposed term seqGWAS is used to distinguish this approach from the well-established genome-wide association study (GWAS) design based on sampling of common variation across the genome using high-throughput single-nucleotide polymorphism genotyping with or without imputation (<xref ref-type="bibr" rid="bib57">McMahon et al., 2021</xref>). Our seqGWAS identified significant associations with common and rare variation that implicated <italic>TBX5</italic> (T-Box Transcription Factor 5) and <italic>PTK7</italic> (Protein Tyrosine Kinase 7), respectively, as well as enrichment of structural variation affecting candidate <italic>cis</italic>-regulatory elements (cCREs). In addition, we demonstrate that a well-controlled diverse ancestry sequencing-based GWAS can increase power for disease locus discovery and facilitate the fine mapping of causal variants.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>We analysed WGS data from 132 unrelated male probands with PUV and 23,727 non-PUV controls (unaffected relatives without known kidney disease), recruited to the UK’s 100,000 Genomes Project (100KGP) (<xref ref-type="bibr" rid="bib79">Smedley et al., 2021</xref>; see <xref ref-type="fig" rid="fig1">Figure 1</xref> for study workflow). The available dataset (version 10) combined WGS data, clinical phenotypes standardized using Human Phenotype Ontology (HPO) codes, and comprehensive hospital clinical records for 89,139 individuals with cancer, rare disease, and their unaffected relatives. None of the cases included had received a definitive genetic diagnosis through the clinical arm of the 100KGP. Two individuals had a pathogenic and likely pathogenic variant affecting <italic>HNF1B</italic> and <italic>FOXC1,</italic> respectively<italic>,</italic> but these were not considered causal for PUV (see Appendix 1). Given the small number of recruited cases with this rare disorder, we chose to jointly analyse individuals from diverse ancestral backgrounds, thereby preserving sample size and boosting power. To mitigate confounding due to population structure whilst using this mixed-ancestry approach, we performed ancestry-matching of cases and controls using weighted principal components (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) and utilized SAIGE which employs a scalable generalized logistic mixed model (GLMM) to account for relatedness between individuals and a saddlepoint approximation to avoid inflated type I error seen with case-control imbalance (<xref ref-type="bibr" rid="bib99">Zhou et al., 2016a</xref>). Clinical characteristics and genetic ancestry of the cases and controls are detailed in <xref ref-type="table" rid="table1"><ext-link ext-link-type="uri" xlink:href="https://docs.google.com/spreadsheets/u/0/d/1OsX07dq2NEP3Cq4U0pDBtt5i43WGnQCle6Ek8ssFU1Y/edit">Table 1</ext-link></xref>.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Study workflow.</title><p>The flowchart shows the number of samples included at each stage of filtering, the analytical strategies employed, and the main findings (blue boxes). PUV, posterior urethral valves; MAF, minor allele frequency; GWAS, genome-wide association study; EUR, European; cCRE, candidate <italic>cis</italic>-regulatory element.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Principal component analysis (PCA) showing the first eight principal components for matched cases (blue) and controls (black) and unmatched cases (orange) and controls (grey).</title><p>Two cases and 2579 controls were excluded from downstream analyses.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig1-figsupp1-v2.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Clinical characteristics and genetic ancestry of the discovery cohort.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top"/><th align="left" valign="top"/><th align="left" valign="top">PUV (n=132)</th><th align="left" valign="top">Controls (n=23,727)</th></tr></thead><tbody><tr><td align="left" valign="top"><bold>Median age (range</bold>)</td><td align="left" valign="top"/><td align="char" char="." valign="top">13 (2–66)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><bold>Males (%</bold>)</td><td align="left" valign="top"/><td align="char" char="." valign="top">132 (100)</td><td align="char" char="." valign="top">10,425 (43.9)</td></tr><tr><td align="left" valign="top"><bold>PCA determined ancestry</bold></td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">EUR (%)</td><td align="char" char="." valign="top">89 (67.4)</td><td align="char" char="." valign="top">19,418 (81.8)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">SAS (%)</td><td align="char" char="." valign="top">18 (13.6)</td><td align="char" char="." valign="top">2847 (12.0)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">AFR (%)</td><td align="char" char="." valign="top">11 (8.3)</td><td align="char" char="." valign="top">449 (1.9)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">AMR (%)</td><td align="char" char="." valign="top">0 (0)</td><td align="char" char="." valign="top">7 (0.03)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Admixed (%)</td><td align="char" char="." valign="top">14 (10.6)</td><td align="char" char="." valign="top">1006 (4.2)</td></tr><tr><td align="left" valign="top"><bold>Additional renal/urinary phenotypes</bold></td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Hydronephrosis (%)</td><td align="char" char="." valign="top">56 (42.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Bladder abnormality (%)</td><td align="char" char="." valign="top">32 (24.2)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Hydroureter (%)</td><td align="char" char="." valign="top">30 (22.7)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">VUR (%)</td><td align="char" char="." valign="top">27 (20.5)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Renal dysplasia (%)</td><td align="char" char="." valign="top">16 (12.1)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Hypertension (%)</td><td align="char" char="." valign="top">11 (8.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Renal agenesis (%)</td><td align="char" char="." valign="top">8 (6.1)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Recurrent UTIs (%)</td><td align="char" char="." valign="top">5 (3.8)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Renal hypoplasia (%)</td><td align="char" char="." valign="top">4 (3.0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Renal duplication (%)</td><td align="char" char="." valign="top">2 (1.5)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><bold>Extrarenal manifestations (%</bold>)</td><td align="left" valign="top"/><td align="char" char="." valign="top">35 (26.5)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Cardiac anomaly (%)</td><td align="char" char="." valign="top">4 (3.0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Neurodevelopmental disorder (%)</td><td align="char" char="." valign="top">7 (5.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><bold>Family history (%</bold>)</td><td align="left" valign="top"/><td align="char" char="." valign="top">5 (3.8)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><bold>End-stage renal disease (%</bold>)</td><td align="left" valign="top"/><td align="char" char="." valign="top">23 (17.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><bold>Median age ESRD (range</bold>)</td><td align="left" valign="top"/><td align="char" char="." valign="top">14 (0–39)</td><td align="left" valign="top"/></tr></tbody></table><table-wrap-foot><fn><p>PUV, posterior urethral valves; PCA, principal component analysis; EUR, European; SAS, South Asian; AFR, African; AMR, Latino/Admixed American; VUR, vesico-ureteral reflux; UTI, urinary tract infection; ESRD, end-stage renal disease.</p></fn></table-wrap-foot></table-wrap><sec id="s2-1"><title>Variation at 12q24.21 and 6p21.1 is associated with PUV</title><p>To determine the contribution of common and low-frequency variation to PUV, we carried out a seqGWAS using 19,651,224 single-nucleotide variants (SNVs) and indels with minor allele frequency (MAF) ≥0.1%. Statistically significant (p&lt;5 × 10<sup>–8</sup>) association was detected at two loci (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="table" rid="table2">Table <ext-link ext-link-type="uri" xlink:href="https://docs.google.com/document/u/0/d/1j0rDePlUzsai1ukWHdYFC0GNO_zeBWjIWkAUhVb8Ej4/edit">2</ext-link></xref>). The genomic inflation factor (λ) of 1.04 confirmed population stratification was well controlled in this diverse ancestry cohort, although this may represent an underestimate given the low power of the cohort (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Manhattan plot for mixed-ancestry sequencing-based genome-wide association study (seqGWAS).</title><p>A genome-wide single-variant association study was carried out in 132 unrelated posterior urethral valves (PUV) cases and 23,727 controls for 19,651,224 variants with minor allele frequency (MAF) &gt;0.1%. Chromosomal position (GRCh38) is denoted along the x axis and strength of association using a –log<sub>10</sub>(p) scale on the y axis. Each dot represents a variant. The red line indicates the Bonferroni adjusted threshold for genome-wide significance (p&lt;5 × 10<sup>–8</sup>). The gene in closest proximity to the lead variant at significant loci is listed.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Joint analysis of common and low-frequency variation (minor allele frequency [MAF] &gt;0.1%) by gene across the exome.</title><p>Data generated using the genome-wide association study (GWAS) summary statistics as input to MAGMA. Gene names are given as ENSEMBL Gene IDs and SYMBOL. CHR, chromosome; NSNPS, number of variants annotated to that gene; NPARAM, number of parameters used in the model; N, sample size; ZSTAT, Z-value for the gene based on permutation p-value; P, p-value.</p></caption><media mimetype="text" mime-subtype="plain" xlink:href="elife-74777-fig2-data1-v2.txt"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Joint analysis of common and low-frequency variation (minor allele frequency [MAF] &gt;0.1%) by gene set.</title><p>Data generated using the genome-wide association study (GWAS) summary statistics as input to MAGMA.</p></caption><media mimetype="text" mime-subtype="plain" xlink:href="elife-74777-fig2-data2-v2.txt"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Quantile-quantile (Q–Q) plot for the mixed-ancestry genome-wide association study (GWAS) displaying the observed vs. the expected –log<sub>10</sub>(p) for each variant tested.</title><p>The grey shaded area represents the 95% confidence interval of the null distribution.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Power calculations for the mixed-ancestry genome-wide association study (GWAS) were performed at various minor allele frequencies (MAF) using 132 cases and 23,727 controls under an additive genetic model to achieve genome-wide significance of p&lt;5 × 10<sup>–8</sup>.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig2-figsupp2-v2.tif"/></fig></fig-group><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Association statistics for significant genome-wide loci.</title><p><supplementary-material id="table2sdata1"><label>Table 2—source data 1.</label><caption><title>Replication study.</title><p>The lead variants at the top four loci with p&lt;5 × 10<sup>–7</sup> were genotyped in an independent European cohort of 395 posterior urethral valves (PUV) cases and 4151 controls. p-Values in the replication cohort were calculated using a one-sided Cochran Armitage Trend test. OR, odds ratio; CI, 95% confidence interval.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74777-table2-data1-v2.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" valign="bottom" colspan="2">P value</th><th align="center" valign="bottom" colspan="2">OR (95% CI)</th><th align="center" valign="bottom" colspan="2">Case EAF</th><th align="center" valign="bottom" colspan="2">Control EAF</th></tr></thead><tbody><tr><td align="left" valign="bottom">Lead variant</td><td align="left" valign="bottom">CHR:POS</td><td align="left" valign="bottom">Effect Allele</td><td align="left" valign="bottom">Closest gene</td><td align="left" valign="bottom">Discovery</td><td align="left" valign="bottom">Replication</td><td align="left" valign="bottom">Discovery</td><td align="left" valign="bottom">Replication</td><td align="left" valign="bottom">Discovery</td><td align="left" valign="bottom">Replication</td><td align="left" valign="bottom">Discovery</td><td align="left" valign="bottom">Replication</td></tr><tr><td align="left" valign="bottom" rowspan="2">rs10774740</td><td align="left" valign="bottom" rowspan="2">chr12:114228397</td><td align="left" valign="bottom" rowspan="2">T</td><td align="left" valign="bottom" rowspan="2"><italic>TBX5</italic></td><td align="left" valign="bottom" rowspan="2">7.81x10<sup>–12</sup></td><td align="left" valign="bottom" rowspan="2">5.17x10<sup>–3</sup></td><td align="left" valign="bottom">0.4</td><td align="left" valign="bottom">0.8</td><td align="left" valign="bottom" rowspan="2">0.19</td><td align="left" valign="bottom" rowspan="2">0.31</td><td align="left" valign="bottom" rowspan="2">0.37</td><td align="left" valign="bottom" rowspan="2">0.36</td></tr><tr><td align="left" valign="bottom">(0.31–0.52)</td><td align="left" valign="bottom">(0.68–0.93)</td></tr><tr><td align="left" valign="bottom" rowspan="2">rs144171242</td><td align="left" valign="bottom" rowspan="2">chr6:43120356</td><td align="left" valign="bottom" rowspan="2">G</td><td align="left" valign="bottom" rowspan="2"><italic>PTK7</italic></td><td align="left" valign="bottom" rowspan="2">2.02x10<sup>–8</sup></td><td align="left" valign="bottom" rowspan="2">7.21x10<sup>–3</sup></td><td align="left" valign="bottom">7.2</td><td align="left" valign="bottom">2.18</td><td align="left" valign="bottom" rowspan="2">0.05</td><td align="left" valign="bottom" rowspan="2">0.018</td><td align="left" valign="bottom" rowspan="2">0.01</td><td align="left" valign="bottom" rowspan="2">0.008</td></tr><tr><td align="left" valign="bottom">(4.08–12.70)</td><td align="left" valign="bottom">(1.22–3.90)</td></tr></tbody></table></table-wrap><p>At 12q24.21, the lead intergenic variant (rs10774740) was common (MAF 0.37) and reached p=7.81 × 10<sup>–12</sup> (OR 0.40; 95% CI 0.31–0.52; <xref ref-type="fig" rid="fig3">Figure 3</xref>). A rare (MAF 0.007) variant (rs144171242) at 6p21.1, located in an intron of <italic>PTK7,</italic> was also significant at p=2.02 × 10<sup>–8</sup> (OR 7.20; 95% CI 4.08–12.70; <xref ref-type="fig" rid="fig4">Figure 4</xref>). The meanDP (mean sequencing depth) and meanGQ (mean genotype quality) at these sites were 33.43 and 133.28, for rs10774740 and 29.34 and 75.59 for rs144171242, respectively, confirming these variants were high-quality calls. Conditional analysis did not identify secondary independent signals at either locus and epistasis was not detected between the two lead variants (p=0.10).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>12q24.21.</title><p>Regional association plot with chromosomal position (GRCh38) denoted along the x axis and strength of association using a –log<sub>10</sub>(p) scale on the y axis. The lead variant (rs10774740) is represented by a purple diamond. Variants are coloured based on their linkage disequilibrium (LD) with the lead variant using 1000 Genomes data from all population groups. Functional annotation of the lead prioritized variant rs10774740 is shown, intersecting with CADD score (version 1.6), PhastCons conserved elements from 100 vertebrates, and ENCODE H3K27ac ChIP-seq, H3K4me3 ChIP-seq, and DNase-seq from mesendoderm cells. ENCODE cCREs active in mesendoderm are represented by shaded boxes; low DNase (grey), DNase-only (green). Genome-wide association study (GWAS) variants with p&lt;0.05 are shown. Note that rs10774740 has a relatively high CADD score for a non-coding variant and intersects with a highly conserved region. PP, posterior probability derived using PAINTOR; cCRE, candidate <italic>cis</italic>-regulatory element.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Heatmap of Hi-C interactions from H1 BMP4-derived mesendoderm cells demonstrating that rs10774740 is located within the same topologically associating domain (TAD) as <italic>TBX5</italic>.</title><p>TADs are represented by blue triangles. Protein-coding genes are denoted in blue, non-coding genes in green.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Circos plot illustrating significant chromatin interactions between 12q24.21 and the promoter of <italic>TBX5</italic>.</title><p>The outer layer represents a Manhattan plot with variants plotted against strength of association. Only variants with p&lt;0.05 are displayed. Genomic risk loci are highlighted in blue in the second layer. Significant chromatin loops detected in H1 BMP4-derived mesendoderm cultured cells are represented in orange.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig3-figsupp2-v2.tif"/></fig></fig-group><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>6p21.1.</title><p>Regional association plot with chromosomal position (GRCh38) along the x axis and strength of association using a –log<sub>10</sub>(p) scale on the y axis. The lead variant (rs144171242) is represented by a purple diamond. Variants are coloured based on their linkage disequilibrium (LD) with the lead variant using 1000 Genomes data from all population groups. Functional annotation of the lead prioritized variant rs144171242 is shown intersecting with ENCODE H3K27ac ChIP-seq, H3K4me3 ChIP-seq, and DNase-seq from mesendoderm cells. ENCODE cCREs active in mesendoderm are represented by shaded boxes; low DNase (grey), DNase-only (green), and distal enhancer-like (orange). ChromHMM illustrates predicted chromatin states using Roadmap Epigenomics imputed 25-state model for mesendoderm cells; active enhancer (orange), weak enhancer (yellow), strong transcription (green), transcribed and weak enhancer (lime green). Predicted transcription factor-binding sites (TFBS) from the JASPAR 2020 CORE collection (<xref ref-type="bibr" rid="bib27">Fornes et al., 2020</xref>) are indicated by dark grey shaded boxes. Genome-wide association study (GWAS) variants with p&lt;0.05 are shown. Note that rs144171242 intersects with both a predicted regulatory region and TFBS. PP, posterior probability derived using PAINTOR; cCREs, candidate <italic>cis</italic>-regulatory elements.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Sequence logos representing the DNA-binding motifs of transcription factors FERD3L and ZNF317.</title><p>The black boxes indicate where the risk allele [G] may disrupt binding.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig4-figsupp1-v2.tif"/></fig></fig-group><p>Due to the male nature of PUV, we also conducted a sex-specific analysis using only male controls (n=10,425) to determine whether any additional signals could be detected by removing females with potentially undetected genitourinary phenotypes. Both lead variants showed stronger evidence of association: rs10774740 at 12q24.21 (p=7.08 × 10<sup>–12</sup>; OR 0.40; 95% CI 0.31–0.52) and rs144171242 at 6p21.1 (p=1.79 × 10<sup>–8</sup>; OR 7.40; 95% CI 4.14–13.22). No significant associations on chromosome X were identified.</p><p>Gene and gene set analysis was carried out to assess the joint effect of common and low-frequency variants and identify potential functional pathways associated with PUV, however, no genes (<xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>) or pathways (<xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>) reached statistical significance after correction for multiple testing.</p></sec><sec id="s2-2"><title>12q24.21 and 6p21.1 replicate in an independent cohort</title><p>We next carried out a replication study in an independent European cohort consisting of 395 individuals with PUV: 333 from Poland and Germany, recruited through the CaRE for LUTO (Cause and Risk Evaluation for Lower Urinary Tract Obstruction) Study, and 62 from the UK; 4151 male individuals recruited to the cancer arm of the 100KGP were used as controls. The ancestry of a subset of cases (n=204) for whom genome-wide genotyping data was available and the control cohort (n=4151) was confirmed as European (<xref ref-type="fig" rid="fig5">Figure 5</xref>). The UK PUV patients and the 100KGP cancer control cohort had not been included in the discovery analyses.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Principal component analysis for the replication cohort.</title><p>Principal component analysis showing the first two principal components for a subset of cases (red) for whom genome-wide genotyping data was available (n=204), and the control (grey) cohort from 100,000 Genomes Project (100KGP) (n=4151) projected onto samples from the 1000 Genomes Project (Phase 3). Both cases and controls had confirmed European ancestry.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig5-v2.tif"/></fig><p>The lead variants at the top four loci with p&lt;5 × 10<sup>–7</sup> were tested for replication. Association at both genome-wide significant lead variants was replicated although with smaller effect sizes (<xref ref-type="table" rid="table2">Table <ext-link ext-link-type="uri" xlink:href="https://docs.google.com/document/u/0/d/1j0rDePlUzsai1ukWHdYFC0GNO_zeBWjIWkAUhVb8Ej4/edit">2</ext-link></xref>): rs10774740 (p=5.17 × 10<sup>–3</sup>; OR 0.80; 95% CI 0.68–0.93) and rs144171242 (p=7.21 × 10<sup>–3</sup>; OR 2.18; 95% CI 1.22–3.90). Two further loci with suggestive evidence of association (10q11.2; rs1471950716; p=1.45 × 10<sup>–7</sup> and 14q21.1; rs199975325; p=2.52 × 10<sup>–7</sup>) did not replicate (<xref ref-type="supplementary-material" rid="table2sdata1">Table 2—source data 1</xref>).</p><p>To confirm this signal was not being driven by case-control imbalance, we repeated the analysis with 500 male controls (a case:control ratio of 1:1.3). rs10774740 at the 12q24.21 locus remained significant (p=9.9 × 10<sup>–3</sup>; OR 0.77; 95% CI 0.63–0.94). rs144171242 at the 6p21.1 locus did not reach statistical significance, but this is likely due to insufficient power (p=0.06; OR 2.24; 95% CI 0.93–5.36). For a rare variant such as rs144171242 (MAF 0.007), a replication study with 500 controls is only powered to detect association with variants that have a large effect size (OR &gt;3.5).</p></sec><sec id="s2-3"><title>Diverse ancestry analysis increases power for discovery</title><p>To ascertain whether the observed associations were being driven by a specific ancestry group, we next repeated the seqGWAS using a subgroup of genetically defined European individuals (88 cases and 17,993 controls) and 16,938,500 variants with MAF ≥0.1%. The 12q24.21 locus remained genome-wide significant (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), however the lead variant (rs2555009) in the region showed weaker association (p=4.02 × 10<sup>–8</sup>; OR 0.43; 95% CI 0.12–0.73) than rs10774740, the lead variant in the diverse ancestry analysis (<xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). Interestingly, the two variants were not in strong linkage disequilibrium (EUR LD; r<sup>2</sup>=0.55). The lead variant at 6p21.1 from the diverse ancestry analysis did not reach genome-wide significance in the European-only study (rs144171242; p=3.60 × 10<sup>–5</sup>; OR 5.90; 95% CI 2.88–12.11) suggesting either that this signal may be being driven partly by non-Europeans or the result of loss of power due to reduced sample size. p-Values and effect sizes were strongly correlated between the diverse ancestry and European-only seqGWAS (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>), demonstrating that inclusion of individuals from diverse backgrounds to increase sample size can be an effective way to boost power and discover new disease loci, even in a small cohort.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Manhattan plot for European sequencing-based genome-wide association study (seqGWAS).</title><p>A genome-wide single-variant association study was carried out in 88 cases and 17,993 controls for 16,938,500 variants with MAF ≥0.1%. All cases and controls had genetically determined European ancestry. Chromosomal position (GRCh38) is denoted along the x axis and strength of association using a –log<sub>10</sub>(p) scale on the y axis. Each dot represents a variant. The red line indicates the Bonferroni adjusted threshold for genome-wide significance (p&lt;5 × 10<sup>–8</sup>). The gene in closest proximity to the lead variant at significant loci are listed.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Comparison of diverse ancestry and European genome-wide association study (GWAS) association statistics.</title><p>The lead variants at the top four loci with p&lt;5 × 10<sup>–7</sup> are shown. OR, odds ratio; CI, 95% confidence interval.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74777-fig6-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Quantile-quantile (Q-Q) plot displaying the observed vs. the expected –log<sub>10</sub>(p) for each variant tested.</title><p>The grey shaded area represents the 95% confidence interval of the null distribution.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig6-figsupp1-v2.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Comparison of (<bold>A</bold>) −log<sub>10</sub>(p) and (<bold>B</bold>) BETA from the diverse ancestry and European-only genome-wide association study (GWAS).</title><p>All variants with p&lt;10<sup>–5</sup> in both cohorts are shown. The shaded grey area represents the 95% confidence interval.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig6-figsupp2-v2.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Ancestry-specific minor allele frequencies for (<bold>A</bold>) rs10774740 (<bold>T</bold>) at 12q24.21 and (<bold>B</bold>) rs144171242 (<bold>G</bold>) at 6p21.1.</title><p>Error bars represent 95% confidence intervals. The lead variant in (<bold>B</bold>) was not identified in individuals with African ancestry in this study. AFR, African ancestry (11 cases; 483 controls); EUR, European ancestry (89 cases; 17,993 controls); SAS, South Asian ancestry (18 cases; 2948 controls).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig6-figsupp3-v2.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>Forest plots demonstrating ancestry-specific odds ratios for (<bold>A</bold>) rs10774740 (<bold>T</bold>) and (<bold>B</bold>) rs144171242 (<bold>G</bold>).</title><p>Error bars represent 95% confidence intervals. The lead variant in (<bold>B</bold>) was not identified in individuals with African ancestry in this study. AFR, African ancestry (11 cases; 483 controls); EUR, European ancestry (89 cases; 17,993 controls); SAS, South Asian ancestry (18 cases; 2948 controls); ALL, mixed-ancestry cohort (132 cases; 23,727 controls).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig6-figsupp4-v2.tif"/></fig><fig id="fig6s5" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 5.</label><caption><title>Linkage disequilibrium (LD) plots for 503 European (EUR), 489 South Asian (SAS), and 661 African (AFR) ancestry individuals from the 1000 Genomes Project (Phase 3).</title><p>Haploview (version 4.2) was used to compute pairwise LD statistics (<bold>r<sup>2</sup></bold>) between variants for each population. The darker the shading, the higher the LD between variants. Black outlined triangles indicate haploblocks. (<bold>A</bold>) LD plot for chr12:114,663,967–114,667,916 (GRCh37) with the position of the lead variant rs10774740 represented by a green arrow; (<bold>B</bold>) LD plot for chr6:43,084,099–43,092,650 (GRCh37) with the lead variant rs144171242 represented by a green arrow. rs144171242 was not seen in the AFR population group.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig6-figsupp5-v2.tif"/></fig></fig-group><p>As the numbers of African, South Asian, and admixed ancestry individuals were too small to reliably carry out subgroup association analyses and subsequent meta-analysis, we instead compared ancestry-specific allele frequencies, effect sizes, and directions for the two lead variants. rs10774740 (T) had a higher allele frequency in individuals of African ancestry (MAF 0.74) compared with European (MAF 0.37) and South Asian (MAF 0.35) populations (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>), however the effect size and direction were similar between the groups (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4</xref>). rs144171242 (G) was present at a lower allele frequency in South Asian (MAF 0.002) compared with European (MAF 0.008) individuals and was not seen in the African ancestry group (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>). The effect size of this rare variant was higher in the South Asian than European population (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4</xref>), which may explain why it only reached genome-wide significance after inclusion of South Asian individuals. Finally, comparison with population allele frequencies from gnomAD (<xref ref-type="bibr" rid="bib39">Karczewski et al., 2020</xref>) demonstrated that although there is large variation in the allele frequency of rs10774740 between ancestries this is away from, not towards, the case allele frequency and suggests that the detected associations are not being driven by differences in allele frequency between populations (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>).</p></sec><sec id="s2-4"><title>Fine mapping predicts lead variants to be likely causal</title><p>WGS enables further interrogation of loci of interest at high resolution. We therefore repeated the diverse ancestry analysis at each genome-wide significant locus using all variants with minor allele count (MAC)≥3, to determine whether additional ultra-rare variants might be driving the observed association signals. Both rs10774740 at 12q24.21 and rs144171242 at 6p21.1 remained most strongly associated, suggesting they are likely to be causal. Comparison of the different LD patterns seen across African, European, and South Asian population groups at these loci demonstrate how a combined ancestry approach can leverage differences in LD to improve the fine mapping of causal variants (<xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5</xref>).</p><p>We next applied the Bayesian fine-mapping tool PAINTOR (<xref ref-type="bibr" rid="bib42">Kichaev et al., 2020</xref>) which integrates the strength of association, LD patterns, and functional annotations to derive the posterior probability (PP) of a variant being causal. Using this alternative statistical approach, both lead variants were identified as having high probability of being causal: rs10774740 (PP with no annotations 0.77, PP with annotations &gt;0.99) and rs144171242 (PP with no annotations 0.83, PP with annotations &gt;0.99). Conservation and ChIP-seq transcription factor (TF)-binding clusters had the largest impact on PP at 12q24.21 and 6p21.1, respectively. Validation of the lead variants using statistical fine mapping illustrates how the increased sensitivity and improved resolution of WGS compared with genotyping arrays may permit the direct identification of underlying causal variants, particularly in the context of examining rarer variants and non-European populations for which imputation performance may be limiting (<xref ref-type="bibr" rid="bib35">Höglund et al., 2019</xref>; <xref ref-type="bibr" rid="bib65">Peterson et al., 2019</xref>).</p></sec><sec id="s2-5"><title>Functional annotation implicates <italic>TBX5</italic> and <italic>PTK7</italic></title><p>To explore the functional relevance of these loci, we next interrogated publicly available datasets via UCSC Genome Browser (<xref ref-type="bibr" rid="bib40">Kent et al., 2002</xref>) and used Functional Mapping and Annotation (FUMA; <xref ref-type="bibr" rid="bib92">Watanabe et al., 2017</xref>) to prioritize candidate genes. Given the urinary tract is derived from both embryonic mesoderm and endoderm, where possible we used experimental data obtained from male H1 BMP4-derived mesendoderm cultured cells.</p><p>The common, non-coding, intergenic lead variant (rs10774740) at the 12q24.21 locus is predicted to be deleterious (combined annotation-dependent depletion CADD [<xref ref-type="bibr" rid="bib70">Rentzsch et al., 2019</xref>] score 15.54) and intersects with a conserved element (chr12:114228397–114228414; logarithm of odds score 33) that is suggestive of a putative TF-binding site (TFBS; <xref ref-type="fig" rid="fig3">Figure 3</xref>), however review of experimentally defined TF-binding profiles (<xref ref-type="bibr" rid="bib27">Fornes et al., 2020</xref>) did not identify any known interactions with DNA-binding motifs at this position. Interrogation of epigenomic data from ENCODE (<xref ref-type="bibr" rid="bib58">Moore et al., 2020</xref>) revealed rs10774740 is located ~35 bp away from a cCRE (EH38E1646218), which although has low DNase activity in mesendoderm cells, displays a distal enhancer-like signature (dELS) in cardiac myocytes. There are no known <italic>cis</italic>-eQTL associations with rs10774740, but using experimental Hi-C data generated from H1 BMP4-derived mesendoderm cells (<xref ref-type="bibr" rid="bib22">Dixon et al., 2015</xref>; <xref ref-type="bibr" rid="bib76">Schmitt et al., 2016</xref>) we were able to determine that this locus is within the same topologically associated domain (TAD) as the TF <italic>TBX5</italic> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Chromatin interaction data mapped this intergenic locus to the promoter of <italic>TBX5</italic> (false discovery rate [FDR] 2.80×10<sup>–13</sup>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>).</p><p>At the 6p21.1 locus, the non-coding lead variant (rs144171242) is in an intron of the inactive tyrosine kinase <italic>PTK7</italic>. This rare variant has a low CADD score (0.93) and lacks any relevant chromatin interaction or known eQTL associations, which is not unexpected given its rarity precludes detection by expression-array experiments. Interrogation of epigenomic annotations from ENCODE (<xref ref-type="bibr" rid="bib58">Moore et al., 2020</xref>) revealed that rs144171242 intersects a cCRE (EH38E2468259) with low DNase activity in mesendoderm cells, but with a dELS in neurons (<xref ref-type="fig" rid="fig4">Figure 4</xref>). NIH Roadmap Epigenomics Consortium (<xref ref-type="bibr" rid="bib47">Kundaje et al., 2015</xref>) data suggests that rs144171242 may have regulatory activity in mesendoderm cells, classifying this region as transcribed/weak enhancer (12TxEnhW) using the imputed ChromHMM 25-chromatin state model (<xref ref-type="fig" rid="fig4">Figure 4</xref>). In addition, interrogation of the JASPAR 2020 (<xref ref-type="bibr" rid="bib27">Fornes et al., 2020</xref>) database of experimentally defined TF-binding profiles revealed that rs144171242 intersects with the DNA-binding motifs of FERD3L, ZNF317, and Zic2 (<xref ref-type="fig" rid="fig4">Figure 4</xref>), suggesting that rs144171242 may potentially affect <italic>PTK7</italic> expression via disruption of TF binding (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>).</p></sec><sec id="s2-6"><title>rs10774740 is associated with prostate cancer and female genitourinary phenotypes</title><p>Interrogation of the NHGR/EBI GWAS Catalog (<xref ref-type="bibr" rid="bib53">MacArthur et al., 2017</xref>) revealed that the risk allele rs10774740 (G) is associated with prostate cancer aggressiveness (<xref ref-type="bibr" rid="bib4">Berndt et al., 2015</xref>; p=3 × 10<sup>–10</sup>; OR 1.14; 95% CI 1.09–1.18). PheWAS data from the UK Biobank demonstrated that the protective allele rs10774740 (T) also has a protective effect in female genitourinary phenotypes (<xref ref-type="fig" rid="fig7">Figure 7</xref>): urinary incontinence (p=8.3 × 10<sup>–12</sup>; OR 0.90; 95% CI 0.87–0.92), female stress incontinence (p=7.9 × 10<sup>–10</sup>; OR 0.89; 95% CI 0.85–0.92), genital prolapse (p=1.1 × 10<sup>–9</sup>; OR 0.92; CI 0.89–0.94) and symptoms involving the female genital tract (p=1.7 × 10<sup>–8</sup>; OR 0.90; 95% CI 0.87–0.94). No significant phenotypic associations affecting other organ systems were seen. These data therefore provide independent validation of a role for <italic>TBX5</italic> in urogenital phenotypes. No known GWAS or PheWAS associations were identified for rs144171242, which is likely too rare to be genotyped or imputed in previous GWAS.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Manhattan plot of PheWAS for rs10774740 (<bold>T</bold>) at 12q24.21.</title><p>Plot downloaded from <ext-link ext-link-type="uri" xlink:href="https://pheweb.org/UKB-SAIGE">https://pheweb.org/UKB-SAIGE</ext-link>. The PheWAS was performed using imputed data from ~400,000 White British participants in the UK Biobank using SAIGE. The triangles indicate the direction of effect. The dashed grey line indicates a Bonferroni adjusted significance level of p&lt; 3.6 x 10<sup>-5</sup> (1403 phenotype codes).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig7-v2.tif"/></fig></sec><sec id="s2-7"><title>TBX5 and PTK7 proteins are detected in the developing urinary tract</title><p>To determine whether TBX5 and PTK7 proteins can be detected during urinary tract development, immunohistochemistry was undertaken in a 7-week gestation normal human embryo (<xref ref-type="fig" rid="fig8">Figure 8</xref>). At this stage of development, the urogenital sinus is a tube composed of epithelia that will differentiate into urothelial cells of the proximal urethra and the urinary bladder. Uroplakin 1B, a water-proofing protein, was detected in urogenital sinus epithelia (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). PTK7 was detected in epithelia lining the urogenital sinus, and intensely in stromal-like cells surrounding the mesonephric ducts (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). TBX5 was detected in a nuclear pattern in a subset of epithelial cells lining the urogenital sinus (<xref ref-type="fig" rid="fig8">Figure 8D</xref>). Omission of primary antibodies resulted in absent signals, as expected (<xref ref-type="fig" rid="fig8">Figure 8E</xref>). Immunostaining of a second human embryo at the same stage of gestation produced similar results, with a prominent signal for PTK7 in stromal cells surrounding the mesonephric duct and a subset of nuclei in the epithelium of the urogenital sinus stained for TBX5 (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>).</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Immunohistochemistry in human embryogenesis.</title><p>(<bold>A</bold>) Overview of transverse section of a normal human embryo 7 weeks after fertilization. The section has been stained with haematoxylin (blue nuclei). Boxes around the urogenital sinus and the mesonephric duct mark similar areas depicted under high power in (<bold>B–E</bold>). In (<bold>B–D</bold>), sections were reacted with primary antibodies, as indicated; in (<bold>E</bold>) the primary antibody was omitted. (<bold>B–E</bold>) were counterstained with haematoxylin. In (<bold>B–E</bold>), the left-hand frame shows the region around the mesonephric duct, while the right-hand frame shows one lateral horn of the urogenital sinus. (<bold>B</bold>) Uroplakin 1b immunostaining revealed positive signal (brown) in the apical aspect of epithelia lining the urogenital sinus (arrows, right frame), the precursor of the urinary bladder and proximal urethra. Uroplakin 1b was also detected in the flat monolayer of mesothelial cells (left frame) that line the body cavity above the mesonephric duct. (<bold>C</bold>) There were strong PTK7 signals (brown cytoplasmic staining) in stromal-like cells around the mesonephric duct (left frame), whereas the epithelia of the duct itself were negative. PTK7 was also detected in a reticular pattern in epithelia lining the urogenital sinus (right frame) and in stromal cells near the sinus. (<bold>D</bold>) A subset of epithelial cells lining the urogenital sinus (right frame) immunostained for TBX5 (brown nuclei; some are arrowed). The mesothelial cells near the mesonephric duct (left frame) were also positive for TBX5. (<bold>E</bold>) This negative control section had the primary antibody omitted; no specific (brown) signal was noted. Bar is 400 μm in (<bold>A</bold>), and bars are 100 μm in (<bold>B–E</bold>). ugs, urogenital sinus; md, mesonephric duct; hg, hindgut; u, ureter.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Immunohistochemistry of a second 7-week human embryo counterstained with haematoxylin.</title><p>(<bold>A</bold>) View of the mesonephric duct (the epithelial tube with <italic>md</italic> in its lumen). Note the prominent signal (brown) for PTK7 in the stromal cells surrounding the duct. (<bold>B</bold>) View of the urogenital sinus (<italic>ugs</italic>) with a subset of nuclei (three shown by arrows) in its monolayer epithelium that stain (light brown) for the transcription factor TBX5. The hindgut (<italic>hg</italic>) is nearby. Bars are 100 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig8-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-8"><title>Monogenic causes of PUV are uncommon</title><p>Having identified two novel gene associations through single-variant association testing, we next aimed to determine whether there was any gene-based enrichment of rare coding variation in this PUV cohort. Single-variant association tests can be underpowered when variants are rare and collapsing variant data into specific regions or genes can increase power and aid gene discovery.</p><p>We therefore aggregated rare (gnomAD allele frequency [AF]&lt;0.1% [<xref ref-type="bibr" rid="bib39">Karczewski et al., 2020</xref>]), predicted deleterious [protein-truncating, or CADD ≥20 [<xref ref-type="bibr" rid="bib70">Rentzsch et al., 2019</xref>]] SNVs and small indels by gene, comparing the burden between cases and controls on an exome-wide basis. No significant enrichment was detected in any of the 19,161 protein-coding genes analysed after correction for multiple testing (<xref ref-type="fig" rid="fig9">Figure 9</xref> and <xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1</xref>). The median number of variants tested per gene was 41 (IQR 47). None of the genes previously associated with congenital bladder outflow obstruction showed evidence of enrichment: <italic>BNC2</italic> (congenital lower urinary tract obstruction, MIM 618612); <italic>FLNA</italic> (frontometaphyseal dysplasia, MIM 305620); <italic>HPSE2</italic> and <italic>LRIG2</italic> (urofacial syndrome, MIM 236730/615112); <italic>CHRM3</italic> (prune-belly syndrome, MIM 100100); <italic>MYOCD</italic> (megabladder, MIM 618719). Despite the limited power of this cohort, the lack of gene-based enrichment seen is consistent with an absence of proven Mendelian causes of non-syndromic PUV.</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Manhattan plot of exome-wide rare coding variant analysis.</title><p>Chromosomal position (GRCh38) is shown on the x axis and strength of association using a –log<sub>10</sub>(p) scale on the y axis. Each dot represents a gene. The red line indicates the Bonferroni adjusted threshold for exome-wide significance (p=2.58 × 10<sup>–6</sup>). Genes with p&lt;10<sup>–4</sup> are labelled.</p><p><supplementary-material id="fig9sdata1"><label>Figure 9—source data 1.</label><caption><title>Exome-wide rare coding variant analysis by gene.</title><p>p-Values generated using SAIGE-GENE and the SKAT-O rare variant test.</p></caption><media mimetype="text" mime-subtype="plain" xlink:href="elife-74777-fig9-data1-v2.txt"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig9-v2.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title>Quantile-quantile (Q-Q) plot displaying the observed vs. the expected –log<sub>10</sub>(p) for each gene tested.</title><p>The grey shaded area represents the 95% confidence interval of the null distribution.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig9-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-9"><title>Structural variation affecting <italic>cis</italic>-regulatory elements is enriched</title><p>Large, rare CNVs have been identified in patients with PUV using conventional microarrays (<xref ref-type="bibr" rid="bib5">Boghossian et al., 2016</xref>; <xref ref-type="bibr" rid="bib9">Caruana et al., 2016</xref>; <xref ref-type="bibr" rid="bib26">Faure et al., 2016</xref>; <xref ref-type="bibr" rid="bib88">Verbitsky et al., 2019</xref>), however high-coverage WGS enables detection of smaller structural variants (SVs) with superior resolution (<xref ref-type="bibr" rid="bib32">Gross et al., 2019</xref>; <xref ref-type="bibr" rid="bib101">Zhou et al., 2016c</xref>), and allows the identification of balanced rearrangements including inversions. We therefore aimed to test for association with different types of SVs, by comparing the burden of rare (MAF &lt;0.1%), autosomal SVs on an exome-wide and <italic>cis</italic>-regulatory element basis.</p><p>We first focused our analysis on rare SVs that were potentially gene-disrupting by extracting those that intersected with at least one exon. Although we observed an increased burden of all SV types in cases compared with controls, this only reached statistical significance for inversions (p=2.1 × 10<sup>–3</sup>) when corrected for the multiple SV comparisons performed (<xref ref-type="table" rid="table3">Table 3</xref>). No difference in SV size between the cohorts was seen. Furthermore, exome-wide gene-based burden analysis did not detect any gene-level enrichment of rare SVs overall or when stratified by type, indicating that, in this cohort at least, rare structural variation does not appear to affect any single gene recurrently.</p><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Structural variant burden analysis.</title><p>The burden of rare autosomal structural variants intersecting with (a) at least one exon or (b) a <italic>cis</italic>-regulatory element was compared between 132 cases and 23,727 controls. cCRE, candidate <italic>cis</italic>-regulatory element; PUV, posterior urethral valves; CNV, copy number variant; DEL, deletion; DUP, duplication; INV, inversion; OR, odds ratio; CI, 95% confidence interval, IQR, interquartile range.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top"/><th align="left" valign="top"/><th align="left" valign="top">EXON</th><th align="left" valign="top"/><th align="left" valign="top">cCRE</th><th align="left" valign="top"/></tr></thead><tbody><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"><bold>PUV</bold></td><td align="left" valign="top"><bold>Controls</bold></td><td align="left" valign="top"><bold>PUV</bold></td><td align="left" valign="top"><bold>Controls</bold></td></tr><tr><td align="left" valign="top"><bold>CNV</bold></td><td align="left" valign="top"><bold>n (%</bold>)</td><td align="char" char="." valign="top">109 (82.6)</td><td align="char" char="." valign="top">17,961 (75.7)</td><td align="char" char="." valign="top">111 (84.1)</td><td align="char" char="." valign="top">18,773 (79.1)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>OR (CI</bold>)</td><td align="char" char="." valign="top">1.52 (0.96–2.50)</td><td align="left" valign="top"/><td align="char" char="." valign="top">1.39 (0.87–2.34)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>Fisher’s exact p</bold></td><td align="char" char="." valign="top">0.07</td><td align="left" valign="top"/><td align="char" char="." valign="top">0.2</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>Median size (kb) (IQR</bold>)</td><td align="char" char="." valign="top">104 (183)</td><td align="char" char="." valign="top">94 (158)</td><td align="char" char="." valign="top">80 (165)</td><td align="char" char="." valign="top">80 (128)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>p (Wilcoxon</bold>)</td><td align="char" char="." valign="top">0.75</td><td align="left" valign="top"/><td align="char" char="." valign="top">0.75</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><bold>DEL</bold></td><td align="left" valign="top"><bold>n (%</bold>)</td><td align="char" char="." valign="top">117 (88.6)</td><td align="char" char="." valign="top">19,987 (84.2)</td><td align="char" char="." valign="top">132 (100)</td><td align="char" char="." valign="top">23,031 (97.1)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>OR (CI</bold>)</td><td align="char" char="." valign="top">1.46 (0.85–2.69)</td><td align="left" valign="top"/><td align="left" valign="top">Inf</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>Fisher’s exact p</bold></td><td align="char" char="." valign="top">0.19</td><td align="left" valign="top"/><td align="char" char="." valign="top">0.04</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>Median size (kb) (IQR</bold>)</td><td align="char" char="." valign="top">1.4 (4.2)</td><td align="char" char="." valign="top">1.8 (4.6)</td><td align="char" char="." valign="top">1.5 (4.1)</td><td align="char" char="." valign="top">1.9 (4.5)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>p (Wilcoxon</bold>)</td><td align="char" char="." valign="top">0.18</td><td align="left" valign="top"/><td align="char" char="ndash" valign="top">4.1×10<sup>–4</sup></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><bold>DUP</bold></td><td align="left" valign="top"><bold>n (%</bold>)</td><td align="char" char="." valign="top">59 (44.7)</td><td align="char" char="." valign="top">8,476 (35.7)</td><td align="char" char="." valign="top">104 (78.8)</td><td align="char" char="." valign="top">16,004 (67.5)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>OR (CI</bold>)</td><td align="char" char="." valign="top">1.45 (1.01–2.08)</td><td align="left" valign="top"/><td align="char" char="." valign="top">1.79 (1.17–2.83)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>Fisher’s exact p</bold></td><td align="char" char="." valign="top">0.04</td><td align="left" valign="top"/><td align="char" char="ndash" valign="top">5.0×10<sup>–3</sup></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>Median size (kb) (IQR</bold>)</td><td align="char" char="." valign="top">3.7 (5.7)</td><td align="char" char="." valign="top">3.0 (5.6)</td><td align="char" char="." valign="top">2.0 (5.3)</td><td align="char" char="." valign="top">2.3 (5.3)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>p (Wilcoxon</bold>)</td><td align="char" char="." valign="top">0.16</td><td align="left" valign="top"/><td align="char" char="." valign="top">0.49</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><bold>INV</bold></td><td align="left" valign="top"><bold>n (%</bold>)</td><td align="char" char="." valign="top">66 (50.0)</td><td align="char" char="." valign="top">8,736 (36.8)</td><td align="char" char="." valign="top">81 (61.4)</td><td align="char" char="." valign="top">11,171 (47.1)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>OR (CI</bold>)</td><td align="char" char="." valign="top">1.72 (1.20–2.45)</td><td align="left" valign="top"/><td align="char" char="." valign="top">1.79 (1.24–2.59)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>Fisher’s exact p</bold></td><td align="char" char="ndash" valign="top">2.1×10<sup>–3</sup></td><td align="left" valign="top"/><td align="char" char="ndash" valign="top">1.2×10<sup>–3</sup></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>Median size (kb) (IQR</bold>)</td><td align="char" char="." valign="top">253 (1931)</td><td align="char" char="." valign="top">261 (1642)</td><td align="char" char="." valign="top">129 (459)</td><td align="char" char="." valign="top">94 (779)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><bold>p (Wilcoxon</bold>)</td><td align="char" char="." valign="top">0.44</td><td align="left" valign="top"/><td align="char" char="." valign="top">0.12</td><td align="left" valign="top"/></tr></tbody></table></table-wrap><p>Given the tightly controlled transcriptional networks that govern embryogenesis, we hypothesized that regulatory regions may be preferentially affected by rare structural variation. To investigate this, we identified rare (MAF &lt;0.1%), autosomal SVs that intersected with 926,535 genome-wide cCREs curated by ENCODE (<xref ref-type="bibr" rid="bib58">Moore et al., 2020</xref>). A significant enrichment of cCRE-intersecting SVs was observed for inversions (61.4% vs. 47.1%, p=1.2 × 10<sup>–3</sup>) and duplications (78.8% vs. 67.5%, p=5.0 × 10<sup>–3</sup>) (<xref ref-type="table" rid="table3">Table 3</xref>). While the median size of inversions was larger in cases, this was not statistically significant (129 kb vs. 94 kb, p=0.12).</p><p>To further characterize this enrichment, we repeated the burden analysis stratifying by cCRE subtype (distal enhancer-like signature [dELS], proximal enhancer-like signature [pELS], promoter-like signature [PLS], CTCF-only and DNase-H3K4me3) and demonstrated a consistent signal across all cCREs for inversions (<xref ref-type="fig" rid="fig10">Figure 10</xref>), most significantly affecting CTCF-only elements (49.2% vs. 31.7%, p=3.1 × 10<sup>–5</sup>, <xref ref-type="supplementary-material" rid="fig10sdata1">Figure 10—source data 1</xref>). These elements act as chromatin loop anchors suggesting that inversions affecting these regions may potentially alter long-range regulatory mechanisms mediated by chromatin conformation. Duplications affecting pELS elements were also significantly enriched in cases (29.5% vs. 16.8%, p=2.7 × 10<sup>–4</sup>).</p><fig id="fig10" position="float"><label>Figure 10.</label><caption><title>Rare structural variant burden analysis.</title><p>The proportion of individuals with ≥1 rare autosomal structural variant intersecting with an ENCODE candidate <italic>cis</italic>-regulatory element (cCRE) in cases and controls was enumerated using a two-sided Fisher’s exact test. Note that inversions affecting cCRE are enriched in PUV. Vertical black bars indicate 95% confidence intervals. Unadjusted p-values shown are significant after correction for multiple testing (p&lt;2.5 × 10<sup>–3</sup>). CNV, copy number variant; DEL, deletion; DUP, duplication; INV, inversion; PUV, posterior urethral valves; dELS, distal enhancer-like signature; pELS, proximal enhancer-like signature; PLS, promoter-like signature; cCRE, candidate <italic>cis</italic>-regulatory element.</p><p><supplementary-material id="fig10sdata1"><label>Figure 10—source data 1.</label><caption><title>Structural variant cCRE analysis.</title><p>The burden of rare autosomal structural variants intersecting with each <italic>cis</italic>-regulatory element type was compared between 132 cases and 23,727 controls. cCRE, candidate <italic>cis</italic>-regulatory element; CNV, copy number variant; DEL, deletion; DUP, duplication; INV, inversion; dELS, distal enhancer-like signature; pELS, proximal enhancer-like signature; PLS, promoter-like signature; OR, odds ratio; CI, 95% confidence interval.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74777-fig10-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74777-fig10-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Using a seqGWAS we have identified the first robust genetic associations of PUV, implicating <italic>TBX5</italic> and <italic>PTK7</italic> in its underlying pathogenesis. We detected an enrichment of rare structural variation affecting cCREs and demonstrate that monogenic causes of PUV are not a common feature, at least within this cohort. We also show that a well-controlled diverse ancestry WGS approach can increase power for disease locus discovery in rare disease and facilitate the fine mapping of causal variants.</p><p>The majority of genetic association studies are carried out in individuals of European ancestry, however with WGS allowing unbiased variant detection combined with the use of appropriate statistical methodology to mitigate confounding by population structure, it is widely recognized that increasing ancestral diversity in genetic studies is scientifically and ethically necessary (<xref ref-type="bibr" rid="bib25">Fatumo et al., 2022</xref>; <xref ref-type="bibr" rid="bib65">Peterson et al., 2019</xref>). On this basis we opted to combine individuals regardless of ancestral background, including a greater proportion of non-White individuals than is present in the UK (87% individuals are recorded as ‘White’ in the 2011 UK census [<xref ref-type="bibr" rid="bib30">General Register Office for Scotland, Northern Ireland Statistics and Research Agency, Office for National Statistics, Census Division, 2020</xref>]), suggesting mitigation of the Euro-centric bias present in most previous genomic studies, at least with respect to the UK population. We used a generalized mixed model association test with saddlepoint approximation to maximize the signal from the resulting diverse ancestry, case-control imbalanced dataset.</p><p>We identified a significant protective effect of the common variant rs10774740 (T), highlighting that common variants can contribute to an individual’s risk of a rare disease, as is increasingly being recognized (<xref ref-type="bibr" rid="bib64">Niemi et al., 2018</xref>). The effect size and direction were consistent between African, European, and South Asian ancestries, despite differences in allele frequency between the population groups. Using experimentally determined chromatin interaction data from mesendoderm cells, we mapped this locus to the promoter of the transcription factor <italic>TBX5,</italic> rare variants of which cause autosomal-dominant Holt-Oram syndrome (MIM 142900), characterized by congenital cardiac septal defects and upper-limb anomalies (<xref ref-type="bibr" rid="bib2">Basson et al., 1997</xref>; <xref ref-type="bibr" rid="bib51">Li et al., 1997</xref>).</p><p>The association of the risk allele (G) with prostate cancer aggressiveness in men and genital prolapse and urinary incontinence in women raises the intriguing possibility that <italic>TBX5,</italic> which shows moderate expression in the adult bladder, is also associated with lower urinary tract phenotypes in adults. These findings are consistent with the observation that variation in genes associated with other developmental anomalies have been linked to malignancy in the same organ (<xref ref-type="bibr" rid="bib81">Su et al., 2012</xref>; <xref ref-type="bibr" rid="bib82">Sun et al., 2017</xref>), highlighting the shared molecular pathways driving both embryogenesis and cancer.</p><p>We also identified an association of the rare variant rs144171242 with PUV, located in an intron of <italic>PTK7</italic> and predicted to have regulatory activity in mesendoderm cells. Given its rarity, this association would not have been detected using a conventional array-based GWAS approach, highlighting the utility of seqGWAS. The inclusion of South Asian individuals, in whom the effect size of rs144171242 is larger, increased our power to detect association which was not genome-wide significant in the European-only analysis. PTK7 (protein tyrosine kinase 7) is an evolutionarily conserved transmembrane receptor required for vertebrate embryonic patterning and morphogenesis, and a key regulator of planar cell polarity (PCP) via the non-canonical Wnt pathway (<xref ref-type="bibr" rid="bib3">Berger et al., 2017</xref>). The PCP pathway is critical for determining the orientation of cells in the plane of an epithelium, regulating a process called convergent extension whereby cells intercalate by converging in one axis and elongating in the perpendicular axis. Altered expression of <italic>PTK7</italic> was initially observed in cancer (<xref ref-type="bibr" rid="bib23">Dunn and Tolwinski, 2016</xref>; <xref ref-type="bibr" rid="bib61">Mossie et al., 1995</xref>), but rare missense variants in <italic>PTK7</italic> have since been linked to neural tube defects (<xref ref-type="bibr" rid="bib50">Lei et al., 2019</xref>; <xref ref-type="bibr" rid="bib91">Wang et al., 2015</xref>) and scoliosis (<xref ref-type="bibr" rid="bib33">Hayes et al., 2014</xref>) in both humans and animal models, confirming a role in embryonic development.</p><p>Aberrations of mesonephric duct and urogenital sinus maturation have been implicated in the pathogenesis of PUV (<xref ref-type="bibr" rid="bib46">Krishnan et al., 2006</xref>). Our observations that TBX5 and PTK7 are present at the appropriate timepoint during normal human embryogenesis, in or around the mesonephric ducts and urogenital sinus, suggest that altered regulation of expression of either may perturb the normal development of these structures. Further functional studies will however be necessary to provide definitive evidence of a role for these proteins in urinary tract development. Interestingly, mesoderm-specific conditional deletion of <italic>Ptk7</italic> in mice has been shown to affect convergent extension and tubular morphogenesis of the mesonephric duct at E18.5, leading to a shortened duct with increased diameter and reduced coiling, resulting in male sterility (<xref ref-type="bibr" rid="bib98">Xu et al., 2018</xref>; <xref ref-type="bibr" rid="bib97">Xu et al., 2016</xref>). Whether similar disruption in mesonephric duct morphogenesis is seen at E14 (corresponding to development of the urethra) remains to be seen but may provide further insights into the biological mechanisms underpinning PUV.</p><p>PUV is a male-limited phenotype, although urethral abnormalities have been reported in the female relatives of affected males (<xref ref-type="bibr" rid="bib44">Kolvenbach et al., 2019</xref>). This sexual dimorphism is most likely the result of anatomical differences in the development and length of the urethra between males and females, with the association between rs10774740 at the <italic>TBX5</italic> locus and female genital prolapse and urinary incontinence suggesting that females may also manifest lower urinary tract phenotypes. While X-linked inheritance has been reported in two patients with syndromic PUV (<xref ref-type="bibr" rid="bib89">Wade et al., 2021</xref>), we detected no significant common or rare variant associations on chromosome X in this cohort to suggest that genetics underpin the male specific nature of this condition.</p><p>Rare CNVs, detected using a microarray-based approach, have recently been shown to be enriched in patients with kidney and urinary tract anomalies, but were not found to be enriched in 141 PUV patients (<xref ref-type="bibr" rid="bib88">Verbitsky et al., 2019</xref>). Similarly, we did not identify an increased burden of rare CNVs in individuals with PUV, but we did observe a higher number of rare, exonic CNVs than Verbitsky et al. (2019) (82.6% vs. 32.6%), most likely reflecting the increased sensitivity and resolution of WGS for SV detection as well as the difference in size threshold for inclusion (&gt;10 kb compared with &gt;100 kb). Importantly, none of the CNVs recurrently affected a particular gene in our cohort which, in combination with the lack of gene-based enrichment seen in our rare SNV/indel analysis, suggests that monogenic causes of PUV are rare, although our sample size would be underpowered to detect significant genetic heterogeneity.</p><p>Intriguingly, we demonstrated an enrichment of rare duplications and inversions affecting cCREs. Genomic duplications have previously been linked with PUV (<xref ref-type="bibr" rid="bib75">Schierbaum et al., 2021</xref>; <xref ref-type="bibr" rid="bib88">Verbitsky et al., 2019</xref>) but this is the first study to examine balanced inversions in a PUV cohort. Current understanding of the functional relevance of inversions is limited as the balanced nature and location of breakpoints within complex repeat regions make detection challenging (<xref ref-type="bibr" rid="bib67">Puig et al., 2015</xref>). Inversions can directly disrupt coding sequences or regulatory elements, as well as predispose to other SVs, and have been associated with hemophilia A (<xref ref-type="bibr" rid="bib48">Lakich et al., 1993</xref>), Hunter syndrome (<xref ref-type="bibr" rid="bib6">Bondeson et al., 2016</xref>), neurodegenerative (<xref ref-type="bibr" rid="bib93">Webb et al., 2008</xref>) and autoimmune disease (<xref ref-type="bibr" rid="bib62">Namjou et al., 2021</xref>; <xref ref-type="bibr" rid="bib73">Salm et al., 2012</xref>). The strongest signal we observed was for inversions affecting CTCF-only regions, potentially implicating disrupted chromatin looping in the underlying pathogenesis of PUV and raising the interesting possibility that non-specific perturbation of long-range regulatory networks or TADs could manifest as PUV, perhaps due to sensitivity of integration of the mesonephric duct into the posterior urethra to even minor abnormalities of gene expression. While the SV analyses described here generate some interesting hypotheses, these findings should be considered exploratory until they can be replicated in an independent cohort.</p><p>In summary, we have shown that both rare and common variation can contribute to an individual’s risk of PUV, and that structural variation affecting regulatory networks may also play a role. Given that PUV does not usually exhibit a Mendelian pattern of inheritance, our data provides support for a complex genetic architecture for this rare disorder, where different types of genetic variation across the allele frequency spectrum may interact to influence susceptibility. Better powered studies will be needed to identify additional genetic risk factors with smaller effect sizes and to explore how these variants might be influenced by maternal or in utero factors (<xref ref-type="bibr" rid="bib63">Nicolaou et al., 2015</xref>).</p><p>This study has several strengths. WGS enables ancestry-independent variant detection, uniform genome-wide coverage, improved SV resolution and detection, as well as direct sequencing of underlying causal variants. Using case-control data from over 20,000 individuals sequenced on the same platform also minimizes confounding by technical artefacts. Inclusion of diverse ancestries increased our power to detect both novel associations and the underlying causal variant, with the lack of genomic inflation and subsequent replication indicating these associations are robust. Furthermore, we integrated seqGWAS, epigenomic and chromatin interaction data to ascertain the functional relevance of loci and identify biologically plausible genes, validated by detection of the relevant proteins at the appropriate site and developmental stage.</p><p>A limitation of this study is its relatively low statistical power to detect association due to the limited size of the cohort; sufficient power exists to detect low-frequency variants with large effects (e.g., MAF 1% with OR &gt;7.5), but rare variants, or those with smaller effect sizes, may be missed with this sample size (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). Future meta-analyses will be necessary to identify additional loci, as well as expanded efforts to recruit non-Europeans given the low absolute numbers of non-European cases in this study. Furthermore, while WGS offers improved SV resolution over microarrays, false positives may occur and are dependent on the SV calling algorithm used. Ideally, long-read sequencing and independent validation would provide more comprehensive SV detection, especially of larger variants in complex, repetitive and GC-rich regions. Finally, although we have assessed the relevance of the associated loci using bioinformatic approaches and shown that publicly available and our own experimental data support the association, the biological mechanisms linking these genes with PUV have yet to be elucidated.</p><p>To our knowledge, this is the first study to utilize diverse ancestry WGS for association testing in a rare disease. Combining WGS data across ancestries increased power to detect the first two robust genetic associations for PUV and identified the likely causal variants through enhanced fine mapping. Finally, integration of functional genomic and experimental data implicated <italic>TBX5</italic> and <italic>PTK7</italic> in the pathogenesis of PUV, providing new insights into the biological pathways underlying this important but poorly understood disorder.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>The 100,000 Genomes Project</title><p>The Genomics England dataset (version 10) (<xref ref-type="bibr" rid="bib79">Smedley et al., 2021</xref>) consists of WGS data, clinical phenotypes encoded using HPO codes (<xref ref-type="bibr" rid="bib43">Köhler et al., 2021</xref>), and retrospective and prospectively ascertained National Health Service (NHS) hospital records for 89,139 individuals recruited with cancer, rare disease, and their unaffected relatives. Ethical approval for the 100KGP was granted by the Research Ethics Committee for East of England – Cambridge South (REC Ref 14/EE/1112). Written informed consent was obtained from all participants and/or their guardians. <xref ref-type="fig" rid="fig1">Figure 1</xref> details the study workflow.</p><p>Cases were recruited from 13 NHS Genomic Medicine Centers across the UK as part of the 100KGP ‘Congenital anomalies of the kidneys and urinary tract (CAKUT)’ cohort with the following inclusion criteria: CAKUT with syndromic manifestations in other organ systems; isolated CAKUT with a first-degree relative with CAKUT or unexplained CKD; multiple distinct renal/urinary tract anomalies; CAKUT with unexplained end-stage kidney disease before the age of 25 years. Those with a clinical or molecular diagnosis of ADPKD or ARPKD, or who had a known genetic or chromosomal abnormality were excluded. One-hundred and thirty-six male individuals with a diagnosis of PUV were identified using the HPO term ‘HP:0010957 congenital posterior urethral valve’.</p><p>All cases underwent assessment via the clinical interpretation arm of the 100KGP to determine a molecular diagnosis. This process involved the examination of protein-truncating and missense variants from an expert-curated panel of 57 CAKUT-associated genes followed by multi-disciplinary review and application of ACMG (<xref ref-type="bibr" rid="bib71">Richards et al., 2015</xref>) criteria to determine pathogenicity. CNVs affecting the 17q12 region (ISCA-37432-Loss), which includes <italic>HNF1B</italic>, were also assessed. No pathogenic/likely pathogenic variants were identified in genes previously associated with congenital bladder outflow obstruction (<italic>HPSE2, LRIG2, CHRM3, MYOCD, BNC2</italic>). Two pathogenic/likely pathogenic variants affecting the 17q12 locus and <italic>FOXC1</italic> were identified in two individuals, but these were not determined to be causal for PUV (see Appendix 1).</p><p>The control cohort consisted of 27,660 unaffected relatives of non-renal rare disease participants, excluding those with HPO terms and/or hospital episode statistics (HES) data consistent with kidney disease or failure. By utilizing a case-control cohort sequenced on the same platform, we aimed to minimize confounding by technical artefacts.</p></sec><sec id="s4-2"><title>DNA preparation and extraction</title><p>Ninety-nine percent of DNA samples were extracted from blood and prepared using EDTA, with the remaining 1% sourced from saliva, tissue, and fibroblasts. Samples underwent quality control assessment based on concentration, volume, purity, and degradation. Libraries were prepared using the Illumina TruSeq DNA PCR-Free High Throughput Sample Preparation kit or the Illumina TruSeq Nano High Throughput Sample Preparation kit.</p></sec><sec id="s4-3"><title>WGS, alignment, and variant calling</title><p>Samples were sequenced with 150 bp paired-end reads using an Illumina HiSeq X and processed on the Illumina North Star Version 4 Whole Genome Sequencing Workflow (NSV4, version 2.6.53.23), comprising the iSAAC Aligner (version 03.16.02.19) and Starling Small Variant Caller (version 2.4.7). Samples were aligned to the <italic>Homo sapiens</italic> NCBI GRCh38 assembly. Alignments had to cover ≥95% of the genome at ≥15X with mapping quality &gt;10 for samples to be retained. Samples achieved a mean of 97.4% coverage at 15X with a median genome-wide coverage of 39X. Samples with &lt;2% cross-contamination as determined by the VerifyBamID algorithm were kept. CNV and SV (&gt;50 bp) calling was performed using CANVAS (<xref ref-type="bibr" rid="bib72">Roller et al., 2016</xref>; version 1.3.1) and MANTA (<xref ref-type="bibr" rid="bib11">Chen et al., 2016a</xref>; version 0.28.0), respectively. CANVAS determines coverage and MAF to assign copy number (&gt;10 kb) whereas MANTA combines paired and split-read algorithms to detect SVs (&lt;10 kb).</p></sec><sec id="s4-4"><title>gVCF annotation and variant-level quality control</title><p>gVCFs were aggregated using gvcfgenotyper (Illumina, version 2019.02.26) with variants normalized and multi-allelic variants decomposed using vt (version 0.57721; <xref ref-type="bibr" rid="bib84">Tan et al., 2015</xref>). Variants were retained if they passed the following filters: missingness ≤5%, median depth ≥10, median GQ ≥15, percentage of heterozygous calls not showing significant allele imbalance for reads supporting the reference and alternate alleles (ABratio) ≥25%, percentage of complete sites (completeGTRatio) ≥50% and p-value for deviations from Hardy-Weinberg equilibrium (HWE) in unrelated samples of inferred European ancestry ≥1 × 10<sup>–5</sup>. Male and female subsets were analysed separately for sex chromosome quality control. Per-variant MAC was calculated across the case-control cohort. Annotation was performed using Variant Effect Predictor (version 98.2; <xref ref-type="bibr" rid="bib56">McLaren et al., 2016</xref>) including CADD (version 1.5; <xref ref-type="bibr" rid="bib70">Rentzsch et al., 2019</xref>), and allele frequencies from publicly available databases including gnomAD (version 3; <xref ref-type="bibr" rid="bib39">Karczewski et al., 2020</xref>) and TOPMed (Freeze 5; <xref ref-type="bibr" rid="bib83">Taliun et al., 2021</xref>). Variants were filtered using bcftools (version 1.11; <xref ref-type="bibr" rid="bib17">Danecek et al., 2021</xref>).</p></sec><sec id="s4-5"><title>Relatedness estimation and principal component analysis</title><p>A set of 127,747 high-quality autosomal LD-pruned bi-allelic SNVs with MAF &gt;1% was generated using PLINK (version 1.9; <xref ref-type="bibr" rid="bib68">Purcell et al., 2007</xref>). SNVs were included if they met all the following criteria: missingness &lt;1%, median GQ ≥30, median depth ≥30, ABratio ≥0.9, completeness ≥0.9. Ambiguous SNVs (A/T or G/C) and those in a region of long-range high LD were excluded. LD pruning was carried out using an r<sup>2</sup> threshold of 0.1 and window of 500 kb. SNVs out of HWE in any of the AFR, EAS, EUR, or SAS 1000 Genomes populations were removed (pHWE &lt;1 × 10<sup>–5</sup>). Using this variant set, a pairwise kinship matrix was generated using the PLINK2 (<xref ref-type="bibr" rid="bib10">Chang et al., 2015</xref>) implementation of the KING-Robust algorithm (<xref ref-type="bibr" rid="bib55">Manichaikul et al., 2010</xref>) and a subset of unrelated samples was ascertained using a kinship coefficient threshold of 0.0884 (second-degree relationships). Two cases and 1354 controls were found to be related by this method and were removed, leaving 134 cases and 26,306 controls. Ten principal components were generated using PLINK2 (<xref ref-type="bibr" rid="bib10">Chang et al., 2015</xref>) for ancestry-matching and for use as covariates in the association analyses.</p></sec><sec id="s4-6"><title>Ancestry-matching of cases and controls</title><p>Given the mixed-ancestry composition of the cohort, we employed a case-control ancestry-matching algorithm to optimize genomic similarity and minimize the effects of population structure. A custom R script (<xref ref-type="supplementary-material" rid="scode1">Source code 1</xref>) was used to match cases to controls within a distance threshold calculated using the top 10 principal components weighted by the percentage of genetic variation explained by each component (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Only controls within a user-defined specified distance of a case were included with each case having to match a minimum of two controls to be included in the final cohort. A total of two cases and 2579 controls were excluded using this approach, leaving 132 cases and 23,727 controls for further analysis.</p><p>For the European-only analysis, a subset of individuals predicted to have ≥0.8 probability of European ancestry inferred by a random forest model (Ntrees = 400) generated using the first eight principal components of the 1000 Genomes Project (Phase 3) data were extracted (89 cases and 19,418 controls). After ancestry-matching 88 cases and 17,993 controls remained for analysis.</p></sec><sec id="s4-7"><title>Single-variant seqGWAS</title><p>Whole-genome single-variant association analysis was carried out using the R package SAIGE (version 0.42.1) (<xref ref-type="bibr" rid="bib99">Zhou et al., 2016a</xref>) which uses a GLMM to account for population stratification. High-quality, autosomal, bi-allelic, LD-pruned SNVs with MAF &gt;5% were used to generate a genetic relationship matrix and fit the null GLMM. Sex and the top 10 principal components were used as covariates (fixed effects). Sex was used as a covariate to control for the anatomical differences in development of the urethra (and in utero hormonal changes) between the sexes in the control cohort. SNVs and indels with MAF ≥0.1% that passed the following quality control filters were retained: MAC ≥20, missingness &lt;1%, HWE p&gt;10<sup>–6</sup>, and differential missingness p&gt;10<sup>–5</sup>. A score test (<xref ref-type="bibr" rid="bib12">Chen et al., 2016b</xref>) for association was performed for 19,651,224 variants (diverse ancestry single-variant seqGWAS) and 16,938,500 variants (European-only seqGWAS). When case-control ratios are unbalanced, as in our study (1:180), type 1 error rates are inflated because the asymptotic assumptions of logistic regression are invalidated. SAIGE employs a saddlepoint approximation (<xref ref-type="bibr" rid="bib21">Dey et al., 2017</xref>) to calibrate score test statistics and obtain more accurate p-values than the normal distribution.</p><p>At each of the genome-wide significant loci, we used SAIGE to perform (a) conditional analysis to identify secondary independent associations and (b) high-resolution single-variant analysis using all variants with MAC ≥3 to ascertain whether the observed signal was being driven by rare variation. Epistasis between the lead variants was assessed using logistic regression in PLINK (version 1.9; <xref ref-type="bibr" rid="bib68">Purcell et al., 2007</xref>). One limitation of SAIGE is that the betas estimated from score tests can be biased at low MACs and therefore odds ratios for variants with MAF &lt;1% were calculated separately using allele counts in R. The R packages qqman (<xref ref-type="bibr" rid="bib87">Turner, 2015</xref>) and GWASTools (<xref ref-type="bibr" rid="bib31">Gogarten et al., 2012</xref>) were used to create Manhattan and Q-Q (quantile-quantile) plots, and LocusZoom (<xref ref-type="bibr" rid="bib66">Pruim et al., 2010</xref>) to visualize regions of interest.</p></sec><sec id="s4-8"><title>Replication</title><p>The replication cohort consisted of 395 individuals with PUV; 333 recruited from Poland and Germany as part of the CaRE for LUTO (Cause and Risk Evaluation for Lower Urinary Tract Obstruction) Study, and 62 from Manchester, UK. None of the individuals had been recruited to the 100KGP. All were of self-reported European ancestry. To confirm that this cohort was also genetically European, we performed a principal component analysis (using PLINK2) analyzing a subset (n=204) of the Polish and German PUV cases for whom genome-wide genotyping data was available, projecting the first two principal components onto samples from the 1000 Genomes Project (Phase 3) (<xref ref-type="bibr" rid="bib1">Auton et al., 2015</xref>) labelled by population group. KASP (Kompetitive Allele-Specific PCR) genotyping of the lead variants at the top four loci using a threshold of p&lt;5 × 10<sup>–7</sup> was carried out: rs10774740 at 12q24.21, rs144171242 at 6p21.1, rs1471950716 at 10q11.21, rs199975325 at 14q21.1. The peri-centromeric location of rs1471950716 at 10q11.21 caused the genotyping assay to fail and another variant with evidence of association (rs137855548; p=1.46 × 10<sup>–6</sup>) was used instead. The replication control cohort consisted of 4151 genetically determined European male individuals who had been recruited to the cancer arm of the 100KGP, excluding those with kidney, bladder, prostate, or childhood malignancy. These individuals had not been used in the discovery analysis.</p><p>Only individuals with high-confidence genotype calls were included in the analysis. Allele counts at each variant were compared between cases and controls using a two-sided Cochran-Armitage trend test. A Bonferroni-corrected p&lt;0.0125 (0.05/4) was used to adjust for the number of loci tested. Power to detect or refute association at each locus was calculated as &gt;0.9.</p></sec><sec id="s4-9"><title>Power</title><p>Statistical power for single-variant association under an additive model for the discovery and replication cohorts was calculated using the R package genpwr (<xref ref-type="bibr" rid="bib59">Moore et al., 2021</xref>). <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref> shows the power calculations for the diverse ancestry seqGWAS at varying allele frequencies and odds ratios.</p></sec><sec id="s4-10"><title>Bayesian fine mapping</title><p>We applied PAINTOR (version 3.1; <xref ref-type="bibr" rid="bib42">Kichaev et al., 2020</xref>), a statistical fine-mapping method which uses an empirical Bayes prior to integrate functional annotation data, LD patterns, and strength of association to estimate the PP of a variant being causal. Variants at each genome-wide significant locus with p&lt;0.05 were extracted. Z-scores were calculated as effect size (β) divided by standard error. LD matrices of pairwise correlation coefficients were derived using EUR 1000 Genomes (Phase 3) (<xref ref-type="bibr" rid="bib1">Auton et al., 2015</xref>) imputed data as a reference, excluding variants with ambiguous alleles (A/T or G/C). Each locus was intersected with the following functional annotations downloaded using UCSC Table Browser (<xref ref-type="bibr" rid="bib40">Kent et al., 2002</xref>): GENCODE (<xref ref-type="bibr" rid="bib28">Frankish et al., 2019</xref>) (version 29) transcripts (wgEncodeGencodeBasicV29, updated 2019-02-15), PhastCons (<xref ref-type="bibr" rid="bib78">Siepel et al., 2005</xref>) (phastConsElements100way, updated 2015-05-08), ENCODE (<xref ref-type="bibr" rid="bib58">Moore et al., 2020</xref>) cCREs (encodeCcreCombined, updated 2020-05-20), TF-binding clusters (encRegTfbsClustered, updated 2019-05-16), DNase I hypersensitivity clusters (wgEncodeRegDnaseClustered, updated 2019-01-08) and H1 Human embryonic stem cell Hi-C data (h1hescInsitu from <xref ref-type="bibr" rid="bib45">Krietenstein et al., 2020</xref>). A total of 351 variants at 12q24.21 and 166 variants at 6p21.1 were analysed under the assumption of one causal variant per locus.</p></sec><sec id="s4-11"><title>Functional annotation</title><p>To explore the functional relevance of the prioritized variants, we used FUMA (version 1.3.6a) (<xref ref-type="bibr" rid="bib92">Watanabe et al., 2017</xref>) to annotate the genome-wide significant loci. This web-based tool integrates functional gene consequences from ANNOVAR (<xref ref-type="bibr" rid="bib90">Wang et al., 2010</xref>), CADD (<xref ref-type="bibr" rid="bib70">Rentzsch et al., 2019</xref>) scores to predict deleteriousness, RegulomeDB score to indicate potential regulatory function (<xref ref-type="bibr" rid="bib7">Boyle et al., 2016</xref>) and 15-core chromatin state (predicted by ChromHMM for 127 tissue/cell types; <xref ref-type="bibr" rid="bib24">Ernst and Kellis, 2012</xref>) representing accessibility of genomic regions. Positional mapping (where a variant is physically located within a 10 kb window of a gene), GTEx (version 8) eQTL data (<xref ref-type="bibr" rid="bib14">Consortium, 2020</xref>) (using <italic>cis</italic>-eQTLs to map variants to genes up to 1 Mb apart) and Hi-C data to detect long-range 3D chromatin interactions is used to prioritize genes that are likely to be affected by variants of interest. Single-variant seqGWAS summary statistics were used as input with genomic positions converted to GRCh37 using the UCSC liftOver tool (<xref ref-type="bibr" rid="bib40">Kent et al., 2002</xref>).</p><p>In addition, we intersected prioritized variants with the following epigenomic datasets from male H1-BMP4 derived mesendoderm cultured cells generated by the ENCODE Project (<xref ref-type="bibr" rid="bib58">Moore et al., 2020</xref>) and Roadmap Epigenomics (<xref ref-type="bibr" rid="bib47">Kundaje et al., 2015</xref>) Consortia using the UCSC Genome Browser (<xref ref-type="bibr" rid="bib40">Kent et al., 2002</xref>): ENCFF918FRW_ENCFF748XLQ_ENCFF313DOD (cCREs, GRCh38); ENCFF918FRW_ENCFF748XLQ_ENCFF313DOD_ENCFF313DOD (H3K27ac ChIP-seq, GRCh38); ENCFF918FRW_ENCFF748XLQ_ENCFF313DOD_ENCFF748XLQ (H3K4me3 ChIP-seq, GRCh38); ENCFF918FRW_ENCFF748XLQ_ENCFF313DOD_ENCFF918FRW (DNase-seq, GRCh38); E004 H1 BMP4 Derived Mesendoderm Cultured Cells ImputedHMM (hg19). Hi-C interactions from H1 mesendoderm cells (<xref ref-type="bibr" rid="bib47">Kundaje et al., 2015</xref>) and TADs were visualized with the 3D Interaction Viewer and Database (http://3div.kr).</p></sec><sec id="s4-12"><title>Gene and gene set analysis</title><p>MAGMA (version 1.6; <xref ref-type="bibr" rid="bib18">de Leeuw et al., 2015</xref>) was used to test the joint association of all variants within a particular gene or gene set using the single-variant seqGWAS summary statistics. Aggregation of variants increases power to detect multiple weaker associations and can test for association with specific biological or functional pathways. MAGMA uses a multiple regression approach to account for LD between variants, using a reference panel derived from 10,000 Europeans in the UK Biobank (release 2b). Variants from the seqGWAS were assigned to 18,757 protein coding genes (Ensembl build 85) with genome-wide significance defined as p=2.67 × 10<sup>–6</sup> (0.05/18,757). Competitive gene set analysis was then performed for 5497 curated gene sets and 9986 Gene Ontology (GO) terms from MsigDB (version 7.0; <xref ref-type="bibr" rid="bib52">Liberzon et al., 2015</xref>) using the results of the gene analysis. Competitive analysis tests whether the joint association of genes in a gene set is stronger than a randomly selected set of similarly sized genes. Bonferroni correction was applied for the total number of tested gene sets (p=0.05/15,483=3.23 × 10<sup>–6</sup>).</p></sec><sec id="s4-13"><title>Identification of TFBS</title><p>The JASPAR 2020 (<xref ref-type="bibr" rid="bib27">Fornes et al., 2020</xref>) CORE collection track (UCSC Genome Browser [<xref ref-type="bibr" rid="bib40">Kent et al., 2002</xref>], updated 2019-10-13) was utilized to identify significant (p&lt;10<sup>–4</sup>) predicted TFBS that might intersect with the lead variants. The JASPAR database consists of manually curated, non-redundant, experimentally defined TF-binding profiles for 746 vertebrates, of which 637 are associated with human TF with known DNA-binding profiles. Sequence logos based on position weight matrices of the DNA-binding motifs were downloaded from JASPAR 2020 (<xref ref-type="bibr" rid="bib27">Fornes et al., 2020</xref>).</p></sec><sec id="s4-14"><title>GWAS and PheWAS associations</title><p>The NHGRI-EBI GWAS Catalog (<xref ref-type="bibr" rid="bib53">MacArthur et al., 2017</xref>) and PheWAS data from the UK Biobank (<ext-link ext-link-type="uri" xlink:href="https://pheweb.org/UKB-SAIGE">https://pheweb.org/UKB-SAIGE</ext-link>) were interrogated to determine known associations of the lead variants. Summary statistics were downloaded from the NHGRI-EBI GWAS Catalog (<xref ref-type="bibr" rid="bib53">MacArthur et al., 2017</xref>) for study GCST002890 (<xref ref-type="bibr" rid="bib4">Berndt et al., 2015</xref>) on 2021-03-17. PheWAS statistics were generated using imputed data from White British participants in the UK Biobank using SAIGE, adjusting for genetic relatedness, sex, birth year, and the first four principal components.</p></sec><sec id="s4-15"><title>Immunohistochemistry</title><p>Human embryonic tissues, collected after maternal consent and ethical approval (REC18/NE/0290), were sourced from the Medical Research Council and Wellcome Trust Human Developmental Biology Resource (<ext-link ext-link-type="uri" xlink:href="https://www.hdbr.org/">https://www.hdbr.org/</ext-link>). Tissue sections were immunostained, as we described previously (<xref ref-type="bibr" rid="bib44">Kolvenbach et al., 2019</xref>). Sections were immunostained with the following primary antibodies: TBX5 (<ext-link ext-link-type="uri" xlink:href="https://www.abcam.com/tbx5-antibody-ab223760.html">https://www.abcam.com/tbx5-antibody-ab223760.html</ext-link>) raised in rabbit; PTK7 (<ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/PTK7-Antibody-Polyclonal/PA5-82070">https://www.thermofisher.com/antibody/product/PTK7-Antibody-Polyclonal/PA5-82070</ext-link>) raised in rabbit; and uroplakin 1B (<ext-link ext-link-type="uri" xlink:href="https://www.abcam.com/uroplakin-ibupib-antibody-upk1b3081-ab263454.html">https://www.abcam.com/uroplakin-ibupib-antibody-upk1b3081-ab263454.html</ext-link>) raised in mouse. Primary antibodies were detected with appropriate second antibodies and signals generated with a peroxidase-based system.</p></sec><sec id="s4-16"><title>Aggregate rare coding variant analysis</title><p>Single-variant association testing is underpowered when variants are rare and a collapsing approach which aggregates variants by gene can be adopted to boost power. We extracted coding SNVs and indels with MAF &lt;0.1% in gnomAD (<xref ref-type="bibr" rid="bib39">Karczewski et al., 2020</xref>), annotated with one of the following: missense, in-frame insertion, in-frame deletion, start loss, stop gain, frameshift, splice donor, or splice acceptor. Variants were further filtered by CADD score (version 1.5; <xref ref-type="bibr" rid="bib70">Rentzsch et al., 2019</xref>) using a threshold of ≥20 corresponding to the top 1% of all predicted deleterious variants in the genome. Variants meeting the following quality control filters were retained: MAC ≤20, median site-wide depth in non-missing samples &gt;20 and median GQ ≥30. Sample-level QC metrics for each site were set to minimum depth per sample of 10, minimum GQ per sample of 20, and ABratio p-value &gt;0.001. Variants with significantly different missingness between cases and controls (p&lt;10<sup>–5</sup>) or &gt;5% missingness overall were excluded. We employed SAIGE-GENE (version 0.42.1; <xref ref-type="bibr" rid="bib100">Zhou et al., 2016b</xref>) to ascertain whether rare coding variation was enriched in cases on a per-gene basis exome-wide. Like SAIGE, SAIGE-GENE utilizes a GLMM to correct for population stratification and cryptic relatedness as well as a saddlepoint approximation and efficient resampling adjustment to account for the inflated type 1 error rates seen with unbalanced case-control ratios. It combines single-variant score statistics and their covariance estimate to perform SKAT-O (<xref ref-type="bibr" rid="bib49">Lee et al., 2012</xref>) gene-based association testing, upweighting rarer variants using the β(1,25) weights option. SKAT-O (<xref ref-type="bibr" rid="bib49">Lee et al., 2012</xref>) is a combination of a traditional burden and variance-component test and provides robust power when the underlying genetic architecture is unknown. Sex and the top 10 principal components were included as fixed effects when fitting the null model. Chromosome X analysis was performed in males only. A Bonferroni adjusted p-value of 2.58×10<sup>–6</sup> (0.05/19,364 genes) was used to determine the exome-wide significance threshold.</p></sec><sec id="s4-17"><title>SV analysis</title><p>SVs (&gt;50 bp) that intersect by a minimum of 1 bp with (a) at least one exon ([GENCODE version 29 [<xref ref-type="bibr" rid="bib28">Frankish et al., 2019</xref>]]) or (b) an ENCODE (<xref ref-type="bibr" rid="bib58">Moore et al., 2020</xref>) cCRE were extracted using BEDTools (version 2.27.1) (<xref ref-type="bibr" rid="bib69">Quinlan and Hall, 2010</xref>). Variants were retained if they fulfilled the following quality filters: Q-score ≥Q10 (CANVAS [<xref ref-type="bibr" rid="bib72">Roller et al., 2016</xref>]) or QUAL ≥20, GQ ≥15, and MaxMQ0Frac &lt;0.4 (MANTA [<xref ref-type="bibr" rid="bib11">Chen et al., 2016a</xref>]). Variants without paired read support, inconsistent ploidy, or depth &gt;×3 the mean chromosome depth near breakends were excluded.</p><p>ENCODE (<xref ref-type="bibr" rid="bib58">Moore et al., 2020</xref>) cCREs are 150–350 bp consensus sites of chromatin accessibility (DNase hypersensitivity sites) with high H3K4me3, high H3K27ac, and/or high CTCF signal in at least one biosample. A list of 926,535 cCREs encoded by 7.9% of the human genome was downloaded from UCSC Table Browser using the encodeCcreCombined track (updated 2020-05-20). This includes ~668,000 dELS elements, ~142,000 pELS elements, ~57,000 CTCF-only elements, ~35,000 PLS, and ~26,000 DNase-H3K4me3 elements (promoter-like signals &gt;200 bp from a transcription start site).</p><p>Variants were separated and filtered by SV type (deletion, duplication, CNV, inversion); those with a minimum 70% reciprocal overlap with common SVs from (a) dbVar (<xref ref-type="bibr" rid="bib54">MacDonald et al., 2014</xref>) or (b) 12,234 cancer patients from the 100KGP were removed. The dbVar NCBI-curated dataset of SVs (nstd186) contains variant calls from studies with at least 100 samples and AF &gt;1% in at least one population, including gnomAD (<xref ref-type="bibr" rid="bib39">Karczewski et al., 2020</xref>), 1000 Genomes (Phase 3; <xref ref-type="bibr" rid="bib1">Auton et al., 2015</xref>) and DECIPHER (<xref ref-type="bibr" rid="bib15">Cooper et al., 2011</xref>). To create a dataset of common SVs from the 100KGP cancer cohort, variants were merged using SURVIVOR (version 1.0.7; <xref ref-type="bibr" rid="bib38">Jeffares et al., 2017</xref>), allowing a maximum distance of 300 bp between pairwise breakpoints, and those with AF &gt;0.1% retained. After removal of overlapping common variants, SVs in the case-control cohort were filtered to keep those with AF &lt;0.1% and aggregated across 19,907 autosomal protein-coding genes and five cCRE types. Exome-wide gene-based and genome-wide cCRE-based burden analysis was carried out using custom R scripts (<xref ref-type="supplementary-material" rid="scode2">Source code 2</xref>). The burden of rare autosomal SVs in cases and controls was enumerated by comparing the number of individuals with ≥1 SV using a two-sided Fisher’s exact test. The Wilcoxon Mann-Whitney test was used to compare median SV size. Bonferroni adjustment for the number of genes (p=0.05/19,907=2.5 × 10<sup>–6</sup>) and cCRE/SV combinations (p=0.05/20=2.5 × 10<sup>–3</sup>) tested was applied.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Methodology, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con4"><p>Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Supervision</p></fn><fn fn-type="con" id="con6"><p>Software</p></fn><fn fn-type="con" id="con7"><p>Validation</p></fn><fn fn-type="con" id="con8"><p>Validation</p></fn><fn fn-type="con" id="con9"><p>Validation</p></fn><fn fn-type="con" id="con10"><p>Validation</p></fn><fn fn-type="con" id="con11"><p>Investigation</p></fn><fn fn-type="con" id="con12"><p>Resources, Project administration</p></fn><fn fn-type="con" id="con13"><p>Resources, Project administration</p></fn><fn fn-type="con" id="con14"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con15"><p>Software, Methodology</p></fn><fn fn-type="con" id="con16"><p>Software, Methodology</p></fn><fn fn-type="con" id="con17"><p>Data curation, Resources</p></fn><fn fn-type="con" id="con18"><p>Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con19"><p>Supervision, Validation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con20"><p>Supervision, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con21"><p>Conceptualization, Software, Formal analysis, Supervision, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con22"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing – original draft, Project administration</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Ethical approval for the 100,000 Genomes Project was granted by the Research Ethics Committee for East of England - Cambridge South (REC Ref 14/EE/1112). Written informed consent was obtained from all participants and/or their guardians. Human embryonic tissues, collected after maternal consent and ethical approval (REC18/NE/0290), were sourced from the Medical Research Council and Wellcome Trust Human Developmental Biology Resource (<ext-link ext-link-type="uri" xlink:href="https://www.hdbr.org/">https://www.hdbr.org/</ext-link>).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-74777-transrepform1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="scode1"><label>Source code 1.</label><caption><title>Ancestry matching.</title></caption><media xlink:href="elife-74777-code1-v2.zip" mimetype="application" mime-subtype="zip"/></supplementary-material><supplementary-material id="scode2"><label>Source code 2.</label><caption><title>SV burden code.</title></caption><media xlink:href="elife-74777-code2-v2.zip" mimetype="application" mime-subtype="zip"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All genetic and phenotypic data from the 100,000 Genomes Project and can be accessed by application to Genomics England Ltd (<ext-link ext-link-type="uri" xlink:href="https://www.genomicsengland.co.uk/about-gecip/joining-research-community/">https://www.genomicsengland.co.uk/about-gecip/joining-research-community/</ext-link>). Access is free for academic research institutions and universities as well as public and private healthcare organisations that undertake significant research activity. This dataset includes de-identified, linked information for each participant including genome sequence data, variant call files, phenotype/clinical data and Hospital Episode Statistics (HES) with access gained through a secure Research Environment. No sequencing or identifiable personal data is available for download. The full GWAS summary statistics have been uploaded to the NHGRI-EBI GWAS Catalog (<ext-link ext-link-type="uri" xlink:href="http://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90134001-GCST90135000/GCST90134254">http://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90134001-GCST90135000/GCST90134254</ext-link>). Source data files have been provided for Figures 2, 6, 9 and 10 containing the numerical data used to generate figures. Code for SAIGE and SAIGE-GENE can be found at <ext-link ext-link-type="uri" xlink:href="https://github.com/weizhouUMICH/SAIGE">https://github.com/weizhouUMICH/SAIGE</ext-link>, (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:84ca3843e323dbe03adc5bb8e034f5319ffb2150;origin=https://github.com/weizhouUMICH/SAIGE;visit=swh:1:snp:e4b94ddcd6f65035c0bab153581a20ed7a71fca8;anchor=swh:1:rev:a41727267cb5f843a4446e4d4809cafc72687a5d">swh:1:rev:a41727267cb5f843a4446e4d4809cafc72687a5d</ext-link>). Code for PAINTOR is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/gkichaev/PAINTOR_V3.0">https://github.com/gkichaev/PAINTOR_V3.0</ext-link>, (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:60c22b931f5ff12a4c1ae28c4841f78c8c62bf59;origin=https://github.com/gkichaev/PAINTOR_V3.0;visit=swh:1:snp:9ebe5c28644f7ce1e6eb541e3c94ea2164deb98e;anchor=swh:1:rev:ffce82a7114eeb98220db39ba5d6b69e5a419a9e">swh:1:rev:ffce82a7114eeb98220db39ba5d6b69e5a419a9e</ext-link>) Functional annotation and MAGMA gene and gene-set analysis were performed using the web-based platform FUMA (<ext-link ext-link-type="uri" xlink:href="https://fuma.ctglab.nl">https://fuma.ctglab.nl</ext-link>). Custom R Code for the case-control ancestry-matching and structural variant burden analysis have been uploaded as Source code 1 (ancestry matching) and Source code 2 (SV burden testing).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>MMY</given-names></name><name><surname>Sadeghi-Alavijeh</surname><given-names>O</given-names></name><collab>Genomics England Research Consortium</collab><name><surname>Levine</surname><given-names>AP</given-names></name><name><surname>Bockenhauer</surname><given-names>D</given-names></name><name><surname>Gale</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>PUV Summary Statistics</data-title><source>GWAS Catalog</source><pub-id pub-id-type="accession" xlink:href="http://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90134001-GCST90135000/GCST90134254">GCST90134254</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>JR</given-names></name><name><surname>Jung</surname><given-names>I</given-names></name><name><surname>Selvaraj</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>Chromatin architecture reorganization during stem cell differentiation</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52457">GSE52457</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Buniello</surname><given-names>A</given-names></name><name><surname>MacArthur</surname><given-names>JAL</given-names></name><name><surname>Cerezo</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019</data-title><source>GWAS Catalog</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/gwas/studies/GCST002890">GCST002890</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This research was made possible through access to the data and findings generated by the 100KGP. The 100KGP is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100KGP is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK, and the Medical Research Council have also funded research infrastructure. The 100KGP uses data provided by patients and collected by the National Health Service as part of their care and support. The authors gratefully acknowledge the participation of the patients and their families recruited to the 100KGP. The authors also gratefully acknowledge the participation of the patients and their families in the replication study, the majority of whom were recruited via the CaRE for LUTO Study.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auton</surname><given-names>A</given-names></name><name><surname>Brooks</surname><given-names>LD</given-names></name><name><surname>Durbin</surname><given-names>RM</given-names></name><name><surname>Garrison</surname><given-names>EP</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Korbel</surname><given-names>JO</given-names></name><name><surname>Marchini</surname><given-names>JL</given-names></name><name><surname>McCarthy</surname><given-names>S</given-names></name><name><surname>McVean</surname><given-names>GA</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><collab>1000 Genomes Project Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>A global reference for human genetic variation</article-title><source>Nature</source><volume>526</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nature15393</pub-id><pub-id pub-id-type="pmid">26432245</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basson</surname><given-names>CT</given-names></name><name><surname>Bachinsky</surname><given-names>DR</given-names></name><name><surname>Lin</surname><given-names>RC</given-names></name><name><surname>Levi</surname><given-names>T</given-names></name><name><surname>Elkins</surname><given-names>JA</given-names></name><name><surname>Soults</surname><given-names>J</given-names></name><name><surname>Grayzel</surname><given-names>D</given-names></name><name><surname>Kroumpouzou</surname><given-names>E</given-names></name><name><surname>Traill</surname><given-names>TA</given-names></name><name><surname>Leblanc-Straceski</surname><given-names>J</given-names></name><name><surname>Renault</surname><given-names>B</given-names></name><name><surname>Kucherlapati</surname><given-names>R</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Mutations in human tbx5 [corrected] cause limb and cardiac malformation in holt-oram syndrome</article-title><source>Nature Genetics</source><volume>15</volume><fpage>30</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/ng0197-30</pub-id><pub-id pub-id-type="pmid">8988165</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>H</given-names></name><name><surname>Wodarz</surname><given-names>A</given-names></name><name><surname>Borchers</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PTK7 faces the wnt in development and disease</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>5</volume><elocation-id>31</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2017.00031</pub-id><pub-id pub-id-type="pmid">28424771</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berndt</surname><given-names>SI</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yeager</surname><given-names>M</given-names></name><name><surname>Alavanja</surname><given-names>MC</given-names></name><name><surname>Albanes</surname><given-names>D</given-names></name><name><surname>Amundadottir</surname><given-names>L</given-names></name><name><surname>Andriole</surname><given-names>G</given-names></name><name><surname>Beane Freeman</surname><given-names>L</given-names></name><name><surname>Campa</surname><given-names>D</given-names></name><name><surname>Cancel-Tassin</surname><given-names>G</given-names></name><name><surname>Canzian</surname><given-names>F</given-names></name><name><surname>Cornu</surname><given-names>JN</given-names></name><name><surname>Cussenot</surname><given-names>O</given-names></name><name><surname>Diver</surname><given-names>WR</given-names></name><name><surname>Gapstur</surname><given-names>SM</given-names></name><name><surname>Grönberg</surname><given-names>H</given-names></name><name><surname>Haiman</surname><given-names>CA</given-names></name><name><surname>Henderson</surname><given-names>B</given-names></name><name><surname>Hutchinson</surname><given-names>A</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Key</surname><given-names>TJ</given-names></name><name><surname>Kolb</surname><given-names>S</given-names></name><name><surname>Koutros</surname><given-names>S</given-names></name><name><surname>Kraft</surname><given-names>P</given-names></name><name><surname>Le Marchand</surname><given-names>L</given-names></name><name><surname>Lindström</surname><given-names>S</given-names></name><name><surname>Machiela</surname><given-names>MJ</given-names></name><name><surname>Ostrander</surname><given-names>EA</given-names></name><name><surname>Riboli</surname><given-names>E</given-names></name><name><surname>Schumacher</surname><given-names>F</given-names></name><name><surname>Siddiq</surname><given-names>A</given-names></name><name><surname>Stanford</surname><given-names>JL</given-names></name><name><surname>Stevens</surname><given-names>VL</given-names></name><name><surname>Travis</surname><given-names>RC</given-names></name><name><surname>Tsilidis</surname><given-names>KK</given-names></name><name><surname>Virtamo</surname><given-names>J</given-names></name><name><surname>Weinstein</surname><given-names>S</given-names></name><name><surname>Wilkund</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Lilly Zheng</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Wheeler</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Sampson</surname><given-names>J</given-names></name><name><surname>Black</surname><given-names>A</given-names></name><name><surname>Jacobs</surname><given-names>K</given-names></name><name><surname>Hoover</surname><given-names>RN</given-names></name><name><surname>Tucker</surname><given-names>M</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><collab>African Ancestry Prostate Cancer GWAS Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Two susceptibility loci identified for prostate cancer aggressiveness</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6889</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7889</pub-id><pub-id pub-id-type="pmid">25939597</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boghossian</surname><given-names>NS</given-names></name><name><surname>Sicko</surname><given-names>RJ</given-names></name><name><surname>Kay</surname><given-names>DM</given-names></name><name><surname>Rigler</surname><given-names>SL</given-names></name><name><surname>Caggana</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>MY</given-names></name><name><surname>Yeung</surname><given-names>EH</given-names></name><name><surname>Pankratz</surname><given-names>N</given-names></name><name><surname>Cole</surname><given-names>BR</given-names></name><name><surname>Druschel</surname><given-names>CM</given-names></name><name><surname>Romitti</surname><given-names>PA</given-names></name><name><surname>Browne</surname><given-names>ML</given-names></name><name><surname>Fan</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>A</given-names></name><name><surname>Brody</surname><given-names>LC</given-names></name><name><surname>Mills</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Rare copy number variants implicated in posterior urethral valves</article-title><source>American Journal of Medical Genetics Part A</source><volume>170</volume><fpage>622</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.37493</pub-id><pub-id pub-id-type="pmid">26663319</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bondeson</surname><given-names>ML</given-names></name><name><surname>Dahl</surname><given-names>N</given-names></name><name><surname>Malmgren</surname><given-names>H</given-names></name><name><surname>Kleijer</surname><given-names>WJ</given-names></name><name><surname>Tönnesen</surname><given-names>T</given-names></name><name><surname>Carlberg</surname><given-names>BM</given-names></name><name><surname>Pettersson</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Inversion of the IDS gene resulting from recombination with IDS-related sequences in a common cause of the hunter syndrome</article-title><source>Human Molecular Genetics</source><volume>4</volume><fpage>615</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1093/hmg/4.4.615</pub-id><pub-id pub-id-type="pmid">7633410</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>AP</given-names></name><name><surname>Hong</surname><given-names>EL</given-names></name><name><surname>Hariharan</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Schaub</surname><given-names>MA</given-names></name><name><surname>Kasowski</surname><given-names>M</given-names></name><name><surname>Karczewski</surname><given-names>KJ</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Hitz</surname><given-names>BC</given-names></name><name><surname>Weng</surname><given-names>S</given-names></name><name><surname>Cherry</surname><given-names>JM</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Annotation of functional variation in personal genomes using regulomedb</article-title><source>Genome Research</source><volume>22</volume><fpage>1790</fpage><lpage>1797</lpage><pub-id pub-id-type="doi">10.1101/gr.137323.112</pub-id><pub-id pub-id-type="pmid">22955989</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brownlee</surname><given-names>E</given-names></name><name><surname>Wragg</surname><given-names>R</given-names></name><name><surname>Robb</surname><given-names>A</given-names></name><name><surname>Chandran</surname><given-names>H</given-names></name><name><surname>Knight</surname><given-names>M</given-names></name><name><surname>McCarthy</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Current epidemiology and antenatal presentation of posterior urethral valves: outcome of BAPS CASS national audit</article-title><source>Journal of Pediatric Surgery</source><volume>54</volume><fpage>318</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.jpedsurg.2018.10.091</pub-id><pub-id pub-id-type="pmid">30528204</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caruana</surname><given-names>G</given-names></name><name><surname>Wong</surname><given-names>MN</given-names></name><name><surname>Walker</surname><given-names>A</given-names></name><name><surname>Heloury</surname><given-names>Y</given-names></name><name><surname>Webb</surname><given-names>N</given-names></name><name><surname>Johnstone</surname><given-names>L</given-names></name><name><surname>James</surname><given-names>PA</given-names></name><name><surname>Burgess</surname><given-names>T</given-names></name><name><surname>Bertram</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Copy-number variation associated with congenital anomalies of the kidney and urinary tract</article-title><source>Pediatric Nephrology</source><volume>30</volume><fpage>487</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1007/s00467-014-2962-9</pub-id><pub-id pub-id-type="pmid">25270717</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Chow</surname><given-names>CC</given-names></name><name><surname>Tellier</surname><given-names>LC</given-names></name><name><surname>Vattikuti</surname><given-names>S</given-names></name><name><surname>Purcell</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Second-generation PLINK: rising to the challenge of larger and richer datasets</article-title><source>GigaScience</source><volume>4</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1186/s13742-015-0047-8</pub-id><pub-id pub-id-type="pmid">25722852</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Schulz-Trieglaff</surname><given-names>O</given-names></name><name><surname>Shaw</surname><given-names>R</given-names></name><name><surname>Barnes</surname><given-names>B</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Källberg</surname><given-names>M</given-names></name><name><surname>Cox</surname><given-names>AJ</given-names></name><name><surname>Kruglyak</surname><given-names>S</given-names></name><name><surname>Saunders</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications</article-title><source>Bioinformatics</source><volume>32</volume><fpage>1220</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv710</pub-id><pub-id pub-id-type="pmid">26647377</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Conomos</surname><given-names>MP</given-names></name><name><surname>Stilp</surname><given-names>AM</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Sofer</surname><given-names>T</given-names></name><name><surname>Szpiro</surname><given-names>AA</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Brehm</surname><given-names>JM</given-names></name><name><surname>Celedón</surname><given-names>JC</given-names></name><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Papanicolaou</surname><given-names>GJ</given-names></name><name><surname>Thornton</surname><given-names>TA</given-names></name><name><surname>Laurie</surname><given-names>CC</given-names></name><name><surname>Rice</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Control for population structure and relatedness for binary traits in genetic association studies via logistic mixed models</article-title><source>American Journal of Human Genetics</source><volume>98</volume><fpage>653</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2016.02.012</pub-id><pub-id pub-id-type="pmid">27018471</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiaramonte</surname><given-names>C</given-names></name><name><surname>Bommarito</surname><given-names>D</given-names></name><name><surname>Zambaiti</surname><given-names>E</given-names></name><name><surname>Antona</surname><given-names>V</given-names></name><name><surname>Li Voti</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genetic basis of posterior urethral valves inheritance</article-title><source>Urology</source><volume>95</volume><fpage>175</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.urology.2016.05.043</pub-id><pub-id pub-id-type="pmid">27261184</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Consortium</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The gtex consortium atlas of genetic regulatory effects across human tissues</article-title><source>Science</source><volume>369</volume><fpage>1318</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.1126/science.aaz1776</pub-id><pub-id pub-id-type="pmid">32913098</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>GM</given-names></name><name><surname>Coe</surname><given-names>BP</given-names></name><name><surname>Girirajan</surname><given-names>S</given-names></name><name><surname>Rosenfeld</surname><given-names>JA</given-names></name><name><surname>Vu</surname><given-names>TH</given-names></name><name><surname>Baker</surname><given-names>C</given-names></name><name><surname>Williams</surname><given-names>C</given-names></name><name><surname>Stalker</surname><given-names>H</given-names></name><name><surname>Hamid</surname><given-names>R</given-names></name><name><surname>Hannig</surname><given-names>V</given-names></name><name><surname>Abdel-Hamid</surname><given-names>H</given-names></name><name><surname>Bader</surname><given-names>P</given-names></name><name><surname>McCracken</surname><given-names>E</given-names></name><name><surname>Niyazov</surname><given-names>D</given-names></name><name><surname>Leppig</surname><given-names>K</given-names></name><name><surname>Thiese</surname><given-names>H</given-names></name><name><surname>Hummel</surname><given-names>M</given-names></name><name><surname>Alexander</surname><given-names>N</given-names></name><name><surname>Gorski</surname><given-names>J</given-names></name><name><surname>Kussmann</surname><given-names>J</given-names></name><name><surname>Shashi</surname><given-names>V</given-names></name><name><surname>Johnson</surname><given-names>K</given-names></name><name><surname>Rehder</surname><given-names>C</given-names></name><name><surname>Ballif</surname><given-names>BC</given-names></name><name><surname>Shaffer</surname><given-names>LG</given-names></name><name><surname>Eichler</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A copy number variation morbidity map of developmental delay</article-title><source>Nature Genetics</source><volume>43</volume><fpage>838</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1038/ng.909</pub-id><pub-id pub-id-type="pmid">21841781</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daly</surname><given-names>SB</given-names></name><name><surname>Urquhart</surname><given-names>JE</given-names></name><name><surname>Hilton</surname><given-names>E</given-names></name><name><surname>McKenzie</surname><given-names>EA</given-names></name><name><surname>Kammerer</surname><given-names>RA</given-names></name><name><surname>Lewis</surname><given-names>M</given-names></name><name><surname>Kerr</surname><given-names>B</given-names></name><name><surname>Stuart</surname><given-names>H</given-names></name><name><surname>Donnai</surname><given-names>D</given-names></name><name><surname>Long</surname><given-names>DA</given-names></name><name><surname>Burgu</surname><given-names>B</given-names></name><name><surname>Aydogdu</surname><given-names>O</given-names></name><name><surname>Derbent</surname><given-names>M</given-names></name><name><surname>Garcia-Minaur</surname><given-names>S</given-names></name><name><surname>Reardon</surname><given-names>W</given-names></name><name><surname>Gener</surname><given-names>B</given-names></name><name><surname>Shalev</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name><name><surname>Black</surname><given-names>GC</given-names></name><name><surname>Newman</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mutations in HPSE2 cause urofacial syndrome</article-title><source>American Journal of Human Genetics</source><volume>86</volume><fpage>963</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2010.05.006</pub-id><pub-id pub-id-type="pmid">20560210</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danecek</surname><given-names>P</given-names></name><name><surname>Bonfield</surname><given-names>JK</given-names></name><name><surname>Liddle</surname><given-names>J</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Ohan</surname><given-names>V</given-names></name><name><surname>Pollard</surname><given-names>MO</given-names></name><name><surname>Whitwham</surname><given-names>A</given-names></name><name><surname>Keane</surname><given-names>T</given-names></name><name><surname>McCarthy</surname><given-names>SA</given-names></name><name><surname>Davies</surname><given-names>RM</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Twelve years of samtools and bcftools</article-title><source>GigaScience</source><volume>10</volume><elocation-id>giab008</elocation-id><pub-id pub-id-type="doi">10.1093/gigascience/giab008</pub-id><pub-id pub-id-type="pmid">33590861</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Leeuw</surname><given-names>CA</given-names></name><name><surname>Mooij</surname><given-names>JM</given-names></name><name><surname>Heskes</surname><given-names>T</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MAGMA: generalized gene-set analysis of GWAS data</article-title><source>PLOS Computational Biology</source><volume>11</volume><elocation-id>e1004219</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004219</pub-id><pub-id pub-id-type="pmid">25885710</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeFoor</surname><given-names>W</given-names></name><name><surname>Clark</surname><given-names>C</given-names></name><name><surname>Jackson</surname><given-names>E</given-names></name><name><surname>Reddy</surname><given-names>P</given-names></name><name><surname>Minevich</surname><given-names>E</given-names></name><name><surname>Sheldon</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Risk factors for end stage renal disease in children with posterior urethral valves</article-title><source>The Journal of Urology</source><volume>180</volume><fpage>1705</fpage><lpage>1708</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2008.03.090</pub-id><pub-id pub-id-type="pmid">18708224</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demirkan</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>An unusual urological manifestation of williams-beuren syndrome: posterior urethral valve</article-title><source>Urologia Internationalis</source><volume>105</volume><fpage>159</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1159/000510529</pub-id><pub-id pub-id-type="pmid">32998153</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dey</surname><given-names>R</given-names></name><name><surname>Schmidt</surname><given-names>EM</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A fast and accurate algorithm to test for binary phenotypes and its application to phewas</article-title><source>American Journal of Human Genetics</source><volume>101</volume><fpage>37</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.05.014</pub-id><pub-id pub-id-type="pmid">28602423</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>JR</given-names></name><name><surname>Jung</surname><given-names>I</given-names></name><name><surname>Selvaraj</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Antosiewicz-Bourget</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>AY</given-names></name><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Kim</surname><given-names>A</given-names></name><name><surname>Rajagopal</surname><given-names>N</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Diao</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Lobanenkov</surname><given-names>VV</given-names></name><name><surname>Ecker</surname><given-names>JR</given-names></name><name><surname>Thomson</surname><given-names>JA</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Chromatin architecture reorganization during stem cell differentiation</article-title><source>Nature</source><volume>518</volume><fpage>331</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1038/nature14222</pub-id><pub-id pub-id-type="pmid">25693564</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>NR</given-names></name><name><surname>Tolwinski</surname><given-names>NS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ptk7 and mcc, unfancied components in non-canonical wnt signaling and cancer</article-title><source>Cancers</source><volume>8</volume><elocation-id>E68</elocation-id><pub-id pub-id-type="doi">10.3390/cancers8070068</pub-id><pub-id pub-id-type="pmid">27438854</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>J</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>ChromHMM: automating chromatin-state discovery and characterization</article-title><source>Nature Methods</source><volume>9</volume><fpage>215</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1906</pub-id><pub-id pub-id-type="pmid">22373907</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatumo</surname><given-names>S</given-names></name><name><surname>Chikowore</surname><given-names>T</given-names></name><name><surname>Choudhury</surname><given-names>A</given-names></name><name><surname>Ayub</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>AR</given-names></name><name><surname>Kuchenbaecker</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A roadmap to increase diversity in genomic studies</article-title><source>Nature Medicine</source><volume>28</volume><fpage>243</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01672-4</pub-id><pub-id pub-id-type="pmid">35145307</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faure</surname><given-names>A</given-names></name><name><surname>Bouty</surname><given-names>A</given-names></name><name><surname>Caruana</surname><given-names>G</given-names></name><name><surname>Williams</surname><given-names>L</given-names></name><name><surname>Burgess</surname><given-names>T</given-names></name><name><surname>Wong</surname><given-names>MN</given-names></name><name><surname>James</surname><given-names>PA</given-names></name><name><surname>O’Brien</surname><given-names>M</given-names></name><name><surname>Walker</surname><given-names>A</given-names></name><name><surname>Bertram</surname><given-names>JF</given-names></name><name><surname>Heloury</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>DNA copy number variants: A potentially useful predictor of early onset renal failure in boys with posterior urethral valves</article-title><source>Journal of Pediatric Urology</source><volume>12</volume><elocation-id>227</elocation-id><pub-id pub-id-type="doi">10.1016/j.jpurol.2016.02.020</pub-id><pub-id pub-id-type="pmid">27160979</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornes</surname><given-names>O</given-names></name><name><surname>Castro-Mondragon</surname><given-names>JA</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>van der Lee</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Richmond</surname><given-names>PA</given-names></name><name><surname>Modi</surname><given-names>BP</given-names></name><name><surname>Correard</surname><given-names>S</given-names></name><name><surname>Gheorghe</surname><given-names>M</given-names></name><name><surname>Baranašić</surname><given-names>D</given-names></name><name><surname>Santana-Garcia</surname><given-names>W</given-names></name><name><surname>Tan</surname><given-names>G</given-names></name><name><surname>Chèneby</surname><given-names>J</given-names></name><name><surname>Ballester</surname><given-names>B</given-names></name><name><surname>Parcy</surname><given-names>F</given-names></name><name><surname>Sandelin</surname><given-names>A</given-names></name><name><surname>Lenhard</surname><given-names>B</given-names></name><name><surname>Wasserman</surname><given-names>WW</given-names></name><name><surname>Mathelier</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>JASPAR 2020: update of the open-access database of transcription factor binding profiles</article-title><source>Nucleic Acids Research</source><volume>48</volume><fpage>D87</fpage><lpage>D92</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz1001</pub-id><pub-id pub-id-type="pmid">31701148</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frankish</surname><given-names>A</given-names></name><name><surname>Diekhans</surname><given-names>M</given-names></name><name><surname>Ferreira</surname><given-names>AM</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Jungreis</surname><given-names>I</given-names></name><name><surname>Loveland</surname><given-names>J</given-names></name><name><surname>Mudge</surname><given-names>JM</given-names></name><name><surname>Sisu</surname><given-names>C</given-names></name><name><surname>Wright</surname><given-names>J</given-names></name><name><surname>Armstrong</surname><given-names>J</given-names></name><name><surname>Barnes</surname><given-names>I</given-names></name><name><surname>Berry</surname><given-names>A</given-names></name><name><surname>Bignell</surname><given-names>A</given-names></name><name><surname>Carbonell Sala</surname><given-names>S</given-names></name><name><surname>Chrast</surname><given-names>J</given-names></name><name><surname>Cunningham</surname><given-names>F</given-names></name><name><surname>Di Domenico</surname><given-names>T</given-names></name><name><surname>Donaldson</surname><given-names>S</given-names></name><name><surname>Fiddes</surname><given-names>IT</given-names></name><name><surname>García Girón</surname><given-names>C</given-names></name><name><surname>Gonzalez</surname><given-names>JM</given-names></name><name><surname>Grego</surname><given-names>T</given-names></name><name><surname>Hardy</surname><given-names>M</given-names></name><name><surname>Hourlier</surname><given-names>T</given-names></name><name><surname>Hunt</surname><given-names>T</given-names></name><name><surname>Izuogu</surname><given-names>OG</given-names></name><name><surname>Lagarde</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>FJ</given-names></name><name><surname>Martínez</surname><given-names>L</given-names></name><name><surname>Mohanan</surname><given-names>S</given-names></name><name><surname>Muir</surname><given-names>P</given-names></name><name><surname>Navarro</surname><given-names>FCP</given-names></name><name><surname>Parker</surname><given-names>A</given-names></name><name><surname>Pei</surname><given-names>B</given-names></name><name><surname>Pozo</surname><given-names>F</given-names></name><name><surname>Ruffier</surname><given-names>M</given-names></name><name><surname>Schmitt</surname><given-names>BM</given-names></name><name><surname>Stapleton</surname><given-names>E</given-names></name><name><surname>Suner</surname><given-names>MM</given-names></name><name><surname>Sycheva</surname><given-names>I</given-names></name><name><surname>Uszczynska-Ratajczak</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Yates</surname><given-names>A</given-names></name><name><surname>Zerbino</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Aken</surname><given-names>B</given-names></name><name><surname>Choudhary</surname><given-names>JS</given-names></name><name><surname>Gerstein</surname><given-names>M</given-names></name><name><surname>Guigó</surname><given-names>R</given-names></name><name><surname>Hubbard</surname><given-names>TJP</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Paten</surname><given-names>B</given-names></name><name><surname>Reymond</surname><given-names>A</given-names></name><name><surname>Tress</surname><given-names>ML</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>GENCODE reference annotation for the human and mouse genomes</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D766</fpage><lpage>D773</lpage><pub-id pub-id-type="doi">10.1093/nar/gky955</pub-id><pub-id pub-id-type="pmid">30357393</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frese</surname><given-names>S</given-names></name><name><surname>Weigert</surname><given-names>A</given-names></name><name><surname>Hoppe</surname><given-names>B</given-names></name><name><surname>Feldkötter</surname><given-names>M</given-names></name><name><surname>Ludwig</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Kiliś-Pstrusińska</surname><given-names>K</given-names></name><name><surname>Zaniew</surname><given-names>M</given-names></name><name><surname>Reutter</surname><given-names>H</given-names></name><name><surname>Hilger</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A classic twin study of lower urinary tract obstruction: report of 3 cases and literature review</article-title><source>Lower Urinary Tract Symptoms</source><volume>11</volume><fpage>O85</fpage><lpage>O88</lpage><pub-id pub-id-type="doi">10.1111/luts.12222</pub-id><pub-id pub-id-type="pmid">29664229</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="data"><person-group person-group-type="author"><collab>General Register Office for Scotland, Northern Ireland Statistics and Research Agency, Office for National Statistics, Census Division</collab></person-group><year iso-8601-date="2020">2020</year><data-title>2001 Census: Aggregate Data</data-title><source>UK Data Service</source><pub-id pub-id-type="doi">10.5257/census/aggregate-2001-2</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gogarten</surname><given-names>SM</given-names></name><name><surname>Bhangale</surname><given-names>T</given-names></name><name><surname>Conomos</surname><given-names>MP</given-names></name><name><surname>Laurie</surname><given-names>CA</given-names></name><name><surname>McHugh</surname><given-names>CP</given-names></name><name><surname>Painter</surname><given-names>I</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Crosslin</surname><given-names>DR</given-names></name><name><surname>Levine</surname><given-names>D</given-names></name><name><surname>Lumley</surname><given-names>T</given-names></name><name><surname>Nelson</surname><given-names>SC</given-names></name><name><surname>Rice</surname><given-names>K</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Swarnkar</surname><given-names>R</given-names></name><name><surname>Weir</surname><given-names>BS</given-names></name><name><surname>Laurie</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>GWASTools: an R/bioconductor package for quality control and analysis of genome-wide association studies</article-title><source>Bioinformatics</source><volume>28</volume><fpage>3329</fpage><lpage>3331</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts610</pub-id><pub-id pub-id-type="pmid">23052040</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>AM</given-names></name><name><surname>Ajay</surname><given-names>SS</given-names></name><name><surname>Rajan</surname><given-names>V</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><name><surname>Bluske</surname><given-names>K</given-names></name><name><surname>Burns</surname><given-names>NJ</given-names></name><name><surname>Chawla</surname><given-names>A</given-names></name><name><surname>Coffey</surname><given-names>AJ</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><name><surname>Scocchia</surname><given-names>A</given-names></name><name><surname>Thorpe</surname><given-names>E</given-names></name><name><surname>Dzidic</surname><given-names>N</given-names></name><name><surname>Hovanes</surname><given-names>K</given-names></name><name><surname>Sahoo</surname><given-names>T</given-names></name><name><surname>Dolzhenko</surname><given-names>E</given-names></name><name><surname>Lajoie</surname><given-names>B</given-names></name><name><surname>Khouzam</surname><given-names>A</given-names></name><name><surname>Chowdhury</surname><given-names>S</given-names></name><name><surname>Belmont</surname><given-names>J</given-names></name><name><surname>Roller</surname><given-names>E</given-names></name><name><surname>Ivakhno</surname><given-names>S</given-names></name><name><surname>Tanner</surname><given-names>S</given-names></name><name><surname>McEachern</surname><given-names>J</given-names></name><name><surname>Hambuch</surname><given-names>T</given-names></name><name><surname>Eberle</surname><given-names>M</given-names></name><name><surname>Hagelstrom</surname><given-names>RT</given-names></name><name><surname>Bentley</surname><given-names>DR</given-names></name><name><surname>Perry</surname><given-names>DL</given-names></name><name><surname>Taft</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Copy-number variants in clinical genome sequencing: deployment and interpretation for rare and undiagnosed disease</article-title><source>Genetics in Medicine</source><volume>21</volume><fpage>1121</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1038/s41436-018-0295-y</pub-id><pub-id pub-id-type="pmid">30293986</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>LX</given-names></name><name><surname>Paria</surname><given-names>N</given-names></name><name><surname>Henkelman</surname><given-names>RM</given-names></name><name><surname>Wise</surname><given-names>CA</given-names></name><name><surname>Ciruna</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ptk7 mutant zebrafish models of congenital and idiopathic scoliosis implicate dysregulated wnt signalling in disease</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>4777</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms5777</pub-id><pub-id pub-id-type="pmid">25182715</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heikkilä</surname><given-names>J</given-names></name><name><surname>Holmberg</surname><given-names>C</given-names></name><name><surname>Kyllönen</surname><given-names>L</given-names></name><name><surname>Rintala</surname><given-names>R</given-names></name><name><surname>Taskinen</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Long-term risk of end stage renal disease in patients with posterior urethral valves</article-title><source>Journal of Urology</source><volume>186</volume><fpage>2392</fpage><lpage>2396</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2011.07.109</pub-id><pub-id pub-id-type="pmid">22014822</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Höglund</surname><given-names>J</given-names></name><name><surname>Rafati</surname><given-names>N</given-names></name><name><surname>Rask-Andersen</surname><given-names>M</given-names></name><name><surname>Enroth</surname><given-names>S</given-names></name><name><surname>Karlsson</surname><given-names>T</given-names></name><name><surname>Ek</surname><given-names>WE</given-names></name><name><surname>Johansson</surname><given-names>Å</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Improved power and precision with whole genome sequencing data in genome-wide association studies of inflammatory biomarkers</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>16844</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-53111-7</pub-id><pub-id pub-id-type="pmid">31727947</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houcinat</surname><given-names>N</given-names></name><name><surname>Llanas</surname><given-names>B</given-names></name><name><surname>Moutton</surname><given-names>S</given-names></name><name><surname>Toutain</surname><given-names>J</given-names></name><name><surname>Cailley</surname><given-names>D</given-names></name><name><surname>Arveiler</surname><given-names>B</given-names></name><name><surname>Combe</surname><given-names>C</given-names></name><name><surname>Lacombe</surname><given-names>D</given-names></name><name><surname>Rooryck</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Homozygous 16p13.11 duplication associated with mild intellectual disability and urinary tract malformations in two siblings born from consanguineous parents</article-title><source>American Journal of Medical Genetics Part A</source><volume>167</volume><fpage>2714</fpage><lpage>2719</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.37212</pub-id><pub-id pub-id-type="pmid">26114937</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houweling</surname><given-names>AC</given-names></name><name><surname>Beaman</surname><given-names>GM</given-names></name><name><surname>Postma</surname><given-names>AV</given-names></name><name><surname>Gainous</surname><given-names>TB</given-names></name><name><surname>Lichtenbelt</surname><given-names>KD</given-names></name><name><surname>Brancati</surname><given-names>F</given-names></name><name><surname>Lopes</surname><given-names>FM</given-names></name><name><surname>van der Made</surname><given-names>I</given-names></name><name><surname>Polstra</surname><given-names>AM</given-names></name><name><surname>Robinson</surname><given-names>ML</given-names></name><name><surname>Wright</surname><given-names>KD</given-names></name><name><surname>Ellingford</surname><given-names>JM</given-names></name><name><surname>Jackson</surname><given-names>AR</given-names></name><name><surname>Overwater</surname><given-names>E</given-names></name><name><surname>Genesio</surname><given-names>R</given-names></name><name><surname>Romano</surname><given-names>S</given-names></name><name><surname>Camerota</surname><given-names>L</given-names></name><name><surname>D’Angelo</surname><given-names>E</given-names></name><name><surname>Meijers-Heijboer</surname><given-names>EJ</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name><name><surname>McHugh</surname><given-names>KM</given-names></name><name><surname>Black</surname><given-names>BL</given-names></name><name><surname>Newman</surname><given-names>WG</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name><name><surname>Creemers</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Loss-of-function variants in myocardin cause congenital megabladder in humans and mice</article-title><source>Journal of Clinical Investigation</source><volume>129</volume><fpage>5374</fpage><lpage>5380</lpage><pub-id pub-id-type="doi">10.1172/JCI128545</pub-id><pub-id pub-id-type="pmid">31513549</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffares</surname><given-names>DC</given-names></name><name><surname>Jolly</surname><given-names>C</given-names></name><name><surname>Hoti</surname><given-names>M</given-names></name><name><surname>Speed</surname><given-names>D</given-names></name><name><surname>Shaw</surname><given-names>L</given-names></name><name><surname>Rallis</surname><given-names>C</given-names></name><name><surname>Balloux</surname><given-names>F</given-names></name><name><surname>Dessimoz</surname><given-names>C</given-names></name><name><surname>Bähler</surname><given-names>J</given-names></name><name><surname>Sedlazeck</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transient structural variations have strong effects on quantitative traits and reproductive isolation in fission yeast</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14061</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14061</pub-id><pub-id pub-id-type="pmid">28117401</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karczewski</surname><given-names>KJ</given-names></name><name><surname>Francioli</surname><given-names>LC</given-names></name><name><surname>Tiao</surname><given-names>G</given-names></name><name><surname>Cummings</surname><given-names>BB</given-names></name><name><surname>Alföldi</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Collins</surname><given-names>RL</given-names></name><name><surname>Laricchia</surname><given-names>KM</given-names></name><name><surname>Ganna</surname><given-names>A</given-names></name><name><surname>Birnbaum</surname><given-names>DP</given-names></name><name><surname>Gauthier</surname><given-names>LD</given-names></name><name><surname>Brand</surname><given-names>H</given-names></name><name><surname>Solomonson</surname><given-names>M</given-names></name><name><surname>Watts</surname><given-names>NA</given-names></name><name><surname>Rhodes</surname><given-names>D</given-names></name><name><surname>Singer-Berk</surname><given-names>M</given-names></name><name><surname>England</surname><given-names>EM</given-names></name><name><surname>Seaby</surname><given-names>EG</given-names></name><name><surname>Kosmicki</surname><given-names>JA</given-names></name><name><surname>Walters</surname><given-names>RK</given-names></name><name><surname>Tashman</surname><given-names>K</given-names></name><name><surname>Farjoun</surname><given-names>Y</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Poterba</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Seed</surname><given-names>C</given-names></name><name><surname>Whiffin</surname><given-names>N</given-names></name><name><surname>Chong</surname><given-names>JX</given-names></name><name><surname>Samocha</surname><given-names>KE</given-names></name><name><surname>Pierce-Hoffman</surname><given-names>E</given-names></name><name><surname>Zappala</surname><given-names>Z</given-names></name><name><surname>O’Donnell-Luria</surname><given-names>AH</given-names></name><name><surname>Minikel</surname><given-names>EV</given-names></name><name><surname>Weisburd</surname><given-names>B</given-names></name><name><surname>Lek</surname><given-names>M</given-names></name><name><surname>Ware</surname><given-names>JS</given-names></name><name><surname>Vittal</surname><given-names>C</given-names></name><name><surname>Armean</surname><given-names>IM</given-names></name><name><surname>Bergelson</surname><given-names>L</given-names></name><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Connolly</surname><given-names>KM</given-names></name><name><surname>Covarrubias</surname><given-names>M</given-names></name><name><surname>Donnelly</surname><given-names>S</given-names></name><name><surname>Ferriera</surname><given-names>S</given-names></name><name><surname>Gabriel</surname><given-names>S</given-names></name><name><surname>Gentry</surname><given-names>J</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Jeandet</surname><given-names>T</given-names></name><name><surname>Kaplan</surname><given-names>D</given-names></name><name><surname>Llanwarne</surname><given-names>C</given-names></name><name><surname>Munshi</surname><given-names>R</given-names></name><name><surname>Novod</surname><given-names>S</given-names></name><name><surname>Petrillo</surname><given-names>N</given-names></name><name><surname>Roazen</surname><given-names>D</given-names></name><name><surname>Ruano-Rubio</surname><given-names>V</given-names></name><name><surname>Saltzman</surname><given-names>A</given-names></name><name><surname>Schleicher</surname><given-names>M</given-names></name><name><surname>Soto</surname><given-names>J</given-names></name><name><surname>Tibbetts</surname><given-names>K</given-names></name><name><surname>Tolonen</surname><given-names>C</given-names></name><name><surname>Wade</surname><given-names>G</given-names></name><name><surname>Talkowski</surname><given-names>ME</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>MacArthur</surname><given-names>DG</given-names></name><collab>Genome Aggregation Database Consortium</collab></person-group><year iso-8601-date="2020">2020</year><article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title><source>Nature</source><volume>581</volume><fpage>434</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id><pub-id pub-id-type="pmid">32461654</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname><given-names>WJ</given-names></name><name><surname>Sugnet</surname><given-names>CW</given-names></name><name><surname>Furey</surname><given-names>TS</given-names></name><name><surname>Roskin</surname><given-names>KM</given-names></name><name><surname>Pringle</surname><given-names>TH</given-names></name><name><surname>Zahler</surname><given-names>AM</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The human genome browser at UCSC</article-title><source>Genome Research</source><volume>12</volume><fpage>996</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1101/gr.229102</pub-id><pub-id pub-id-type="pmid">12045153</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalil</surname><given-names>A</given-names></name><name><surname>Al-Haddad</surname><given-names>C</given-names></name><name><surname>Hariri</surname><given-names>H</given-names></name><name><surname>Shibbani</surname><given-names>K</given-names></name><name><surname>Bitar</surname><given-names>F</given-names></name><name><surname>Kurban</surname><given-names>M</given-names></name><name><surname>Nemer</surname><given-names>G</given-names></name><name><surname>Arabi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A novel mutation in <italic>foxc1</italic> in A lebanese family with congenital heart disease and anterior segment dysgenesis: potential roles for <italic>nfatc1</italic> and <italic>dpt</italic> in the phenotypic variations</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>4</volume><fpage>58</fpage><pub-id pub-id-type="doi">10.3389/fcvm.2017.00058</pub-id><pub-id pub-id-type="pmid">28979898</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kichaev</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>WY</given-names></name><name><surname>Lindstrom</surname><given-names>S</given-names></name><name><surname>Hormozdiari</surname><given-names>F</given-names></name><name><surname>Eskin</surname><given-names>E</given-names></name><name><surname>Price</surname><given-names>AL</given-names></name><name><surname>Kraft</surname><given-names>P</given-names></name><name><surname>Pasaniuc</surname><given-names>B</given-names></name><name><surname>Di Rienzo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Integrating functional data to prioritize causal variants in statistical fine-mapping studies</article-title><source>PLOS Genetics</source><volume>10</volume><elocation-id>e1004722</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004722</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köhler</surname><given-names>S</given-names></name><name><surname>Gargano</surname><given-names>M</given-names></name><name><surname>Matentzoglu</surname><given-names>N</given-names></name><name><surname>Carmody</surname><given-names>LC</given-names></name><name><surname>Lewis-Smith</surname><given-names>D</given-names></name><name><surname>Vasilevsky</surname><given-names>NA</given-names></name><name><surname>Danis</surname><given-names>D</given-names></name><name><surname>Balagura</surname><given-names>G</given-names></name><name><surname>Baynam</surname><given-names>G</given-names></name><name><surname>Brower</surname><given-names>AM</given-names></name><name><surname>Callahan</surname><given-names>TJ</given-names></name><name><surname>Chute</surname><given-names>CG</given-names></name><name><surname>Est</surname><given-names>JL</given-names></name><name><surname>Galer</surname><given-names>PD</given-names></name><name><surname>Ganesan</surname><given-names>S</given-names></name><name><surname>Griese</surname><given-names>M</given-names></name><name><surname>Haimel</surname><given-names>M</given-names></name><name><surname>Pazmandi</surname><given-names>J</given-names></name><name><surname>Hanauer</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>NL</given-names></name><name><surname>Hartnett</surname><given-names>MJ</given-names></name><name><surname>Hastreiter</surname><given-names>M</given-names></name><name><surname>Hauck</surname><given-names>F</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Jeske</surname><given-names>T</given-names></name><name><surname>Kearney</surname><given-names>H</given-names></name><name><surname>Kindle</surname><given-names>G</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Knoflach</surname><given-names>K</given-names></name><name><surname>Krause</surname><given-names>R</given-names></name><name><surname>Lagorce</surname><given-names>D</given-names></name><name><surname>McMurry</surname><given-names>JA</given-names></name><name><surname>Miller</surname><given-names>JA</given-names></name><name><surname>Munoz-Torres</surname><given-names>MC</given-names></name><name><surname>Peters</surname><given-names>RL</given-names></name><name><surname>Rapp</surname><given-names>CK</given-names></name><name><surname>Rath</surname><given-names>AM</given-names></name><name><surname>Rind</surname><given-names>SA</given-names></name><name><surname>Rosenberg</surname><given-names>AZ</given-names></name><name><surname>Segal</surname><given-names>MM</given-names></name><name><surname>Seidel</surname><given-names>MG</given-names></name><name><surname>Smedley</surname><given-names>D</given-names></name><name><surname>Talmy</surname><given-names>T</given-names></name><name><surname>Thomas</surname><given-names>Y</given-names></name><name><surname>Wiafe</surname><given-names>SA</given-names></name><name><surname>Xian</surname><given-names>J</given-names></name><name><surname>Yüksel</surname><given-names>Z</given-names></name><name><surname>Helbig</surname><given-names>I</given-names></name><name><surname>Mungall</surname><given-names>CJ</given-names></name><name><surname>Haendel</surname><given-names>MA</given-names></name><name><surname>Robinson</surname><given-names>PN</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The human phenotype ontology in 2021</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>D1207</fpage><lpage>D1217</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1043</pub-id><pub-id pub-id-type="pmid">33264411</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolvenbach</surname><given-names>CM</given-names></name><name><surname>Dworschak</surname><given-names>GC</given-names></name><name><surname>Frese</surname><given-names>S</given-names></name><name><surname>Japp</surname><given-names>AS</given-names></name><name><surname>Schuster</surname><given-names>P</given-names></name><name><surname>Wenzlitschke</surname><given-names>N</given-names></name><name><surname>Yilmaz</surname><given-names>Ö</given-names></name><name><surname>Lopes</surname><given-names>FM</given-names></name><name><surname>Pryalukhin</surname><given-names>A</given-names></name><name><surname>Schierbaum</surname><given-names>L</given-names></name><name><surname>van der Zanden</surname><given-names>LFM</given-names></name><name><surname>Kause</surname><given-names>F</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Taranta-Janusz</surname><given-names>K</given-names></name><name><surname>Szczepańska</surname><given-names>M</given-names></name><name><surname>Pawlaczyk</surname><given-names>K</given-names></name><name><surname>Newman</surname><given-names>WG</given-names></name><name><surname>Beaman</surname><given-names>GM</given-names></name><name><surname>Stuart</surname><given-names>HM</given-names></name><name><surname>Cervellione</surname><given-names>RM</given-names></name><name><surname>Feitz</surname><given-names>WFJ</given-names></name><name><surname>van Rooij</surname><given-names>I</given-names></name><name><surname>Schreuder</surname><given-names>MF</given-names></name><name><surname>Steffens</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Merz</surname><given-names>WM</given-names></name><name><surname>Feldkötter</surname><given-names>M</given-names></name><name><surname>Hoppe</surname><given-names>B</given-names></name><name><surname>Thiele</surname><given-names>H</given-names></name><name><surname>Altmüller</surname><given-names>J</given-names></name><name><surname>Berg</surname><given-names>C</given-names></name><name><surname>Kristiansen</surname><given-names>G</given-names></name><name><surname>Ludwig</surname><given-names>M</given-names></name><name><surname>Reutter</surname><given-names>H</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name><name><surname>Hildebrandt</surname><given-names>F</given-names></name><name><surname>Grote</surname><given-names>P</given-names></name><name><surname>Zaniew</surname><given-names>M</given-names></name><name><surname>Odermatt</surname><given-names>B</given-names></name><name><surname>Hilger</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Rare variants in BNC2 are implicated in autosomal-dominant congenital lower urinary-tract obstruction</article-title><source>American Journal of Human Genetics</source><volume>104</volume><fpage>994</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2019.03.023</pub-id><pub-id pub-id-type="pmid">31051115</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krietenstein</surname><given-names>N</given-names></name><name><surname>Abraham</surname><given-names>S</given-names></name><name><surname>Venev</surname><given-names>SV</given-names></name><name><surname>Abdennur</surname><given-names>N</given-names></name><name><surname>Gibcus</surname><given-names>J</given-names></name><name><surname>Hsieh</surname><given-names>THS</given-names></name><name><surname>Parsi</surname><given-names>KM</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Maehr</surname><given-names>R</given-names></name><name><surname>Mirny</surname><given-names>LA</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>Rando</surname><given-names>OJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ultrastructural details of mammalian chromosome architecture</article-title><source>Molecular Cell</source><volume>78</volume><fpage>554</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.03.003</pub-id><pub-id pub-id-type="pmid">32213324</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>A</given-names></name><name><surname>de Souza</surname><given-names>A</given-names></name><name><surname>Konijeti</surname><given-names>R</given-names></name><name><surname>Baskin</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The anatomy and embryology of posterior urethral valves</article-title><source>The Journal of Urology</source><volume>175</volume><fpage>1214</fpage><lpage>1220</lpage><pub-id pub-id-type="doi">10.1016/S0022-5347(05)00642-7</pub-id><pub-id pub-id-type="pmid">16515962</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundaje</surname><given-names>A</given-names></name><name><surname>Meuleman</surname><given-names>W</given-names></name><name><surname>Ernst</surname><given-names>J</given-names></name><name><surname>Bilenky</surname><given-names>M</given-names></name><name><surname>Yen</surname><given-names>A</given-names></name><name><surname>Heravi-Moussavi</surname><given-names>A</given-names></name><name><surname>Kheradpour</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ziller</surname><given-names>MJ</given-names></name><name><surname>Amin</surname><given-names>V</given-names></name><name><surname>Whitaker</surname><given-names>JW</given-names></name><name><surname>Schultz</surname><given-names>MD</given-names></name><name><surname>Ward</surname><given-names>LD</given-names></name><name><surname>Sarkar</surname><given-names>A</given-names></name><name><surname>Quon</surname><given-names>G</given-names></name><name><surname>Sandstrom</surname><given-names>RS</given-names></name><name><surname>Eaton</surname><given-names>ML</given-names></name><name><surname>Wu</surname><given-names>YC</given-names></name><name><surname>Pfenning</surname><given-names>AR</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Claussnitzer</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Coarfa</surname><given-names>C</given-names></name><name><surname>Harris</surname><given-names>RA</given-names></name><name><surname>Shoresh</surname><given-names>N</given-names></name><name><surname>Epstein</surname><given-names>CB</given-names></name><name><surname>Gjoneska</surname><given-names>E</given-names></name><name><surname>Leung</surname><given-names>D</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Hawkins</surname><given-names>RD</given-names></name><name><surname>Lister</surname><given-names>R</given-names></name><name><surname>Hong</surname><given-names>C</given-names></name><name><surname>Gascard</surname><given-names>P</given-names></name><name><surname>Mungall</surname><given-names>AJ</given-names></name><name><surname>Moore</surname><given-names>R</given-names></name><name><surname>Chuah</surname><given-names>E</given-names></name><name><surname>Tam</surname><given-names>A</given-names></name><name><surname>Canfield</surname><given-names>TK</given-names></name><name><surname>Hansen</surname><given-names>RS</given-names></name><name><surname>Kaul</surname><given-names>R</given-names></name><name><surname>Sabo</surname><given-names>PJ</given-names></name><name><surname>Bansal</surname><given-names>MS</given-names></name><name><surname>Carles</surname><given-names>A</given-names></name><name><surname>Dixon</surname><given-names>JR</given-names></name><name><surname>Farh</surname><given-names>KH</given-names></name><name><surname>Feizi</surname><given-names>S</given-names></name><name><surname>Karlic</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>AR</given-names></name><name><surname>Kulkarni</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Lowdon</surname><given-names>R</given-names></name><name><surname>Elliott</surname><given-names>G</given-names></name><name><surname>Mercer</surname><given-names>TR</given-names></name><name><surname>Neph</surname><given-names>SJ</given-names></name><name><surname>Onuchic</surname><given-names>V</given-names></name><name><surname>Polak</surname><given-names>P</given-names></name><name><surname>Rajagopal</surname><given-names>N</given-names></name><name><surname>Ray</surname><given-names>P</given-names></name><name><surname>Sallari</surname><given-names>RC</given-names></name><name><surname>Siebenthall</surname><given-names>KT</given-names></name><name><surname>Sinnott-Armstrong</surname><given-names>NA</given-names></name><name><surname>Stevens</surname><given-names>M</given-names></name><name><surname>Thurman</surname><given-names>RE</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Beaudet</surname><given-names>AE</given-names></name><name><surname>Boyer</surname><given-names>LA</given-names></name><name><surname>De Jager</surname><given-names>PL</given-names></name><name><surname>Farnham</surname><given-names>PJ</given-names></name><name><surname>Fisher</surname><given-names>SJ</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name><name><surname>Jones</surname><given-names>SJM</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Marra</surname><given-names>MA</given-names></name><name><surname>McManus</surname><given-names>MT</given-names></name><name><surname>Sunyaev</surname><given-names>S</given-names></name><name><surname>Thomson</surname><given-names>JA</given-names></name><name><surname>Tlsty</surname><given-names>TD</given-names></name><name><surname>Tsai</surname><given-names>LH</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Waterland</surname><given-names>RA</given-names></name><name><surname>Zhang</surname><given-names>MQ</given-names></name><name><surname>Chadwick</surname><given-names>LH</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Costello</surname><given-names>JF</given-names></name><name><surname>Ecker</surname><given-names>JR</given-names></name><name><surname>Hirst</surname><given-names>M</given-names></name><name><surname>Meissner</surname><given-names>A</given-names></name><name><surname>Milosavljevic</surname><given-names>A</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name><name><surname>Stamatoyannopoulos</surname><given-names>JA</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><collab>Roadmap Epigenomics Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Integrative analysis of 111 reference human epigenomes</article-title><source>Nature</source><volume>518</volume><fpage>317</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1038/nature14248</pub-id><pub-id pub-id-type="pmid">25693563</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakich</surname><given-names>D</given-names></name><name><surname>Kazazian</surname><given-names>HH</given-names></name><name><surname>Antonarakis</surname><given-names>SE</given-names></name><name><surname>Gitschier</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Inversions disrupting the factor VIII gene are A common cause of severe haemophilia A</article-title><source>Nature Genetics</source><volume>5</volume><fpage>236</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1038/ng1193-236</pub-id><pub-id pub-id-type="pmid">8275087</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Emond</surname><given-names>MJ</given-names></name><name><surname>Bamshad</surname><given-names>MJ</given-names></name><name><surname>Barnes</surname><given-names>KC</given-names></name><name><surname>Rieder</surname><given-names>MJ</given-names></name><name><surname>Nickerson</surname><given-names>DA</given-names></name><name><surname>Christiani</surname><given-names>DC</given-names></name><name><surname>Wurfel</surname><given-names>MM</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><collab>NHLBI GO Exome Sequencing Project—ESP Lung Project Team</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies</article-title><source>American Journal of Human Genetics</source><volume>91</volume><fpage>224</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2012.06.007</pub-id><pub-id pub-id-type="pmid">22863193</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>SE</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>HY</given-names></name><name><surname>Finnell</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Variants identified in PTK7 associated with neural tube defects</article-title><source>Molecular Genetics &amp; Genomic Medicine</source><volume>7</volume><elocation-id>e00584</elocation-id><pub-id pub-id-type="doi">10.1002/mgg3.584</pub-id><pub-id pub-id-type="pmid">30689296</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>QY</given-names></name><name><surname>Newbury-Ecob</surname><given-names>RA</given-names></name><name><surname>Terrett</surname><given-names>JA</given-names></name><name><surname>Wilson</surname><given-names>DI</given-names></name><name><surname>Curtis</surname><given-names>AR</given-names></name><name><surname>Yi</surname><given-names>CH</given-names></name><name><surname>Gebuhr</surname><given-names>T</given-names></name><name><surname>Bullen</surname><given-names>PJ</given-names></name><name><surname>Robson</surname><given-names>SC</given-names></name><name><surname>Strachan</surname><given-names>T</given-names></name><name><surname>Bonnet</surname><given-names>D</given-names></name><name><surname>Lyonnet</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>ID</given-names></name><name><surname>Raeburn</surname><given-names>JA</given-names></name><name><surname>Buckler</surname><given-names>AJ</given-names></name><name><surname>Law</surname><given-names>DJ</given-names></name><name><surname>Brook</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Holt-oram syndrome is caused by mutations in TBX5, a member of the brachyury (T) gene family</article-title><source>Nature Genetics</source><volume>15</volume><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/ng0197-21</pub-id><pub-id pub-id-type="pmid">8988164</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberzon</surname><given-names>A</given-names></name><name><surname>Birger</surname><given-names>C</given-names></name><name><surname>Thorvaldsdóttir</surname><given-names>H</given-names></name><name><surname>Ghandi</surname><given-names>M</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The molecular signatures database (msigdb) hallmark gene set collection</article-title><source>Cell Systems</source><volume>1</volume><fpage>417</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2015.12.004</pub-id><pub-id pub-id-type="pmid">26771021</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacArthur</surname><given-names>J</given-names></name><name><surname>Bowler</surname><given-names>E</given-names></name><name><surname>Cerezo</surname><given-names>M</given-names></name><name><surname>Gil</surname><given-names>L</given-names></name><name><surname>Hall</surname><given-names>P</given-names></name><name><surname>Hastings</surname><given-names>E</given-names></name><name><surname>Junkins</surname><given-names>H</given-names></name><name><surname>McMahon</surname><given-names>A</given-names></name><name><surname>Milano</surname><given-names>A</given-names></name><name><surname>Morales</surname><given-names>J</given-names></name><name><surname>Pendlington</surname><given-names>ZM</given-names></name><name><surname>Welter</surname><given-names>D</given-names></name><name><surname>Burdett</surname><given-names>T</given-names></name><name><surname>Hindorff</surname><given-names>L</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Cunningham</surname><given-names>F</given-names></name><name><surname>Parkinson</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The new NHGRI-EBI catalog of published genome-wide association studies (GWAS catalog)</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>D896</fpage><lpage>D901</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw1133</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>JR</given-names></name><name><surname>Ziman</surname><given-names>R</given-names></name><name><surname>Yuen</surname><given-names>RKC</given-names></name><name><surname>Feuk</surname><given-names>L</given-names></name><name><surname>Scherer</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The database of genomic variants: a curated collection of structural variation in the human genome</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>D986</fpage><lpage>D992</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt958</pub-id><pub-id pub-id-type="pmid">24174537</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manichaikul</surname><given-names>A</given-names></name><name><surname>Mychaleckyj</surname><given-names>JC</given-names></name><name><surname>Rich</surname><given-names>SS</given-names></name><name><surname>Daly</surname><given-names>K</given-names></name><name><surname>Sale</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Robust relationship inference in genome-wide association studies</article-title><source>Bioinformatics</source><volume>26</volume><fpage>2867</fpage><lpage>2873</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq559</pub-id><pub-id pub-id-type="pmid">20926424</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaren</surname><given-names>W</given-names></name><name><surname>Gil</surname><given-names>L</given-names></name><name><surname>Hunt</surname><given-names>SE</given-names></name><name><surname>Riat</surname><given-names>HS</given-names></name><name><surname>Ritchie</surname><given-names>GRS</given-names></name><name><surname>Thormann</surname><given-names>A</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Cunningham</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The ensembl variant effect predictor</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>122</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-0974-4</pub-id><pub-id pub-id-type="pmid">27268795</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>E</given-names></name><name><surname>Buniello</surname><given-names>A</given-names></name><name><surname>Cerezo</surname><given-names>M</given-names></name><name><surname>Hall</surname><given-names>P</given-names></name><name><surname>Sollis</surname><given-names>E</given-names></name><name><surname>Parkinson</surname><given-names>H</given-names></name><name><surname>Hindorff</surname><given-names>LA</given-names></name><name><surname>Harris</surname><given-names>LW</given-names></name><name><surname>MacArthur</surname><given-names>JAL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Sequencing-based genome-wide association studies reporting standards</article-title><source>Cell Genomics</source><volume>1</volume><elocation-id>100005</elocation-id><pub-id pub-id-type="doi">10.1016/j.xgen.2021.100005</pub-id><pub-id pub-id-type="pmid">34870259</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>JE</given-names></name><name><surname>Purcaro</surname><given-names>MJ</given-names></name><name><surname>Pratt</surname><given-names>HE</given-names></name><name><surname>Epstein</surname><given-names>CB</given-names></name><name><surname>Shoresh</surname><given-names>N</given-names></name><name><surname>Adrian</surname><given-names>J</given-names></name><name><surname>Kawli</surname><given-names>T</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Kaul</surname><given-names>R</given-names></name><name><surname>Halow</surname><given-names>J</given-names></name><name><surname>Van Nostrand</surname><given-names>EL</given-names></name><name><surname>Freese</surname><given-names>P</given-names></name><name><surname>Gorkin</surname><given-names>DU</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Mackiewicz</surname><given-names>M</given-names></name><name><surname>Pauli-Behn</surname><given-names>F</given-names></name><name><surname>Williams</surname><given-names>BA</given-names></name><name><surname>Mortazavi</surname><given-names>A</given-names></name><name><surname>Keller</surname><given-names>CA</given-names></name><name><surname>Zhang</surname><given-names>X-O</given-names></name><name><surname>Elhajjajy</surname><given-names>SI</given-names></name><name><surname>Huey</surname><given-names>J</given-names></name><name><surname>Dickel</surname><given-names>DE</given-names></name><name><surname>Snetkova</surname><given-names>V</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Rivera-Mulia</surname><given-names>JC</given-names></name><name><surname>Rozowsky</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chhetri</surname><given-names>SB</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Victorsen</surname><given-names>A</given-names></name><name><surname>White</surname><given-names>KP</given-names></name><name><surname>Visel</surname><given-names>A</given-names></name><name><surname>Yeo</surname><given-names>GW</given-names></name><name><surname>Burge</surname><given-names>CB</given-names></name><name><surname>Lécuyer</surname><given-names>E</given-names></name><name><surname>Gilbert</surname><given-names>DM</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>Rinn</surname><given-names>J</given-names></name><name><surname>Mendenhall</surname><given-names>EM</given-names></name><name><surname>Ecker</surname><given-names>JR</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>RJ</given-names></name><name><surname>Noble</surname><given-names>WS</given-names></name><name><surname>Kundaje</surname><given-names>A</given-names></name><name><surname>Guigó</surname><given-names>R</given-names></name><name><surname>Farnham</surname><given-names>PJ</given-names></name><name><surname>Cherry</surname><given-names>JM</given-names></name><name><surname>Myers</surname><given-names>RM</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name><name><surname>Graveley</surname><given-names>BR</given-names></name><name><surname>Gerstein</surname><given-names>MB</given-names></name><name><surname>Pennacchio</surname><given-names>LA</given-names></name><name><surname>Snyder</surname><given-names>MP</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Wold</surname><given-names>B</given-names></name><name><surname>Hardison</surname><given-names>RC</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name><name><surname>Stamatoyannopoulos</surname><given-names>JA</given-names></name><name><surname>Weng</surname><given-names>Z</given-names></name><collab>ENCODE Project Consortium</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Expanded encyclopaedias of DNA elements in the human and mouse genomes</article-title><source>Nature</source><volume>583</volume><fpage>699</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2493-4</pub-id><pub-id pub-id-type="pmid">32728249</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>CM</given-names></name><name><surname>Jacobson</surname><given-names>SA</given-names></name><name><surname>Fingerlin</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Power and sample size calculations for genetic association studies in the presence of genetic model misspecification</article-title><source>Human Heredity</source><volume>84</volume><fpage>256</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1159/000508558</pub-id><pub-id pub-id-type="pmid">32721961</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morini</surname><given-names>F</given-names></name><name><surname>Ilari</surname><given-names>M</given-names></name><name><surname>Casati</surname><given-names>A</given-names></name><name><surname>Piserà</surname><given-names>A</given-names></name><name><surname>Oriolo</surname><given-names>L</given-names></name><name><surname>Cozzi</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Posterior urethral valves and mirror image anomalies in monozygotic twins</article-title><source>American Journal of Medical Genetics</source><volume>111</volume><fpage>210</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1002/ajmg.10563</pub-id><pub-id pub-id-type="pmid">12210353</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossie</surname><given-names>K</given-names></name><name><surname>Jallal</surname><given-names>B</given-names></name><name><surname>Alves</surname><given-names>F</given-names></name><name><surname>Sures</surname><given-names>I</given-names></name><name><surname>Plowman</surname><given-names>GD</given-names></name><name><surname>Ullrich</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family</article-title><source>Oncogene</source><volume>11</volume><fpage>2179</fpage><lpage>2184</lpage><pub-id pub-id-type="pmid">7478540</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namjou</surname><given-names>B</given-names></name><name><surname>Ni</surname><given-names>Y</given-names></name><name><surname>Harley</surname><given-names>ITW</given-names></name><name><surname>Chepelev</surname><given-names>I</given-names></name><name><surname>Cobb</surname><given-names>B</given-names></name><name><surname>Kottyan</surname><given-names>LC</given-names></name><name><surname>Gaffney</surname><given-names>PM</given-names></name><name><surname>Guthridge</surname><given-names>JM</given-names></name><name><surname>Kaufman</surname><given-names>K</given-names></name><name><surname>Harley</surname><given-names>JB</given-names></name><name><surname>Montgomery</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The effect of inversion at 8p23 on BLK association with lupus in caucasian population</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e115614</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0115614</pub-id><pub-id pub-id-type="pmid">25545785</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolaou</surname><given-names>N</given-names></name><name><surname>Renkema</surname><given-names>KY</given-names></name><name><surname>Bongers</surname><given-names>E</given-names></name><name><surname>Giles</surname><given-names>RH</given-names></name><name><surname>Knoers</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genetic, environmental, and epigenetic factors involved in CAKUT</article-title><source>Nature Reviews. Nephrology</source><volume>11</volume><fpage>720</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1038/nrneph.2015.140</pub-id><pub-id pub-id-type="pmid">26281895</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niemi</surname><given-names>MEK</given-names></name><name><surname>Martin</surname><given-names>HC</given-names></name><name><surname>Rice</surname><given-names>DL</given-names></name><name><surname>Gallone</surname><given-names>G</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Kelemen</surname><given-names>M</given-names></name><name><surname>McAloney</surname><given-names>K</given-names></name><name><surname>McRae</surname><given-names>J</given-names></name><name><surname>Radford</surname><given-names>EJ</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Gecz</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>Wright</surname><given-names>CF</given-names></name><name><surname>Fitzpatrick</surname><given-names>DR</given-names></name><name><surname>Firth</surname><given-names>HV</given-names></name><name><surname>Hurles</surname><given-names>ME</given-names></name><name><surname>Barrett</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Common genetic variants contribute to risk of rare severe neurodevelopmental disorders</article-title><source>Nature</source><volume>562</volume><fpage>268</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0566-4</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>RE</given-names></name><name><surname>Kuchenbaecker</surname><given-names>K</given-names></name><name><surname>Walters</surname><given-names>RK</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Popejoy</surname><given-names>AB</given-names></name><name><surname>Periyasamy</surname><given-names>S</given-names></name><name><surname>Lam</surname><given-names>M</given-names></name><name><surname>Iyegbe</surname><given-names>C</given-names></name><name><surname>Strawbridge</surname><given-names>RJ</given-names></name><name><surname>Brick</surname><given-names>L</given-names></name><name><surname>Carey</surname><given-names>CE</given-names></name><name><surname>Martin</surname><given-names>AR</given-names></name><name><surname>Meyers</surname><given-names>JL</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Edwards</surname><given-names>AC</given-names></name><name><surname>Kalungi</surname><given-names>A</given-names></name><name><surname>Koen</surname><given-names>N</given-names></name><name><surname>Majara</surname><given-names>L</given-names></name><name><surname>Schwarz</surname><given-names>E</given-names></name><name><surname>Smoller</surname><given-names>JW</given-names></name><name><surname>Stahl</surname><given-names>EA</given-names></name><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>Vassos</surname><given-names>E</given-names></name><name><surname>Mowry</surname><given-names>B</given-names></name><name><surname>Prieto</surname><given-names>ML</given-names></name><name><surname>Cuellar-Barboza</surname><given-names>A</given-names></name><name><surname>Bigdeli</surname><given-names>TB</given-names></name><name><surname>Edenberg</surname><given-names>HJ</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Duncan</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations</article-title><source>Cell</source><volume>179</volume><fpage>589</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.08.051</pub-id><pub-id pub-id-type="pmid">31607513</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruim</surname><given-names>RJ</given-names></name><name><surname>Welch</surname><given-names>RP</given-names></name><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>Teslovich</surname><given-names>TM</given-names></name><name><surname>Chines</surname><given-names>PS</given-names></name><name><surname>Gliedt</surname><given-names>TP</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>LocusZoom: regional visualization of genome-wide association scan results</article-title><source>Bioinformatics</source><volume>26</volume><fpage>2336</fpage><lpage>2337</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq419</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puig</surname><given-names>M</given-names></name><name><surname>Casillas</surname><given-names>S</given-names></name><name><surname>Villatoro</surname><given-names>S</given-names></name><name><surname>Cáceres</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Human inversions and their functional consequences</article-title><source>Briefings in Functional Genomics</source><volume>14</volume><fpage>369</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1093/bfgp/elv020</pub-id><pub-id pub-id-type="pmid">25998059</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>MAR</given-names></name><name><surname>Bender</surname><given-names>D</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>de Bakker</surname><given-names>PIW</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title><source>American Journal of Human Genetics</source><volume>81</volume><fpage>559</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1086/519795</pub-id><pub-id pub-id-type="pmid">17701901</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname><given-names>AR</given-names></name><name><surname>Hall</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title><source>Bioinformatics</source><volume>26</volume><fpage>841</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id><pub-id pub-id-type="pmid">20110278</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rentzsch</surname><given-names>P</given-names></name><name><surname>Witten</surname><given-names>D</given-names></name><name><surname>Cooper</surname><given-names>GM</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name><name><surname>Kircher</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CADD: predicting the deleteriousness of variants throughout the human genome</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D886</fpage><lpage>D894</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1016</pub-id><pub-id pub-id-type="pmid">30371827</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>S</given-names></name><name><surname>Aziz</surname><given-names>N</given-names></name><name><surname>Bale</surname><given-names>S</given-names></name><name><surname>Bick</surname><given-names>D</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Gastier-Foster</surname><given-names>J</given-names></name><name><surname>Grody</surname><given-names>WW</given-names></name><name><surname>Hegde</surname><given-names>M</given-names></name><name><surname>Lyon</surname><given-names>E</given-names></name><name><surname>Spector</surname><given-names>E</given-names></name><name><surname>Voelkerding</surname><given-names>K</given-names></name><name><surname>Rehm</surname><given-names>HL</given-names></name><name><surname>Committee</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology</article-title><source>Genetics in Medicine</source><volume>17</volume><fpage>405</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id><pub-id pub-id-type="pmid">25741868</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roller</surname><given-names>E</given-names></name><name><surname>Ivakhno</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Royce</surname><given-names>T</given-names></name><name><surname>Tanner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Canvas: versatile and scalable detection of copy number variants</article-title><source>Bioinformatics</source><volume>32</volume><fpage>2375</fpage><lpage>2377</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw163</pub-id><pub-id pub-id-type="pmid">27153601</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salm</surname><given-names>MPA</given-names></name><name><surname>Horswell</surname><given-names>SD</given-names></name><name><surname>Hutchison</surname><given-names>CE</given-names></name><name><surname>Speedy</surname><given-names>HE</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Schadt</surname><given-names>EE</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name><name><surname>Wierzbicki</surname><given-names>AS</given-names></name><name><surname>Naoumova</surname><given-names>RP</given-names></name><name><surname>Shoulders</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The origin, global distribution, and functional impact of the human 8p23 inversion polymorphism</article-title><source>Genome Research</source><volume>22</volume><fpage>1144</fpage><lpage>1153</lpage><pub-id pub-id-type="doi">10.1101/gr.126037.111</pub-id><pub-id pub-id-type="pmid">22399572</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanna-Cherchi</surname><given-names>S</given-names></name><name><surname>Ravani</surname><given-names>P</given-names></name><name><surname>Corbani</surname><given-names>V</given-names></name><name><surname>Parodi</surname><given-names>S</given-names></name><name><surname>Haupt</surname><given-names>R</given-names></name><name><surname>Piaggio</surname><given-names>G</given-names></name><name><surname>Innocenti</surname><given-names>MLD</given-names></name><name><surname>Somenzi</surname><given-names>D</given-names></name><name><surname>Trivelli</surname><given-names>A</given-names></name><name><surname>Caridi</surname><given-names>G</given-names></name><name><surname>Izzi</surname><given-names>C</given-names></name><name><surname>Scolari</surname><given-names>F</given-names></name><name><surname>Mattioli</surname><given-names>G</given-names></name><name><surname>Allegri</surname><given-names>L</given-names></name><name><surname>Ghiggeri</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Renal outcome in patients with congenital anomalies of the kidney and urinary tract</article-title><source>Kidney International</source><volume>76</volume><fpage>528</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1038/ki.2009.220</pub-id><pub-id pub-id-type="pmid">19536081</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schierbaum</surname><given-names>LM</given-names></name><name><surname>Schneider</surname><given-names>S</given-names></name><name><surname>Herms</surname><given-names>S</given-names></name><name><surname>Sivalingam</surname><given-names>S</given-names></name><name><surname>Fabian</surname><given-names>J</given-names></name><name><surname>Reutter</surname><given-names>H</given-names></name><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Merz</surname><given-names>WM</given-names></name><name><surname>Tkaczyk</surname><given-names>M</given-names></name><name><surname>Miklaszewska</surname><given-names>M</given-names></name><name><surname>Sikora</surname><given-names>P</given-names></name><name><surname>Szmigielska</surname><given-names>A</given-names></name><name><surname>Krzemien</surname><given-names>G</given-names></name><name><surname>Zachwieja</surname><given-names>K</given-names></name><name><surname>Szczepanska</surname><given-names>M</given-names></name><name><surname>Taranta-Janusz</surname><given-names>K</given-names></name><name><surname>Kroll</surname><given-names>P</given-names></name><name><surname>Polok</surname><given-names>M</given-names></name><name><surname>Zaniew</surname><given-names>M</given-names></name><name><surname>Hilger</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Genome-wide survey for microdeletions or -duplications in 155 patients with lower urinary tract obstructions (LUTO)</article-title><source>Genes</source><volume>12</volume><elocation-id>1449</elocation-id><pub-id pub-id-type="doi">10.3390/genes12091449</pub-id><pub-id pub-id-type="pmid">34573432</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>AD</given-names></name><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Jung</surname><given-names>I</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>CL</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Barr</surname><given-names>CL</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A compendium of chromatin contact maps reveals spatially active regions in the human genome</article-title><source>Cell Reports</source><volume>17</volume><fpage>2042</fpage><lpage>2059</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.10.061</pub-id><pub-id pub-id-type="pmid">27851967</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreuder</surname><given-names>MF</given-names></name><name><surname>van der Horst</surname><given-names>HJR</given-names></name><name><surname>Bökenkamp</surname><given-names>A</given-names></name><name><surname>Beckers</surname><given-names>GMA</given-names></name><name><surname>van Wijk</surname><given-names>JAE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Posterior urethral valves in three siblings: a case report and review of the literature</article-title><source>Birth Defects Research Part A</source><volume>82</volume><fpage>232</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1002/bdra.20439</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siepel</surname><given-names>A</given-names></name><name><surname>Bejerano</surname><given-names>G</given-names></name><name><surname>Pedersen</surname><given-names>JS</given-names></name><name><surname>Hinrichs</surname><given-names>AS</given-names></name><name><surname>Hou</surname><given-names>M</given-names></name><name><surname>Rosenbloom</surname><given-names>K</given-names></name><name><surname>Clawson</surname><given-names>H</given-names></name><name><surname>Spieth</surname><given-names>J</given-names></name><name><surname>Hillier</surname><given-names>LW</given-names></name><name><surname>Richards</surname><given-names>S</given-names></name><name><surname>Weinstock</surname><given-names>GM</given-names></name><name><surname>Wilson</surname><given-names>RK</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Kent</surname><given-names>WJ</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes</article-title><source>Genome Research</source><volume>15</volume><fpage>1034</fpage><lpage>1050</lpage><pub-id pub-id-type="doi">10.1101/gr.3715005</pub-id><pub-id pub-id-type="pmid">16024819</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smedley</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>KR</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>EA</given-names></name><name><surname>McDonagh</surname><given-names>EM</given-names></name><name><surname>Cipriani</surname><given-names>V</given-names></name><name><surname>Ellingford</surname><given-names>JM</given-names></name><name><surname>Arno</surname><given-names>G</given-names></name><name><surname>Tucci</surname><given-names>A</given-names></name><name><surname>Vandrovcova</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>G</given-names></name><name><surname>Williams</surname><given-names>HJ</given-names></name><name><surname>Ratnaike</surname><given-names>T</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Stirrups</surname><given-names>K</given-names></name><name><surname>Ibanez</surname><given-names>K</given-names></name><name><surname>Moutsianas</surname><given-names>L</given-names></name><name><surname>Wielscher</surname><given-names>M</given-names></name><name><surname>Need</surname><given-names>A</given-names></name><name><surname>Barnes</surname><given-names>MR</given-names></name><name><surname>Vestito</surname><given-names>L</given-names></name><name><surname>Buchanan</surname><given-names>J</given-names></name><name><surname>Wordsworth</surname><given-names>S</given-names></name><name><surname>Ashford</surname><given-names>S</given-names></name><name><surname>Rehmström</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>E</given-names></name><name><surname>Fuller</surname><given-names>G</given-names></name><name><surname>Twiss</surname><given-names>P</given-names></name><name><surname>Spasic-Boskovic</surname><given-names>O</given-names></name><name><surname>Halsall</surname><given-names>S</given-names></name><name><surname>Floto</surname><given-names>RA</given-names></name><name><surname>Poole</surname><given-names>K</given-names></name><name><surname>Wagner</surname><given-names>A</given-names></name><name><surname>Mehta</surname><given-names>SG</given-names></name><name><surname>Gurnell</surname><given-names>M</given-names></name><name><surname>Burrows</surname><given-names>N</given-names></name><name><surname>James</surname><given-names>R</given-names></name><name><surname>Penkett</surname><given-names>C</given-names></name><name><surname>Dewhurst</surname><given-names>E</given-names></name><name><surname>Gräf</surname><given-names>S</given-names></name><name><surname>Mapeta</surname><given-names>R</given-names></name><name><surname>Kasanicki</surname><given-names>M</given-names></name><name><surname>Haworth</surname><given-names>A</given-names></name><name><surname>Savage</surname><given-names>H</given-names></name><name><surname>Babcock</surname><given-names>M</given-names></name><name><surname>Reese</surname><given-names>MG</given-names></name><name><surname>Bale</surname><given-names>M</given-names></name><name><surname>Baple</surname><given-names>E</given-names></name><name><surname>Boustred</surname><given-names>C</given-names></name><name><surname>Brittain</surname><given-names>H</given-names></name><name><surname>de Burca</surname><given-names>A</given-names></name><name><surname>Bleda</surname><given-names>M</given-names></name><name><surname>Devereau</surname><given-names>A</given-names></name><name><surname>Halai</surname><given-names>D</given-names></name><name><surname>Haraldsdottir</surname><given-names>E</given-names></name><name><surname>Hyder</surname><given-names>Z</given-names></name><name><surname>Kasperaviciute</surname><given-names>D</given-names></name><name><surname>Patch</surname><given-names>C</given-names></name><name><surname>Polychronopoulos</surname><given-names>D</given-names></name><name><surname>Matchan</surname><given-names>A</given-names></name><name><surname>Sultana</surname><given-names>R</given-names></name><name><surname>Ryten</surname><given-names>M</given-names></name><name><surname>Tavares</surname><given-names>ALT</given-names></name><name><surname>Tregidgo</surname><given-names>C</given-names></name><name><surname>Turnbull</surname><given-names>C</given-names></name><name><surname>Welland</surname><given-names>M</given-names></name><name><surname>Wood</surname><given-names>S</given-names></name><name><surname>Snow</surname><given-names>C</given-names></name><name><surname>Williams</surname><given-names>E</given-names></name><name><surname>Leigh</surname><given-names>S</given-names></name><name><surname>Foulger</surname><given-names>RE</given-names></name><name><surname>Daugherty</surname><given-names>LC</given-names></name><name><surname>Niblock</surname><given-names>O</given-names></name><name><surname>Leong</surname><given-names>IUS</given-names></name><name><surname>Wright</surname><given-names>CF</given-names></name><name><surname>Davies</surname><given-names>J</given-names></name><name><surname>Crichton</surname><given-names>C</given-names></name><name><surname>Welch</surname><given-names>J</given-names></name><name><surname>Woods</surname><given-names>K</given-names></name><name><surname>Abulhoul</surname><given-names>L</given-names></name><name><surname>Aurora</surname><given-names>P</given-names></name><name><surname>Bockenhauer</surname><given-names>D</given-names></name><name><surname>Broomfield</surname><given-names>A</given-names></name><name><surname>Cleary</surname><given-names>MA</given-names></name><name><surname>Lam</surname><given-names>T</given-names></name><name><surname>Dattani</surname><given-names>M</given-names></name><name><surname>Footitt</surname><given-names>E</given-names></name><name><surname>Ganesan</surname><given-names>V</given-names></name><name><surname>Grunewald</surname><given-names>S</given-names></name><name><surname>Compeyrot-Lacassagne</surname><given-names>S</given-names></name><name><surname>Muntoni</surname><given-names>F</given-names></name><name><surname>Pilkington</surname><given-names>C</given-names></name><name><surname>Quinlivan</surname><given-names>R</given-names></name><name><surname>Thapar</surname><given-names>N</given-names></name><name><surname>Wallis</surname><given-names>C</given-names></name><name><surname>Wedderburn</surname><given-names>LR</given-names></name><name><surname>Worth</surname><given-names>A</given-names></name><name><surname>Bueser</surname><given-names>T</given-names></name><name><surname>Compton</surname><given-names>C</given-names></name><name><surname>Deshpande</surname><given-names>C</given-names></name><name><surname>Fassihi</surname><given-names>H</given-names></name><name><surname>Haque</surname><given-names>E</given-names></name><name><surname>Izatt</surname><given-names>L</given-names></name><name><surname>Josifova</surname><given-names>D</given-names></name><name><surname>Mohammed</surname><given-names>S</given-names></name><name><surname>Robert</surname><given-names>L</given-names></name><name><surname>Rose</surname><given-names>S</given-names></name><name><surname>Ruddy</surname><given-names>D</given-names></name><name><surname>Sarkany</surname><given-names>R</given-names></name><name><surname>Say</surname><given-names>G</given-names></name><name><surname>Shaw</surname><given-names>AC</given-names></name><name><surname>Wolejko</surname><given-names>A</given-names></name><name><surname>Habib</surname><given-names>B</given-names></name><name><surname>Burns</surname><given-names>G</given-names></name><name><surname>Hunter</surname><given-names>S</given-names></name><name><surname>Grocock</surname><given-names>RJ</given-names></name><name><surname>Humphray</surname><given-names>SJ</given-names></name><name><surname>Robinson</surname><given-names>PN</given-names></name><name><surname>Haendel</surname><given-names>M</given-names></name><name><surname>Simpson</surname><given-names>MA</given-names></name><name><surname>Banka</surname><given-names>S</given-names></name><name><surname>Clayton-Smith</surname><given-names>J</given-names></name><name><surname>Douzgou</surname><given-names>S</given-names></name><name><surname>Hall</surname><given-names>G</given-names></name><name><surname>Thomas</surname><given-names>HB</given-names></name><name><surname>O’Keefe</surname><given-names>RT</given-names></name><name><surname>Michaelides</surname><given-names>M</given-names></name><name><surname>Moore</surname><given-names>AT</given-names></name><name><surname>Malka</surname><given-names>S</given-names></name><name><surname>Pontikos</surname><given-names>N</given-names></name><name><surname>Browning</surname><given-names>AC</given-names></name><name><surname>Straub</surname><given-names>V</given-names></name><name><surname>Gorman</surname><given-names>GS</given-names></name><name><surname>Horvath</surname><given-names>R</given-names></name><name><surname>Quinton</surname><given-names>R</given-names></name><name><surname>Schaefer</surname><given-names>AM</given-names></name><name><surname>Yu-Wai-Man</surname><given-names>P</given-names></name><name><surname>Turnbull</surname><given-names>DM</given-names></name><name><surname>McFarland</surname><given-names>R</given-names></name><name><surname>Taylor</surname><given-names>RW</given-names></name><name><surname>O’Connor</surname><given-names>E</given-names></name><name><surname>Yip</surname><given-names>J</given-names></name><name><surname>Newland</surname><given-names>K</given-names></name><name><surname>Morris</surname><given-names>HR</given-names></name><name><surname>Polke</surname><given-names>J</given-names></name><name><surname>Wood</surname><given-names>NW</given-names></name><name><surname>Campbell</surname><given-names>C</given-names></name><name><surname>Camps</surname><given-names>C</given-names></name><name><surname>Gibson</surname><given-names>K</given-names></name><name><surname>Koelling</surname><given-names>N</given-names></name><name><surname>Lester</surname><given-names>T</given-names></name><name><surname>Németh</surname><given-names>AH</given-names></name><name><surname>Palles</surname><given-names>C</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Roy</surname><given-names>NBA</given-names></name><name><surname>Sen</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>J</given-names></name><name><surname>Cacheiro</surname><given-names>P</given-names></name><name><surname>Jacobsen</surname><given-names>JO</given-names></name><name><surname>Seaby</surname><given-names>EG</given-names></name><name><surname>Davison</surname><given-names>V</given-names></name><name><surname>Chitty</surname><given-names>L</given-names></name><name><surname>Douglas</surname><given-names>A</given-names></name><name><surname>Naresh</surname><given-names>K</given-names></name><name><surname>McMullan</surname><given-names>D</given-names></name><name><surname>Ellard</surname><given-names>S</given-names></name><name><surname>Temple</surname><given-names>IK</given-names></name><name><surname>Mumford</surname><given-names>AD</given-names></name><name><surname>Wilson</surname><given-names>G</given-names></name><name><surname>Beales</surname><given-names>P</given-names></name><name><surname>Bitner-Glindzicz</surname><given-names>M</given-names></name><name><surname>Black</surname><given-names>G</given-names></name><name><surname>Bradley</surname><given-names>JR</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Burn</surname><given-names>J</given-names></name><name><surname>Chinnery</surname><given-names>PF</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Flinter</surname><given-names>F</given-names></name><name><surname>Houlden</surname><given-names>H</given-names></name><name><surname>Irving</surname><given-names>M</given-names></name><name><surname>Newman</surname><given-names>W</given-names></name><name><surname>Rahman</surname><given-names>S</given-names></name><name><surname>Sayer</surname><given-names>JA</given-names></name><name><surname>Taylor</surname><given-names>JC</given-names></name><name><surname>Webster</surname><given-names>AR</given-names></name><name><surname>Wilkie</surname><given-names>AOM</given-names></name><name><surname>Ouwehand</surname><given-names>WH</given-names></name><name><surname>Raymond</surname><given-names>FL</given-names></name><name><surname>Chisholm</surname><given-names>J</given-names></name><name><surname>Hill</surname><given-names>S</given-names></name><name><surname>Bentley</surname><given-names>D</given-names></name><name><surname>Scott</surname><given-names>RH</given-names></name><name><surname>Fowler</surname><given-names>T</given-names></name><name><surname>Rendon</surname><given-names>A</given-names></name><name><surname>Caulfield</surname><given-names>M</given-names></name><collab>100,000 Genomes Project Pilot Investigators</collab></person-group><year iso-8601-date="2021">2021</year><article-title>100,000 genomes pilot on rare-disease diagnosis in health care - preliminary report</article-title><source>The New England Journal of Medicine</source><volume>385</volume><fpage>1868</fpage><lpage>1880</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2035790</pub-id><pub-id pub-id-type="pmid">34758253</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>HM</given-names></name><name><surname>Roberts</surname><given-names>NA</given-names></name><name><surname>Burgu</surname><given-names>B</given-names></name><name><surname>Daly</surname><given-names>SB</given-names></name><name><surname>Urquhart</surname><given-names>JE</given-names></name><name><surname>Bhaskar</surname><given-names>S</given-names></name><name><surname>Dickerson</surname><given-names>JE</given-names></name><name><surname>Mermerkaya</surname><given-names>M</given-names></name><name><surname>Silay</surname><given-names>MS</given-names></name><name><surname>Lewis</surname><given-names>MA</given-names></name><name><surname>Olondriz</surname><given-names>MBO</given-names></name><name><surname>Gener</surname><given-names>B</given-names></name><name><surname>Beetz</surname><given-names>C</given-names></name><name><surname>Varga</surname><given-names>RE</given-names></name><name><surname>Gülpınar</surname><given-names>Ö</given-names></name><name><surname>Süer</surname><given-names>E</given-names></name><name><surname>Soygür</surname><given-names>T</given-names></name><name><surname>Özçakar</surname><given-names>ZB</given-names></name><name><surname>Yalçınkaya</surname><given-names>F</given-names></name><name><surname>Kavaz</surname><given-names>A</given-names></name><name><surname>Bulum</surname><given-names>B</given-names></name><name><surname>Gücük</surname><given-names>A</given-names></name><name><surname>Yue</surname><given-names>WW</given-names></name><name><surname>Erdogan</surname><given-names>F</given-names></name><name><surname>Berry</surname><given-names>A</given-names></name><name><surname>Hanley</surname><given-names>NA</given-names></name><name><surname>McKenzie</surname><given-names>EA</given-names></name><name><surname>Hilton</surname><given-names>EN</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name><name><surname>Newman</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>LRIG2 mutations cause urofacial syndrome</article-title><source>The American Journal of Human Genetics</source><volume>92</volume><fpage>259</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2012.12.002</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Gay</surname><given-names>LJ</given-names></name><name><surname>Strange</surname><given-names>A</given-names></name><name><surname>Palles</surname><given-names>C</given-names></name><name><surname>Band</surname><given-names>G</given-names></name><name><surname>Whiteman</surname><given-names>DC</given-names></name><name><surname>Lescai</surname><given-names>F</given-names></name><name><surname>Langford</surname><given-names>C</given-names></name><name><surname>Nanji</surname><given-names>M</given-names></name><name><surname>Edkins</surname><given-names>S</given-names></name><name><surname>van der Winkel</surname><given-names>A</given-names></name><name><surname>Levine</surname><given-names>D</given-names></name><name><surname>Sasieni</surname><given-names>P</given-names></name><name><surname>Bellenguez</surname><given-names>C</given-names></name><name><surname>Howarth</surname><given-names>K</given-names></name><name><surname>Freeman</surname><given-names>C</given-names></name><name><surname>Trudgill</surname><given-names>N</given-names></name><name><surname>Tucker</surname><given-names>AT</given-names></name><name><surname>Pirinen</surname><given-names>M</given-names></name><name><surname>Peppelenbosch</surname><given-names>MP</given-names></name><name><surname>van der Laan</surname><given-names>LJW</given-names></name><name><surname>Kuipers</surname><given-names>EJ</given-names></name><name><surname>Drenth</surname><given-names>JPH</given-names></name><name><surname>Peters</surname><given-names>WH</given-names></name><name><surname>Reynolds</surname><given-names>JV</given-names></name><name><surname>Kelleher</surname><given-names>DP</given-names></name><name><surname>McManus</surname><given-names>R</given-names></name><name><surname>Grabsch</surname><given-names>H</given-names></name><name><surname>Prenen</surname><given-names>H</given-names></name><name><surname>Bisschops</surname><given-names>R</given-names></name><name><surname>Krishnadath</surname><given-names>K</given-names></name><name><surname>Siersema</surname><given-names>PD</given-names></name><name><surname>van Baal</surname><given-names>J</given-names></name><name><surname>Middleton</surname><given-names>M</given-names></name><name><surname>Petty</surname><given-names>R</given-names></name><name><surname>Gillies</surname><given-names>R</given-names></name><name><surname>Burch</surname><given-names>N</given-names></name><name><surname>Bhandari</surname><given-names>P</given-names></name><name><surname>Paterson</surname><given-names>S</given-names></name><name><surname>Edwards</surname><given-names>C</given-names></name><name><surname>Penman</surname><given-names>I</given-names></name><name><surname>Vaidya</surname><given-names>K</given-names></name><name><surname>Ang</surname><given-names>Y</given-names></name><name><surname>Murray</surname><given-names>I</given-names></name><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Ye</surname><given-names>W</given-names></name><name><surname>Mullins</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>AH</given-names></name><name><surname>Bird</surname><given-names>NC</given-names></name><name><surname>Dallal</surname><given-names>H</given-names></name><name><surname>Shaheen</surname><given-names>NJ</given-names></name><name><surname>Murray</surname><given-names>LJ</given-names></name><name><surname>Koss</surname><given-names>K</given-names></name><name><surname>Bernstein</surname><given-names>L</given-names></name><name><surname>Romero</surname><given-names>Y</given-names></name><name><surname>Hardie</surname><given-names>LJ</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Winter</surname><given-names>H</given-names></name><name><surname>Corley</surname><given-names>DA</given-names></name><name><surname>Panter</surname><given-names>S</given-names></name><name><surname>Risch</surname><given-names>HA</given-names></name><name><surname>Reid</surname><given-names>BJ</given-names></name><name><surname>Sargeant</surname><given-names>I</given-names></name><name><surname>Gammon</surname><given-names>MD</given-names></name><name><surname>Smart</surname><given-names>H</given-names></name><name><surname>Dhar</surname><given-names>A</given-names></name><name><surname>McMurtry</surname><given-names>H</given-names></name><name><surname>Ali</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Casson</surname><given-names>AG</given-names></name><name><surname>Chow</surname><given-names>WH</given-names></name><name><surname>Rutter</surname><given-names>M</given-names></name><name><surname>Tawil</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>D</given-names></name><name><surname>Nwokolo</surname><given-names>C</given-names></name><name><surname>Isaacs</surname><given-names>P</given-names></name><name><surname>Rodgers</surname><given-names>C</given-names></name><name><surname>Ragunath</surname><given-names>K</given-names></name><name><surname>MacDonald</surname><given-names>C</given-names></name><name><surname>Haigh</surname><given-names>C</given-names></name><name><surname>Monk</surname><given-names>D</given-names></name><name><surname>Davies</surname><given-names>G</given-names></name><name><surname>Wajed</surname><given-names>S</given-names></name><name><surname>Johnston</surname><given-names>D</given-names></name><name><surname>Gibbons</surname><given-names>M</given-names></name><name><surname>Cullen</surname><given-names>S</given-names></name><name><surname>Church</surname><given-names>N</given-names></name><name><surname>Langley</surname><given-names>R</given-names></name><name><surname>Griffin</surname><given-names>M</given-names></name><name><surname>Alderson</surname><given-names>D</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Hunt</surname><given-names>SE</given-names></name><name><surname>Gray</surname><given-names>E</given-names></name><name><surname>Dronov</surname><given-names>S</given-names></name><name><surname>Potter</surname><given-names>SC</given-names></name><name><surname>Tashakkori-Ghanbaria</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>M</given-names></name><name><surname>Brooks</surname><given-names>C</given-names></name><name><surname>Blackwell</surname><given-names>JM</given-names></name><name><surname>Bramon</surname><given-names>E</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name><name><surname>Casas</surname><given-names>JP</given-names></name><name><surname>Corvin</surname><given-names>A</given-names></name><name><surname>Duncanson</surname><given-names>A</given-names></name><name><surname>Markus</surname><given-names>HS</given-names></name><name><surname>Mathew</surname><given-names>CG</given-names></name><name><surname>Palmer</surname><given-names>CNA</given-names></name><name><surname>Plomin</surname><given-names>R</given-names></name><name><surname>Rautanen</surname><given-names>A</given-names></name><name><surname>Sawcer</surname><given-names>SJ</given-names></name><name><surname>Trembath</surname><given-names>RC</given-names></name><name><surname>Viswanathan</surname><given-names>AC</given-names></name><name><surname>Wood</surname><given-names>N</given-names></name><name><surname>Trynka</surname><given-names>G</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Cazier</surname><given-names>JB</given-names></name><name><surname>Atherfold</surname><given-names>P</given-names></name><name><surname>Nicholson</surname><given-names>AM</given-names></name><name><surname>Gellatly</surname><given-names>NL</given-names></name><name><surname>Glancy</surname><given-names>D</given-names></name><name><surname>Cooper</surname><given-names>SC</given-names></name><name><surname>Cunningham</surname><given-names>D</given-names></name><name><surname>Lind</surname><given-names>T</given-names></name><name><surname>Hapeshi</surname><given-names>J</given-names></name><name><surname>Ferry</surname><given-names>D</given-names></name><name><surname>Rathbone</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>J</given-names></name><name><surname>Love</surname><given-names>S</given-names></name><name><surname>Attwood</surname><given-names>S</given-names></name><name><surname>MacGregor</surname><given-names>S</given-names></name><name><surname>Watson</surname><given-names>P</given-names></name><name><surname>Sanders</surname><given-names>S</given-names></name><name><surname>Ek</surname><given-names>W</given-names></name><name><surname>Harrison</surname><given-names>RF</given-names></name><name><surname>Moayyedi</surname><given-names>P</given-names></name><name><surname>de Caestecker</surname><given-names>J</given-names></name><name><surname>Barr</surname><given-names>H</given-names></name><name><surname>Stupka</surname><given-names>E</given-names></name><name><surname>Vaughan</surname><given-names>TL</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name><name><surname>Spencer</surname><given-names>CCA</given-names></name><name><surname>Tomlinson</surname><given-names>I</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name><name><surname>Jankowski</surname><given-names>JAZ</given-names></name><collab>Esophageal Adenocarcinoma Genetics Consortium</collab><collab>Wellcome Trust Case Control Consortium 2</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Common variants at the MHC locus and at chromosome 16q24.1 predispose to barrett’s esophagus</article-title><source>Nature Genetics</source><volume>44</volume><fpage>1131</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1038/ng.2408</pub-id><pub-id pub-id-type="pmid">22961001</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Tong</surname><given-names>P</given-names></name><name><surname>Kong</surname><given-names>W</given-names></name><name><surname>Dong</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>IY</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>XD</given-names></name><name><surname>Ding</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>S</given-names></name><name><surname>German</surname><given-names>P</given-names></name><name><surname>Powell</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Tong</surname><given-names>X</given-names></name><name><surname>Tannir</surname><given-names>NM</given-names></name><name><surname>Matin</surname><given-names>SF</given-names></name><name><surname>Rathmell</surname><given-names>WK</given-names></name><name><surname>Fuller</surname><given-names>GN</given-names></name><name><surname>McCutcheon</surname><given-names>IE</given-names></name><name><surname>Walker</surname><given-names>CL</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Jonasch</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>HNF1B loss exacerbates the development of chromophobe renal cell carcinomas</article-title><source>Cancer Research</source><volume>77</volume><fpage>5313</fpage><lpage>5326</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-0986</pub-id><pub-id pub-id-type="pmid">28807937</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taliun</surname><given-names>D</given-names></name><name><surname>Harris</surname><given-names>DN</given-names></name><name><surname>Kessler</surname><given-names>MD</given-names></name><name><surname>Carlson</surname><given-names>J</given-names></name><name><surname>Szpiech</surname><given-names>ZA</given-names></name><name><surname>Torres</surname><given-names>R</given-names></name><name><surname>Taliun</surname><given-names>SAG</given-names></name><name><surname>Corvelo</surname><given-names>A</given-names></name><name><surname>Gogarten</surname><given-names>SM</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Pitsillides</surname><given-names>AN</given-names></name><name><surname>LeFaive</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>SB</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Browning</surname><given-names>BL</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Emde</surname><given-names>AK</given-names></name><name><surname>Clarke</surname><given-names>WE</given-names></name><name><surname>Loesch</surname><given-names>DP</given-names></name><name><surname>Shetty</surname><given-names>AC</given-names></name><name><surname>Blackwell</surname><given-names>TW</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Wong</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Conomos</surname><given-names>MP</given-names></name><name><surname>Bobo</surname><given-names>DM</given-names></name><name><surname>Aguet</surname><given-names>F</given-names></name><name><surname>Albert</surname><given-names>C</given-names></name><name><surname>Alonso</surname><given-names>A</given-names></name><name><surname>Ardlie</surname><given-names>KG</given-names></name><name><surname>Arking</surname><given-names>DE</given-names></name><name><surname>Aslibekyan</surname><given-names>S</given-names></name><name><surname>Auer</surname><given-names>PL</given-names></name><name><surname>Barnard</surname><given-names>J</given-names></name><name><surname>Barr</surname><given-names>RG</given-names></name><name><surname>Barwick</surname><given-names>L</given-names></name><name><surname>Becker</surname><given-names>LC</given-names></name><name><surname>Beer</surname><given-names>RL</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Bielak</surname><given-names>LF</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Bowden</surname><given-names>DW</given-names></name><name><surname>Brody</surname><given-names>JA</given-names></name><name><surname>Burchard</surname><given-names>EG</given-names></name><name><surname>Cade</surname><given-names>BE</given-names></name><name><surname>Casella</surname><given-names>JF</given-names></name><name><surname>Chalazan</surname><given-names>B</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Chen</surname><given-names>YDI</given-names></name><name><surname>Cho</surname><given-names>MH</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Chung</surname><given-names>MK</given-names></name><name><surname>Clish</surname><given-names>CB</given-names></name><name><surname>Correa</surname><given-names>A</given-names></name><name><surname>Curran</surname><given-names>JE</given-names></name><name><surname>Custer</surname><given-names>B</given-names></name><name><surname>Darbar</surname><given-names>D</given-names></name><name><surname>Daya</surname><given-names>M</given-names></name><name><surname>de Andrade</surname><given-names>M</given-names></name><name><surname>DeMeo</surname><given-names>DL</given-names></name><name><surname>Dutcher</surname><given-names>SK</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Emery</surname><given-names>LS</given-names></name><name><surname>Eng</surname><given-names>C</given-names></name><name><surname>Fatkin</surname><given-names>D</given-names></name><name><surname>Fingerlin</surname><given-names>T</given-names></name><name><surname>Forer</surname><given-names>L</given-names></name><name><surname>Fornage</surname><given-names>M</given-names></name><name><surname>Franceschini</surname><given-names>N</given-names></name><name><surname>Fuchsberger</surname><given-names>C</given-names></name><name><surname>Fullerton</surname><given-names>SM</given-names></name><name><surname>Germer</surname><given-names>S</given-names></name><name><surname>Gladwin</surname><given-names>MT</given-names></name><name><surname>Gottlieb</surname><given-names>DJ</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Hall</surname><given-names>ME</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Heard-Costa</surname><given-names>NL</given-names></name><name><surname>Heckbert</surname><given-names>SR</given-names></name><name><surname>Irvin</surname><given-names>MR</given-names></name><name><surname>Johnsen</surname><given-names>JM</given-names></name><name><surname>Johnson</surname><given-names>AD</given-names></name><name><surname>Kaplan</surname><given-names>R</given-names></name><name><surname>Kardia</surname><given-names>SLR</given-names></name><name><surname>Kelly</surname><given-names>T</given-names></name><name><surname>Kelly</surname><given-names>S</given-names></name><name><surname>Kenny</surname><given-names>EE</given-names></name><name><surname>Kiel</surname><given-names>DP</given-names></name><name><surname>Klemmer</surname><given-names>R</given-names></name><name><surname>Konkle</surname><given-names>BA</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>Köttgen</surname><given-names>A</given-names></name><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>Lasky-Su</surname><given-names>J</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>KH</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Garman</surname><given-names>L</given-names></name><name><surname>Gerszten</surname><given-names>R</given-names></name><name><surname>Lubitz</surname><given-names>SA</given-names></name><name><surname>Lunetta</surname><given-names>KL</given-names></name><name><surname>Mak</surname><given-names>ACY</given-names></name><name><surname>Manichaikul</surname><given-names>A</given-names></name><name><surname>Manning</surname><given-names>AK</given-names></name><name><surname>Mathias</surname><given-names>RA</given-names></name><name><surname>McManus</surname><given-names>DD</given-names></name><name><surname>McGarvey</surname><given-names>ST</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Meyers</surname><given-names>DA</given-names></name><name><surname>Mikulla</surname><given-names>JL</given-names></name><name><surname>Minear</surname><given-names>MA</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Mohanty</surname><given-names>S</given-names></name><name><surname>Montasser</surname><given-names>ME</given-names></name><name><surname>Montgomery</surname><given-names>C</given-names></name><name><surname>Morrison</surname><given-names>AC</given-names></name><name><surname>Murabito</surname><given-names>JM</given-names></name><name><surname>Natale</surname><given-names>A</given-names></name><name><surname>Natarajan</surname><given-names>P</given-names></name><name><surname>Nelson</surname><given-names>SC</given-names></name><name><surname>North</surname><given-names>KE</given-names></name><name><surname>O’Connell</surname><given-names>JR</given-names></name><name><surname>Palmer</surname><given-names>ND</given-names></name><name><surname>Pankratz</surname><given-names>N</given-names></name><name><surname>Peloso</surname><given-names>GM</given-names></name><name><surname>Peyser</surname><given-names>PA</given-names></name><name><surname>Pleiness</surname><given-names>J</given-names></name><name><surname>Post</surname><given-names>WS</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Rao</surname><given-names>DC</given-names></name><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Reiner</surname><given-names>AP</given-names></name><name><surname>Roden</surname><given-names>D</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Ruczinski</surname><given-names>I</given-names></name><name><surname>Sarnowski</surname><given-names>C</given-names></name><name><surname>Schoenherr</surname><given-names>S</given-names></name><name><surname>Schwartz</surname><given-names>DA</given-names></name><name><surname>Seo</surname><given-names>JS</given-names></name><name><surname>Seshadri</surname><given-names>S</given-names></name><name><surname>Sheehan</surname><given-names>VA</given-names></name><name><surname>Sheu</surname><given-names>WH</given-names></name><name><surname>Shoemaker</surname><given-names>MB</given-names></name><name><surname>Smith</surname><given-names>NL</given-names></name><name><surname>Smith</surname><given-names>JA</given-names></name><name><surname>Sotoodehnia</surname><given-names>N</given-names></name><name><surname>Stilp</surname><given-names>AM</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><name><surname>Telen</surname><given-names>M</given-names></name><name><surname>Thornton</surname><given-names>TA</given-names></name><name><surname>Tracy</surname><given-names>RP</given-names></name><name><surname>Van Den Berg</surname><given-names>DJ</given-names></name><name><surname>Vasan</surname><given-names>RS</given-names></name><name><surname>Viaud-Martinez</surname><given-names>KA</given-names></name><name><surname>Vrieze</surname><given-names>S</given-names></name><name><surname>Weeks</surname><given-names>DE</given-names></name><name><surname>Weir</surname><given-names>BS</given-names></name><name><surname>Weiss</surname><given-names>ST</given-names></name><name><surname>Weng</surname><given-names>LC</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Arnett</surname><given-names>DK</given-names></name><name><surname>Ashley-Koch</surname><given-names>AE</given-names></name><name><surname>Barnes</surname><given-names>KC</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Gabriel</surname><given-names>S</given-names></name><name><surname>Gibbs</surname><given-names>R</given-names></name><name><surname>Rice</surname><given-names>KM</given-names></name><name><surname>Rich</surname><given-names>SS</given-names></name><name><surname>Silverman</surname><given-names>EK</given-names></name><name><surname>Qasba</surname><given-names>P</given-names></name><name><surname>Gan</surname><given-names>W</given-names></name><name><surname>Papanicolaou</surname><given-names>GJ</given-names></name><name><surname>Nickerson</surname><given-names>DA</given-names></name><name><surname>Browning</surname><given-names>SR</given-names></name><name><surname>Zody</surname><given-names>MC</given-names></name><name><surname>Zöllner</surname><given-names>S</given-names></name><name><surname>Wilson</surname><given-names>JG</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Laurie</surname><given-names>CC</given-names></name><name><surname>Jaquish</surname><given-names>CE</given-names></name><name><surname>Hernandez</surname><given-names>RD</given-names></name><name><surname>O’Connor</surname><given-names>TD</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><collab>NHLBI Trans-Omics for Precision Medicine TOPMed Consortium</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Sequencing of 53,831 diverse genomes from the NHLBI topmed program</article-title><source>Nature</source><volume>590</volume><fpage>290</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03205-y</pub-id><pub-id pub-id-type="pmid">33568819</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>A</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Unified representation of genetic variants</article-title><source>Bioinformatics</source><volume>31</volume><fpage>2202</fpage><lpage>2204</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv112</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thakkar</surname><given-names>D</given-names></name><name><surname>Deshpande</surname><given-names>AV</given-names></name><name><surname>Kennedy</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Epidemiology and demography of recently diagnosed cases of posterior urethral valves</article-title><source>Pediatric Research</source><volume>76</volume><fpage>560</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1038/pr.2014.134</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>CC</given-names></name><name><surname>Duffy</surname><given-names>KA</given-names></name><name><surname>Chu</surname><given-names>DI</given-names></name><name><surname>Weiss</surname><given-names>DA</given-names></name><name><surname>Srinivasan</surname><given-names>AK</given-names></name><name><surname>Canning</surname><given-names>DA</given-names></name><name><surname>Kalish</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Urological findings in beckwith-wiedemann syndrome with chromosomal duplications of 11p15.5: evaluation and management</article-title><source>Urology</source><volume>100</volume><fpage>224</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.urology.2016.08.037</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>qqman: an R package for visualizing GWAS results using Q-Q and manhattan plots</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/005165</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verbitsky</surname><given-names>M</given-names></name><name><surname>Westland</surname><given-names>R</given-names></name><name><surname>Perez</surname><given-names>A</given-names></name><name><surname>Kiryluk</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Krithivasan</surname><given-names>P</given-names></name><name><surname>Mitrotti</surname><given-names>A</given-names></name><name><surname>Fasel</surname><given-names>DA</given-names></name><name><surname>Batourina</surname><given-names>E</given-names></name><name><surname>Sampson</surname><given-names>MG</given-names></name><name><surname>Bodria</surname><given-names>M</given-names></name><name><surname>Werth</surname><given-names>M</given-names></name><name><surname>Kao</surname><given-names>C</given-names></name><name><surname>Martino</surname><given-names>J</given-names></name><name><surname>Capone</surname><given-names>VP</given-names></name><name><surname>Vivante</surname><given-names>A</given-names></name><name><surname>Shril</surname><given-names>S</given-names></name><name><surname>Kil</surname><given-names>BH</given-names></name><name><surname>Marasà</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>JY</given-names></name><name><surname>Na</surname><given-names>YJ</given-names></name><name><surname>Lim</surname><given-names>TY</given-names></name><name><surname>Ahram</surname><given-names>D</given-names></name><name><surname>Weng</surname><given-names>PL</given-names></name><name><surname>Heinzen</surname><given-names>EL</given-names></name><name><surname>Carrea</surname><given-names>A</given-names></name><name><surname>Piaggio</surname><given-names>G</given-names></name><name><surname>Gesualdo</surname><given-names>L</given-names></name><name><surname>Manca</surname><given-names>V</given-names></name><name><surname>Masnata</surname><given-names>G</given-names></name><name><surname>Gigante</surname><given-names>M</given-names></name><name><surname>Cusi</surname><given-names>D</given-names></name><name><surname>Izzi</surname><given-names>C</given-names></name><name><surname>Scolari</surname><given-names>F</given-names></name><name><surname>van Wijk</surname><given-names>JAE</given-names></name><name><surname>Saraga</surname><given-names>M</given-names></name><name><surname>Santoro</surname><given-names>D</given-names></name><name><surname>Conti</surname><given-names>G</given-names></name><name><surname>Zamboli</surname><given-names>P</given-names></name><name><surname>White</surname><given-names>H</given-names></name><name><surname>Drozdz</surname><given-names>D</given-names></name><name><surname>Zachwieja</surname><given-names>K</given-names></name><name><surname>Miklaszewska</surname><given-names>M</given-names></name><name><surname>Tkaczyk</surname><given-names>M</given-names></name><name><surname>Tomczyk</surname><given-names>D</given-names></name><name><surname>Krakowska</surname><given-names>A</given-names></name><name><surname>Sikora</surname><given-names>P</given-names></name><name><surname>Jarmoliński</surname><given-names>T</given-names></name><name><surname>Borszewska-Kornacka</surname><given-names>MK</given-names></name><name><surname>Pawluch</surname><given-names>R</given-names></name><name><surname>Szczepanska</surname><given-names>M</given-names></name><name><surname>Adamczyk</surname><given-names>P</given-names></name><name><surname>Mizerska-Wasiak</surname><given-names>M</given-names></name><name><surname>Krzemien</surname><given-names>G</given-names></name><name><surname>Szmigielska</surname><given-names>A</given-names></name><name><surname>Zaniew</surname><given-names>M</given-names></name><name><surname>Dobson</surname><given-names>MG</given-names></name><name><surname>Darlow</surname><given-names>JM</given-names></name><name><surname>Puri</surname><given-names>P</given-names></name><name><surname>Barton</surname><given-names>DE</given-names></name><name><surname>Furth</surname><given-names>SL</given-names></name><name><surname>Warady</surname><given-names>BA</given-names></name><name><surname>Gucev</surname><given-names>Z</given-names></name><name><surname>Lozanovski</surname><given-names>VJ</given-names></name><name><surname>Tasic</surname><given-names>V</given-names></name><name><surname>Pisani</surname><given-names>I</given-names></name><name><surname>Allegri</surname><given-names>L</given-names></name><name><surname>Rodas</surname><given-names>LM</given-names></name><name><surname>Campistol</surname><given-names>JM</given-names></name><name><surname>Jeanpierre</surname><given-names>C</given-names></name><name><surname>Alam</surname><given-names>S</given-names></name><name><surname>Casale</surname><given-names>P</given-names></name><name><surname>Wong</surname><given-names>CS</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Miranda</surname><given-names>DM</given-names></name><name><surname>Oliveira</surname><given-names>EA</given-names></name><name><surname>Simões-E-Silva</surname><given-names>AC</given-names></name><name><surname>Barasch</surname><given-names>JM</given-names></name><name><surname>Levy</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>N</given-names></name><name><surname>Hildebrandt</surname><given-names>F</given-names></name><name><surname>Ghiggeri</surname><given-names>GM</given-names></name><name><surname>Latos-Bielenska</surname><given-names>A</given-names></name><name><surname>Materna-Kiryluk</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name><name><surname>Papaioannou</surname><given-names>VE</given-names></name><name><surname>Mendelsohn</surname><given-names>CL</given-names></name><name><surname>Gharavi</surname><given-names>AG</given-names></name><name><surname>Sanna-Cherchi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The copy number variation landscape of congenital anomalies of the kidney and urinary tract</article-title><source>Nature Genetics</source><volume>51</volume><fpage>117</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0281-y</pub-id><pub-id pub-id-type="pmid">30578417</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wade</surname><given-names>EM</given-names></name><name><surname>Jenkins</surname><given-names>ZA</given-names></name><name><surname>Morgan</surname><given-names>T</given-names></name><name><surname>Gimenez</surname><given-names>G</given-names></name><name><surname>Gibson</surname><given-names>H</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Sanchez Russo</surname><given-names>R</given-names></name><name><surname>Skraban</surname><given-names>CM</given-names></name><name><surname>Bedoukian</surname><given-names>E</given-names></name><name><surname>Robertson</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Exon skip-inducing variants in FLNA in an attenuated form of frontometaphyseal dysplasia</article-title><source>American Journal of Medical Genetics. Part A</source><volume>185</volume><fpage>3675</fpage><lpage>3682</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.62424</pub-id><pub-id pub-id-type="pmid">34272929</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title><source>Nucleic Acids Research</source><volume>38</volume><elocation-id>e164</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id><pub-id pub-id-type="pmid">20601685</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>De Marco</surname><given-names>P</given-names></name><name><surname>Merello</surname><given-names>E</given-names></name><name><surname>Drapeau</surname><given-names>P</given-names></name><name><surname>Capra</surname><given-names>V</given-names></name><name><surname>Kibar</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Role of the planar cell polarity gene protein tyrosine kinase 7 in neural tube defects in humans</article-title><source>Birth Defects Research Part A</source><volume>103</volume><fpage>1021</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1002/bdra.23422</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Taskesen</surname><given-names>E</given-names></name><name><surname>van Bochoven</surname><given-names>A</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Functional mapping and annotation of genetic associations with FUMA</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>1826</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01261-5</pub-id><pub-id pub-id-type="pmid">29184056</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>B</given-names></name><name><surname>Bonasera</surname><given-names>S</given-names></name><name><surname>Boxer</surname><given-names>A</given-names></name><name><surname>Karydas</surname><given-names>A</given-names></name><name><surname>Wilhelmsen</surname><given-names>KC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders</article-title><source>Archives of Neurology</source><volume>65</volume><fpage>1473</fpage><lpage>1478</lpage><pub-id pub-id-type="doi">10.1001/archneur.65.11.1473</pub-id><pub-id pub-id-type="pmid">19001166</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Mir</surname><given-names>S</given-names></name><name><surname>Schlingmann</surname><given-names>KP</given-names></name><name><surname>Nürnberg</surname><given-names>G</given-names></name><name><surname>Becker</surname><given-names>C</given-names></name><name><surname>Kara</surname><given-names>PE</given-names></name><name><surname>Ozkayin</surname><given-names>N</given-names></name><name><surname>Konrad</surname><given-names>M</given-names></name><name><surname>Nürnberg</surname><given-names>P</given-names></name><name><surname>Schaefer</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene locus ambiguity in posterior urethral valves/prune-belly syndrome</article-title><source>Pediatric Nephrology</source><volume>20</volume><fpage>1036</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.1007/s00467-005-1977-7</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Thiele</surname><given-names>H</given-names></name><name><surname>Mir</surname><given-names>S</given-names></name><name><surname>Toliat</surname><given-names>MR</given-names></name><name><surname>Sozeri</surname><given-names>B</given-names></name><name><surname>Reutter</surname><given-names>H</given-names></name><name><surname>Draaken</surname><given-names>M</given-names></name><name><surname>Ludwig</surname><given-names>M</given-names></name><name><surname>Altmüller</surname><given-names>J</given-names></name><name><surname>Frommolt</surname><given-names>P</given-names></name><name><surname>Stuart</surname><given-names>HM</given-names></name><name><surname>Ranjzad</surname><given-names>P</given-names></name><name><surname>Hanley</surname><given-names>NA</given-names></name><name><surname>Jennings</surname><given-names>R</given-names></name><name><surname>Newman</surname><given-names>WG</given-names></name><name><surname>Wilcox</surname><given-names>DT</given-names></name><name><surname>Thiel</surname><given-names>U</given-names></name><name><surname>Schlingmann</surname><given-names>KP</given-names></name><name><surname>Beetz</surname><given-names>R</given-names></name><name><surname>Hoyer</surname><given-names>PF</given-names></name><name><surname>Konrad</surname><given-names>M</given-names></name><name><surname>Schaefer</surname><given-names>F</given-names></name><name><surname>Nürnberg</surname><given-names>P</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Muscarinic acetylcholine receptor M3 mutation causes urinary bladder disease and a prune-belly-like syndrome</article-title><source>American Journal of Human Genetics</source><volume>89</volume><fpage>668</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2011.10.007</pub-id><pub-id pub-id-type="pmid">22077972</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C-HW</given-names></name><name><surname>Mann</surname><given-names>N</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Connaughton</surname><given-names>DM</given-names></name><name><surname>Dai</surname><given-names>R</given-names></name><name><surname>Kolvenbach</surname><given-names>CM</given-names></name><name><surname>Kause</surname><given-names>F</given-names></name><name><surname>Ottlewski</surname><given-names>I</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Klämbt</surname><given-names>V</given-names></name><name><surname>Seltzsam</surname><given-names>S</given-names></name><name><surname>Lai</surname><given-names>EW</given-names></name><name><surname>Selvin</surname><given-names>A</given-names></name><name><surname>Senguttuva</surname><given-names>P</given-names></name><name><surname>Bodamer</surname><given-names>O</given-names></name><name><surname>Stein</surname><given-names>DR</given-names></name><name><surname>El Desoky</surname><given-names>S</given-names></name><name><surname>Kari</surname><given-names>JA</given-names></name><name><surname>Tasic</surname><given-names>V</given-names></name><name><surname>Bauer</surname><given-names>SB</given-names></name><name><surname>Shril</surname><given-names>S</given-names></name><name><surname>Hildebrandt</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Phenotype expansion of heterozygous FOXC1 pathogenic variants toward involvement of congenital anomalies of the kidneys and urinary tract (CAKUT)</article-title><source>Genetics in Medicine</source><volume>22</volume><fpage>1673</fpage><lpage>1681</lpage><pub-id pub-id-type="doi">10.1038/s41436-020-0844-z</pub-id><pub-id pub-id-type="pmid">32475988</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Washington</surname><given-names>AM</given-names></name><name><surname>Domeniconi</surname><given-names>RF</given-names></name><name><surname>Ferreira Souza</surname><given-names>AC</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Sutherland</surname><given-names>A</given-names></name><name><surname>Hinton</surname><given-names>BT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Protein tyrosine kinase 7 is essential for tubular morphogenesis of the wolffian duct</article-title><source>Developmental Biology</source><volume>412</volume><fpage>219</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2016.02.029</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Santos</surname><given-names>SAA</given-names></name><name><surname>Hinton</surname><given-names>BT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Protein tyrosine kinase 7 regulates extracellular matrix integrity and mesenchymal intracellular RAC1 and myosin II activities during wolffian duct morphogenesis</article-title><source>Developmental Biology</source><volume>438</volume><fpage>33</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2018.03.011</pub-id><pub-id pub-id-type="pmid">29580943</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Nielsen</surname><given-names>JB</given-names></name><name><surname>Fritsche</surname><given-names>LG</given-names></name><name><surname>Dey</surname><given-names>R</given-names></name><name><surname>Gabrielsen</surname><given-names>ME</given-names></name><name><surname>Wolford</surname><given-names>BN</given-names></name><name><surname>LeFaive</surname><given-names>J</given-names></name><name><surname>VandeHaar</surname><given-names>P</given-names></name><name><surname>Gagliano</surname><given-names>SA</given-names></name><name><surname>Gifford</surname><given-names>A</given-names></name><name><surname>Bastarache</surname><given-names>LA</given-names></name><name><surname>Wei</surname><given-names>WQ</given-names></name><name><surname>Denny</surname><given-names>JC</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Hveem</surname><given-names>K</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies</article-title><source>Nature Genetics</source><volume>50</volume><fpage>1335</fpage><lpage>1341</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0184-y</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Nielsen</surname><given-names>JB</given-names></name><name><surname>Fritsche</surname><given-names>LG</given-names></name><name><surname>LeFaive</surname><given-names>J</given-names></name><name><surname>Gagliano Taliun</surname><given-names>SA</given-names></name><name><surname>Bi</surname><given-names>W</given-names></name><name><surname>Gabrielsen</surname><given-names>ME</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Hveem</surname><given-names>K</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Scalable generalized linear mixed model for region-based association tests in large biobanks and cohorts</article-title><source>Nature Genetics</source><volume>52</volume><fpage>634</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1038/s41588-020-0621-6</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Ho</surname><given-names>SS</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Pattni</surname><given-names>R</given-names></name><name><surname>Haraksingh</surname><given-names>RR</given-names></name><name><surname>Urban</surname><given-names>AE</given-names></name></person-group><year iso-8601-date="2016">2016c</year><article-title>Whole-genome sequencing analysis of CNV using low-coverage and paired-end strategies is efficient and outperforms array-based CNV analysis</article-title><source>Journal of Medical Genetics</source><volume>55</volume><fpage>735</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1136/jmedgenet-2018-105272</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><sec sec-type="appendix" id="s8"><title>Pathogenic/likely pathogenic variants identified in PUV cases</title><p>One individual was heterozygous for a pathogenic 1.5 Mb 17q12 deletion (affecting HNF1B) which has previously been associated with autosomal-dominant renal cysts and diabetes syndrome (RCAD, MIM 137920). Review of available clinical information revealed the presence of renal cysts, hypomagnesemia, and hypokalemia, which is consistent with HNF1B-related disease. There was no reported family history which is often seen since ~50% of whole gene deletions are de novo and there is variable expressivity. Identification of this variant was reported back to the clinical team for validation and to inform surveillance for additional manifestations (e.g., diabetes, hyperuricemia, autism) and screening of family members. Review of hospital records confirmed that this individual had undergone endoscopic valve ablation for PUV as an infant and therefore had two separate diagnoses with the 17q12 deletion not determined as causal for PUV.</p><p>Another individual with a diagnosis of PUV, ocular hypertension, neurodevelopmental delay, and autistic behavior was found to be heterozygous for a likely pathogenic missense variant FOXC1:c.379C&gt;T; p.(Arg127Cys). This variant has been previously reported in individuals with pediatric glaucoma (<xref ref-type="bibr" rid="bib41">Khalil et al., 2017</xref>) and heterozygous FOXC1 variants have been identified in individuals with syndromic CAKUT, one of whom had PUV (<xref ref-type="bibr" rid="bib96">Wu et al., 2020</xref>). After multi-disciplinary review of the available evidence, this variant was not thought to fully explain the patient’s phenotype.</p></sec></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74777.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Germino</surname><given-names>Gregory G</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2021.08.09.21261801" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2021.08.09.21261801"/></front-stub><body><p>Prior work has linked posterior urethral valves (PUV), a common cause of end stage renal disease in children, with chromosomal abnormalities and rare copy number variants, but the genetic causes of PUV remain incompletely defined. In this study, the authors have used a diverse ancestry whole-genome sequencing association study to identify two novel genes, <italic>TBX5</italic> and <italic>PTK7</italic>, and an enrichment of rare duplications and inversions affecting candidate <italic>cis</italic>-regulatory elements as possible causes of this condition. These findings represent the first robust genetic associations of PUV, provide the foundation for developing a mechanistic understanding of the cause of this condition, and demonstrate how a diverse ancestry seqGWAS can be used for disease locus discovery in a rare disease.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74777.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Germino</surname><given-names>Gregory G</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Flannick</surname><given-names>Jason</given-names></name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.08.09.21261801">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2021.08.09.21261801v2.full">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Diverse ancestry whole-genome sequencing association study identifies <italic>TBX5</italic> and <italic>PTK7</italic> as susceptibility genes for posterior urethral valves&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Martin Pollak as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Jason Flannick (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>As you can see from the detailed comments below, the reviewers were generally quite positive about the study but did have several issues they wanted addressed before acceptance. Through our consultation process, we came to a consensus that a satisfactory response to any one of the three items would be acceptable:</p><p>1. The authors provide more direct biological evidence showing that variants associated with PUV affect TBX5 or PTK7 expression while other nearby variants not associated with PUV do not; or that altering the expression of either gene results in GU abnormalities.</p><p>2. The authors provide stronger evidence in support of the PTK7 locus with more stringent analysis and more robust replication.</p><p>3. If it is not practically possible to provide stronger evidence in support of the PTK7 locus in a timely way, the authors should otherwise address the major concerns raised by Reviewer 2.</p><p>The reviewers have also made a number of other non-essential recommendations that they suggest you consider in your resubmission.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The genetic studies are well-done and provide a good basis for discovery of novel processes causing this important condition. The identification of TBX5 as a potential cause of PUV is particularly interesting given that other TBX genes have also been associated with CAKUT (which includes PUV). However, the study's conclusions would be greatly strengthened with experimental validation. Perhaps the authors could do CRISPR to the mesodermal cell line, introducing the variant associated with protection from PUV, and then show how this affects TBX5 and PTK7 expression. Or they could use the approach of Verbitsky et al. and characterize mouse models to show that variants in the putative genes result in a GU phenotype in males.</p><p>One trivial observation: the authors should explain the significance of the green arrow in Figure 2B that crosses the DNAse line. It wasn't obvious from either the text or the figure legend what this arrow was pointing to or indicating.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>1. The sample size is small for genetic discovery and more quantitative discussion of power limitations should be included in the discussion of limitations, mainly to help the readers understand what variant effects are detectable in the discovery phase. The power plot clearly demonstrates that the present design has limited power for variants with MAF&lt;0.01, and this should be discussed especially in the context of the PTK7 locus.</p><p>2. PheWAS findings from the UK Biobank for TBX5 locus are interesting, providing independent validation of the role of this gene in urogenital development. It would be helpful to include a PheWAS plot and mention if there are any non-urogenital associations (e.g. cardiac phenotypes, limb defects, other).</p><p>3. Gene-based burden tests were largely negative but it would be helpful to see QQ plots and the assessment of genomic inflation (with sample size correction).</p><p>4. Page 12 Line 182 &quot;the two variants were not in strong linkage disequilibrium (LD; r2 183 = 0.54).&quot; Please state ancestral population used whenever providing LD estimates.</p><p>5. Some of the discussion language comes across as too strong given the small size of the case cohort. For example, I would suggest changing more general statements such as &quot;monogenic causes of PUV are not a common feature&quot; to be more specific by adding &quot;known monogenic causes&quot; and &quot;in our cohort&quot;. In my opinion, limited sample size of this study precludes these more general conclusions. There may be unknown Monogenic causes in the cohorts that the authors are unable to identify.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>This paper is well-written, and the analysis approach is very strong. Overall I have very few objections to anything in the manuscript. Here are a few suggestions that the authors could consider that I think would further increase the impact of this work:</p><p>1. I found the background on what is known about the genetic architecture of PUV to be a bit cursory. I think the introduction indicates that a monogenic eitiology of PUV has not been identified. Does this mean that no genes have been implicated in the disease? Or have some cases been solved but others remain to be solved? What is the inheritance pattern? Is it Mendelian or complex? A clearer description would better motivate the GWAS as the appropriate study design.</p><p>2. I felt that the motivation for replication study was a little unclear. If the cases were matched to controls in the 100KGP, why weren't they included from the start? Were the matched controls intentionally held out of the discovery analysis? Was it just chance that the best matches for the replication controls happened not to be included in the discovery study?</p><p>3. I didn't find a discussion as to how much of the genetic basis of PUV were explained by the new variants. This is related to point #1 above. Are there now &quot;solved&quot; cases? Or are these just risk factors in the population? How much heritability is explained by them? How big of an impact do they have in understanding the basis of PUV?</p><p>4. The conclusion that monogenic causes of PUV are rare does not follow in my opinion from the lack of significant burden test results. Monogenic causes could exist but not produce significant associations due to power issues or due to the inclusion of too many benign variants. Conversely, burden test results may not reveal monogenic causes but instead just moderate effect variants (most burden test results to date are for common diseases). I think these conclusions need to be more carefully worded, or their logic needs to be more clearly spelled out.</p><p>5. I didn't understand the impact of the genome-wide SV analyses. I think I follow that previous studies have shown a role for SVs in disease. But global enrichments, or even enrichments across all cREs, seem to tell us so little about disease. I think the model for this analysis, and what it tells us about disease beyond a broad enrichment, needs to be more clearly spelled out. At minimum, how much of the genetic basis of PUV is explained by these variants? And, ideally, what implications does it have for how we might diagnose or treat PUV?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74777.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>The genetic studies are well-done and provide a good basis for discovery of novel processes causing this important condition. The identification of TBX5 as a potential cause of PUV is particularly interesting given that other TBX genes have also been associated with CAKUT (which includes PUV). However, the study's conclusions would be greatly strengthened with experimental validation.</p></disp-quote><p>We would like to thank the reviewer for their comments regarding the robustness of the genetic associations and bioinformatic approaches used. Whilst we appreciate that this manuscript does not include in vitro or in vivo functional experiments, we have shown a clear statistically significant difference between individuals with PUV and an ancestry-matched control population, which we have replicated in an independent cohort. The strength of this study lies in its statistical robustness and whilst we agree that functional experiments will certainly be necessary to better understand the biological mechanisms underpinning these findings, these will be the focus of subsequent work. We have clearly stated this as a limitation of the study on page 23, lines 524-527.</p><disp-quote content-type="editor-comment"><p>Perhaps the authors could do CRISPR to the mesodermal cell line, introducing the variant associated with protection from PUV, and then show how this affects TBX5 and PTK7 expression. Or they could use the approach of Verbitsky et al. and characterize mouse models to show that variants in the putative genes result in a GU phenotype in males.</p></disp-quote><p>Thank you for these very useful suggestions. We envisage that publication of these statistically robust genetic findings will catalyze further mechanistic studies such as those mentioned by the reviewer above by both us and other groups in the field, but such experiments would likely be the subject of a subsequent manuscript. However, we would like to emphasise again, that ours is an association study and we therefore do not describe a Mendelian disorder, in which rare and highly penetrant variants cause a specific disorder. Rather, the statistically significant enrichment in the cases compared to controls of the variants in our study imply that these variants provide a susceptibility for developing PUV but are not causative on their own. This clearly complicates mechanistic studies, which is why we believe, that they will constitute subsequent work.</p><p>With regards to evidence in support of these genes causing a genitourinary phenotype, we have added additional phenotypic detail from the published literature to the discussion (page 19-20, line 445-449) that show that mesoderm-specific conditional deletion of <italic>Ptk7</italic> in mice results in genitourinary abnormalities (Xu et al. 2016; Xu, Santos, and Hinton 2018). Furthermore, the PheWAS data detailed on page 13, lines 290-300 provide independent validation of a role for <italic>TBX5</italic> in lower urinary tract phenotypes in humans.</p><disp-quote content-type="editor-comment"><p>One trivial observation: the authors should explain the significance of the green arrow in Figure 2B that crosses the DNAse line. It wasn't obvious from either the text or the figure legend what this arrow was pointing to or indicating.</p></disp-quote><p>In Figure 3, there is a green box signifying a <italic>cis</italic>-regulatory element underneath the green DNase signal plot which we believe the reviewer may have mistaken for an arrow. This may be a formatting issue and we will confirm the final figure is clear before publication.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1. The sample size is small for genetic discovery and more quantitative discussion of power limitations should be included in the discussion of limitations, mainly to help the readers understand what variant effects are detectable in the discovery phase. The power plot clearly demonstrates that the present design has limited power for variants with MAF&lt;0.01, and this should be discussed especially in the context of the PTK7 locus.</p></disp-quote><p>A more detailed comment on the power limitations of the study has been added to the discussion of limitations as suggested (page 22, line 514-517).</p><disp-quote content-type="editor-comment"><p>2. PheWAS findings from the UK Biobank for TBX5 locus are interesting, providing independent validation of the role of this gene in urogenital development. It would be helpful to include a PheWAS plot and mention if there are any non-urogenital associations (e.g. cardiac phenotypes, limb defects, other).</p></disp-quote><p>This has been added as Figure 7. No non-urogenital associations were detected with this variant which has been added to the results (page 13, line 297-300).</p><disp-quote content-type="editor-comment"><p>3. Gene-based burden tests were largely negative but it would be helpful to see QQ plots and the assessment of genomic inflation (with sample size correction).</p></disp-quote><p>The Q-Q plot for the rare variant gene burden analysis has been added as Figure 9 – supplemental figure 1. When the case:control ratio is very unbalanced (as in this analysis), the allele counts in cases for rare variants can be very low and the association tests lack power resulting in a deflation at the bottom left corner of the QQ plot. For this reason, the genomic inflation factor (<inline-formula><mml:math id="sa2m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>λ</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula>) can be unreliable and we suggest it would not add any useful additional information to the interpretation of the results in this context, especially in the absence of any significant results.</p><disp-quote content-type="editor-comment"><p>4. Page 12 Line 182 &quot;the two variants were not in strong linkage disequilibrium (LD; r2 183 = 0.54).&quot; Please state ancestral population used whenever providing LD estimates.</p></disp-quote><p>This has been added to the manuscript on page 9, lines 193-194.</p><disp-quote content-type="editor-comment"><p>5. Some of the discussion language comes across as too strong given the small size of the case cohort. For example, I would suggest changing more general statements such as &quot;monogenic causes of PUV are not a common feature&quot; to be more specific by adding &quot;known monogenic causes&quot; and &quot;in our cohort&quot;. In my opinion, limited sample size of this study precludes these more general conclusions. There may be unknown Monogenic causes in the cohorts that the authors are unable to identify.</p></disp-quote><p>We appreciate the reviewer’s point, although would reply that we have simply stated that monogenic causes of PUV are not a ‘common feature’ and there are indeed no proven Mendelian monogenic causes of non-syndromic PUV that have been identified. We have however moderated some of the language as suggested in the Results (page 14, line 318 and line 321, and page 15, lines 336-338) and Discussion (page 17, line 382-383; page 22, lines 514-517).</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>This paper is well-written, and the analysis approach is very strong. Overall I have very few objections to anything in the manuscript. Here are a few suggestions that the authors could consider that I think would further increase the impact of this work:</p><p>1. I found the background on what is known about the genetic architecture of PUV to be a bit cursory. I think the introduction indicates that a monogenic eitiology of PUV has not been identified. Does this mean that no genes have been implicated in the disease? Or have some cases been solved but others remain to be solved? What is the inheritance pattern? Is it Mendelian or complex? A clearer description would better motivate the GWAS as the appropriate study design.</p></disp-quote><p>Many thanks for highlighting this, we have expanded and clarified the background section as suggested (page 4, lines 74-93).</p><disp-quote content-type="editor-comment"><p>2. I felt that the motivation for replication study was a little unclear. If the cases were matched to controls in the 100KGP, why weren't they included from the start? Were the matched controls intentionally held out of the discovery analysis? Was it just chance that the best matches for the replication controls happened not to be included in the discovery study?</p></disp-quote><p>We have clarified this in the methods section (Page 29, lines 674-692). The 100KGP consists of two main cohorts: cancer patients and rare disease patients and their families. The control population used for the discovery cohort were the unaffected relatives of participants recruited to the 100KGP with non-renal rare diseases. Given this was &gt; 20,000 individuals, there was no appreciable increase in power by addition of more controls from the cancer arm of the 100KGP. For the replication study, we used the ~10,000 additional EUR patients who had been recruited to the 100KGP with non-renal or urinary tract adult-onset cancer (but had not been used in the discovery stage).</p><disp-quote content-type="editor-comment"><p>3. I didn't find a discussion as to how much of the genetic basis of PUV were explained by the new variants. This is related to point #1 above. Are there now &quot;solved&quot; cases? Or are these just risk factors in the population? How much heritability is explained by them? How big of an impact do they have in understanding the basis of PUV?</p></disp-quote><p>We thank the reviewer for pointing this out and have added a paragraph regarding what these results indicate for the genetic basis of PUV to the discussion (page 21, line 494--502). Unfortunately, the cohort size is too small to produce a reliable estimate of SNP-heritability: we did use GCTA’s GREML-LDMS approach to estimate the <italic>observed</italic> narrow-sense heritability attributable to variants with MAF &gt; 0.1% to be 0.31 (SE 0.05) in the European subset of the cohort. However, with the small sample size and low disease prevalence this cannot be transformed reliably onto the liability scale which would allow comparison with other cohorts. For this reason, we made the decision not to include these data in the manuscript.</p><disp-quote content-type="editor-comment"><p>4. The conclusion that monogenic causes of PUV are rare does not follow in my opinion from the lack of significant burden test results. Monogenic causes could exist but not produce significant associations due to power issues or due to the inclusion of too many benign variants. Conversely, burden test results may not reveal monogenic causes but instead just moderate effect variants (most burden test results to date are for common diseases). I think these conclusions need to be more carefully worded, or their logic needs to be more clearly spelled out.</p></disp-quote><p>We appreciate the reviewer’s comments and have moderated our discussion of the rare variant burden analysis in the Results section and discussion.</p><disp-quote content-type="editor-comment"><p>5. I didn't understand the impact of the genome-wide SV analyses. I think I follow that previous studies have shown a role for SVs in disease. But global enrichments, or even enrichments across all cREs, seem to tell us so little about disease. I think the model for this analysis, and what it tells us about disease beyond a broad enrichment, needs to be more clearly spelled out. At minimum, how much of the genetic basis of PUV is explained by these variants? And, ideally, what implications does it have for how we might diagnose or treat PUV?</p></disp-quote><p>Please see response to Reviewer 2 – major point 3: we have stressed the hypothesis generating and exploratory nature of these analyses in the discussion (page 21, lines 491-493) and suggest that ‘ non-specific perturbation of long-range regulatory networks or TADs could manifest as PUV, perhaps due to sensitivity of integration of the mesonephric duct into the posterior urethra to even minor abnormalities of gene expression’. Given the exploratory nature of these analyses we think it would be premature to draw any more concrete conclusions regarding heritability, diagnosis, and treatment.</p><p>References</p><p>Gimelli, Stefania, Gianluca Caridi, Silvana Beri, Kyle McCracken, Renata Bocciardi, Paola Zordan, Monica Dagnino, et al. 2010. “Mutations in SOX17 Are Associated with Congenital Anomalies of the Kidney and the Urinary Tract.” Human Mutation 31 (12): 1352–59.</p><p>Krishnan, Anand, Antonio de Souza, Rama Konijeti, and Laurence S. Baskin. 2006. “The Anatomy and Embryology of Posterior Urethral Valves.” The Journal of Urology 175 (4): 1214–20.</p><p>Ober, Carole, Dagan A. Loisel, and Yoav Gilad. 2008. “Sex-Specific Genetic Architecture of Human Disease.” Nature Reviews. Genetics 9 (12): 911–22.</p><p>Ruf, Rainer G., Pin-Xian Xu, Derek Silvius, Edgar A. Otto, Frank Beekmann, Ulla T. Muerb, Shrawan Kumar, et al. 2004. “SIX1 Mutations Cause Branchio-Oto-Renal Syndrome by Disruption of EYA1-SIX1-DNA Complexes.” Proceedings of the National Academy of Sciences of the United States of America 101 (21): 8090–95.</p><p>Sanna-Cherchi, Simone, Rosemary V. Sampogna, Natalia Papeta, Katelyn E. Burgess, Shannon N. Nees, Brittany J. Perry, Murim Choi, et al. 2013. “Mutations in DSTYK and Dominant Urinary Tract Malformations.” The New England Journal of Medicine 369 (7): 621–29.</p><p>Shin, Jimin, and Chaeyoung Lee. 2015. “A Mixed Model Reduces Spurious Genetic Associations Produced by Population Stratification in Genome-Wide Association Studies.” Genomics 105 (4): 191–96.</p><p>Xu, Bingfang, Sérgio A. A. Santos, and Barry T. Hinton. 2018. “Protein Tyrosine Kinase 7 Regulates Extracellular Matrix Integrity and Mesenchymal Intracellular RAC1 and Myosin II Activities during Wolffian Duct Morphogenesis.” Developmental Biology 438 (1): 33–43.</p><p>Xu, Bingfang, Angela M. Washington, Raquel Fantin Domeniconi, Ana Cláudia Ferreira Souza, Xiaowei Lu, Ann Sutherland, and Barry T. Hinton. 2016. “Protein Tyrosine Kinase 7 Is Essential for Tubular Morphogenesis of the Wolffian Duct.” Developmental Biology 412 (2): 219–33.</p><p>Yang, Jian, the GIANT Consortium, Michael N. Weedon, Shaun Purcell, Guillaume Lettre, Karol Estrada, Cristen J. Willer, et al. 2011. “Genomic Inflation Factors under Polygenic Inheritance.” European Journal of Human Genetics: EJHG 19 (7): 807–12.</p></body></sub-article></article>